| For: | Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13(17): 2436-2441 [PMID: 17552026 DOI: 10.3748/wjg.v13.i17.2436] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2436.htm |
| Number | Citing Articles |
| 1 |
Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Hepatology 2011; 53(4) doi: 10.1002/hep.24169
|
| 2 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 3 |
Alexandra Wimmer, János Fehér, Gabriella Lengyel. Successful clearing of hepatitis C virus after liver lobectomy in a patient with hepatocellular carcinoma. Orvosi Hetilap 2008; 149(45) doi: 10.1556/oh.2008.28489
|
| 4 |
Laura Waley, Laura McManus. Tackling Students’ Attitudes Towards Substance Use Disorders. Academic Psychiatry 2017; 41(4) doi: 10.1007/s40596-017-0747-8
|
| 5 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers 2023; 15(20) doi: 10.3390/cancers15204993
|
| 6 |
Nabeen C. Nayak. Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesis. Current Medicine Research and Practice 2014; 4(2) doi: 10.1016/j.cmrp.2014.03.003
|
| 7 |
R. Bahsi, Z. Dogan, N. Taser, M. N. Aktas, L. Filik. Acute cor pulmonale: an unusual presentation of hepatocellular carcinoma. Acta Clinica Belgica 2015; 70(1) doi: 10.1179/2295333714Y.0000000071
|
| 8 |
Geraldo Duarte, Paula Pezzuto, Tiago Dahrug Barros, Gláucio Mosimann Junior, Flor Ernestina Martínez-Espinosa. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: hepatites virais. Epidemiologia e Serviços de Saúde 2021; 30(spe1) doi: 10.1590/s1679-4974202100016.esp1
|
| 9 |
Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients. Journal of Interferon & Cytokine Research 2015; 35(8) doi: 10.1089/jir.2014.0137
|
| 10 |
Aaditya Bhatt, K.R. Gurukumar, Amartya Basu, Maulik R. Patel, Neerja Kaushik-Basu, Tanaji T. Talele. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition. European Journal of Medicinal Chemistry 2011; 46(10) doi: 10.1016/j.ejmech.2011.08.028
|
| 11 |
Lyuba Azbel, Jeffrey A. Wickersham, Yevgeny Grishaev, Sergey Dvoryak, Frederick L. Altice, Joan A. Caylà. Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the Community. PLoS ONE 2013; 8(3) doi: 10.1371/journal.pone.0059643
|
| 12 |
Itatiana F. Rodart, Madalena M. Pares, Aline Mendes, Camila M. Accardo, João R. M. Martins, Cleidenice B. Silva, Fabrício O. Carvalho, José A. Barreto, Mitermayer G. Reis, Ivarne L. S. Tersariol, Helena B. Nader. Diagnostic Accuracy of Serum Hyaluronan for Detecting HCV Infection and Liver Fibrosis in Asymptomatic Blood Donors. Molecules 2021; 26(13) doi: 10.3390/molecules26133892
|
| 13 |
Pietro Torre, Mariano Festa, Tommaso Sarcina, Mario Masarone, Marcello Persico. Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years. Viruses 2024; 16(11) doi: 10.3390/v16111792
|
| 14 |
E. Papasavvas, L. Azzoni, X. Yin, Q. Liu, J. Joseph, A. Mackiewicz, B. Ross, K. M. Lynn, J. M. Jacobson, K. Mounzer, J. R. Kostman, L. J. Montaner. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy‐treated HIV/HCV‐co‐infected subjects. Journal of Viral Hepatitis 2017; 24(10) doi: 10.1111/jvh.12714
|
| 15 |
M. F. Bassendine, D. A. Sheridan, S. H. Bridge, D. J. Felmlee, R. D. G. Neely. Lipids and HCV. Seminars in Immunopathology 2013; 35(1) doi: 10.1007/s00281-012-0356-2
|
| 16 |
Urwa Nasir, Akash John, Nasir Ameen, Miss Sehrish, Amina Sharif Bhatti. Assessment of Knowledge Regarding Hepatitis C Transmission, Treatment, and Vaccination among Health Care Providers. Pakistan BioMedical Journal 2022; doi: 10.54393/pbmj.v5i4.376
|
| 17 |
Hiam Chemaitelly, Sarwat Mahmud, Ghina R. Mumtaz, Lenka Benova, Houssein H. Ayoub, Silva P. Kouyoumjian, Zaina Al-Kanaani, Laith J. Abu-Raddad. Handbook of Healthcare in the Arab World. 2021; doi: 10.1007/978-3-030-36811-1_138
|
| 18 |
Mitchell L. Shiffman, Nadege T. Gunn. Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy. Current Hepatology Reports 2017; 16(3) doi: 10.1007/s11901-017-0352-z
|
| 19 |
N. Palmateer, S. Hutchinson, G. McAllister, A. Munro, S. Cameron, D. Goldberg, A. Taylor. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross‐sectional survey data. Journal of Viral Hepatitis 2014; 21(1) doi: 10.1111/jvh.12117
|
| 20 |
Mehlayl Tariq, Abu Bakar Shoukat, Sedrah Akbar, Samaia Hameed, Muniba Zainab Naqvi, Ayesha Azher, Muhammad Saad, Muhammad Rizwan, Muhammad Nadeem, Anum Javed, Asad Ali, Shahid Aziz. Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection. SAGE Open Medicine 2022; 10 doi: 10.1177/20503121221105957
|
| 21 |
Irene Vafiadis, Panagiotis Trilianos, Jiannis Vlachogiannakos, Markisia Karagiorga, Antonia Hatziliami, Ersi Voskaridou, Spiros D. Ladas. Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit. Annals of Hepatology 2013; 12(4) doi: 10.1016/S1665-2681(19)31336-5
|
| 22 |
Saira Munir, Sana Saleem, Muhammad Idrees, Aaliyah Tariq, Sadia Butt, Bisma Rauff, Abrar Hussain, Sadaf Badar, Mahrukh Naudhani, Zareen Fatima, Muhmmad Ali, Liaqat Ali, Madiha Akram, Mahwish Aftab, Bushra Khubaib, Zunaira Awan. Hepatitis C Treatment: current and future perspectives. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-296
|
| 23 |
Yong-Yuan Zhang, Bai-Hua Zhang, Koji Ishii, T. Jake Liang. Novel Function of CD81 in Controlling Hepatitis C Virus Replication. Journal of Virology 2010; 84(7) doi: 10.1128/JVI.02391-09
|
| 24 |
Garrick K. Wilson, Zania Stamataki. In Vitro Systems for the Study of Hepatitis C Virus Infection. International Journal of Hepatology 2012; 2012 doi: 10.1155/2012/292591
|
| 25 |
Alina M. Allen, W. Ray Kim, James P. Moriarty, Nilay D. Shah, Joseph J. Larson, Patrick S. Kamath. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology 2016; 64(6) doi: 10.1002/hep.28812
|
| 26 |
Jing-Hong Hu, Mei-Yen Chen, Chau-Ting Yeh, Wen-Nan Chiu, Ming-shih Chiang, Ming-Ling Chang. Effects of gender and age on prevalence of cholelithiasis in patients with chronic HCV infection. Medicine 2018; 97(22) doi: 10.1097/MD.0000000000010846
|
| 27 |
Xianfeng Li, Yang Liu, Yong-Kang Zhang, Jacob J. Plattner, Stephen J. Baker, Wei Bu, Liang Liu, Yasheen Zhou, Charles Z. Ding, Suoming Zhang, Wieslaw M. Kazmierski, Robert Hamatake, Maosheng Duan, Lois L. Wright, Gary K. Smith, Richard L. Jarvest, Jing-Jing Ji, Joel P. Cooper, Matthew D. Tallant, Renae M. Crosby, Katrina Creech, Amy Wang. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups. Bioorganic & Medicinal Chemistry Letters 2012; 22(24) doi: 10.1016/j.bmcl.2012.10.075
|
| 28 |
Cara S. Kosack, Sigrid Nick, Leslie Shanks. Diagnostic accuracy evaluation of the ImmunoFlow HCV rapid immunochromatographic test for the detection of hepatitis C antibodies. Journal of Virological Methods 2014; 204 doi: 10.1016/j.jviromet.2014.03.012
|
| 29 |
Sergio Cortelazzo, Andrés Ferreri, Dieter Hoelzer, Maurilio Ponzoni. Lymphoblastic lymphoma. Critical Reviews in Oncology/Hematology 2017; 113 doi: 10.1016/j.critrevonc.2017.03.020
|
| 30 |
Camila Rodrigues Bressane Cruz, Miriam Matsura Shirassu, Wellington P. Martins. Comparação do perfil epidemiológico das hepatites B e C em um serviço público de São Paulo. Arquivos de Gastroenterologia 2009; 46(3) doi: 10.1590/S0004-28032009000300016
|
| 31 |
Tatsuya Aikawa, Maki Kojima, Kuniko Miyamoto, Chisato Ueno, Masaharu Takahashi, Hiroaki Okamoto. A case of acute hepatitis C, most likely by interspousal sexual transmission after 40 years of marriage. Kanzo 2008; 49(8) doi: 10.2957/kanzo.49.352
|
| 32 |
Shih-Yi Lin, Cheng-Li Lin, Shu-Woei Ju, I-Kuan Wang, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Ji-An Liang, Tatsuo Kanda. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0173125
|
| 33 |
Muhammad Ali, Irshad Ur Rehman, Muhammad Idrees. Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan. Virus Genes 2014; 48(3) doi: 10.1007/s11262-014-1047-y
|
| 34 |
Don C Des Jarlais, Jonathan P Feelemyer, Shilpa N Modi, Abu Abdul-Quader, Holly Hagan. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health 2013; 13(1) doi: 10.1186/1471-2458-13-53
|
| 35 |
Fawad Karim, Abu Nasar, Ibrar Alam, Iftikhar Alam, Said Hassan, Rahmat Gul, Sana Ullah, Muhammad Rizwan. Incidence of Active HCV infection amongst Blood Donors of Mardan District, Pakistan. Asian Pacific Journal of Cancer Prevention 2016; 17(1) doi: 10.7314/APJCP.2016.17.1.235
|
| 36 |
Ching-Chih Hu, Chih-Lang Lin, Liang-Che Chang, Cheng-Hung Chien, Li-Wei Chen, Ching-Jung Liu, Rong-Nan Chien. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0888-x
|
| 37 |
F. DeWolfe Miller, Laith J. Abu-Raddad. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the National Academy of Sciences 2010; 107(33) doi: 10.1073/pnas.1008877107
|
| 38 |
Eslam Saber Esmail, Fat-heyah Elsayed Asal, Mohammed Yussif, Asem Ahmed Elfert. Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatment. Arab Journal of Gastroenterology 2015; 16(3-4) doi: 10.1016/j.ajg.2015.09.012
|
| 39 |
Abdallah M. AlQaraawi, Faisal M. Sanai, Hussa Al-Husseini, Ali Albenmousa, Abdulmalik AlSheikh, Lubna Rizwan Ahmed, Ahmad Hersi, Molfi M. Al-Otaibi, Mohammed Syed, Safiyya M. Ali, Waleed Al-hamoudi, Khalid A. Alswat, Ayman A. Abdo. Prevalence and Impact of Hepatic Steatosis on the Response to Antiviral Therapy in Saudi Patients with Genotypes 1 and 4 Chronic Hepatitis C. Digestive Diseases and Sciences 2011; 56(4) doi: 10.1007/s10620-010-1417-9
|
| 40 |
Zeze Th. Atwa, Wafaa Y. Abdel Wahed. Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factors. Journal of Infection and Public Health 2017; 10(6) doi: 10.1016/j.jiph.2017.02.012
|
| 41 |
Desta Ayana, Gadissa Gutema, Atsbeha Gebreegziabxier, Hana Mekonnen Shewangizaw, Tolewak sura, Gebremedhin Gebremicael, Dereje Leta, Getachew Tollera, Regasa Diriba, Kassu Desta Tulu, John F. Dillon. Seroprevalence and viremia of hepatitis C virus among HIV-infected patients on ART with unsuppressed HIV viral load in Ethiopia. AIDS Research and Therapy 2026; 23(1) doi: 10.1186/s12981-026-00884-3
|
| 42 |
Sofia Lourenço, Sébastien Boni, Denis Furling, François-Loïc Cosset, Annie Cahour. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site. Journal of Virological Methods 2009; 158(1-2) doi: 10.1016/j.jviromet.2009.02.007
|
| 43 |
Gabriele Aquery, Newton S. de Carvalho. Seroprevalence of hepatitis C antibodies in pregnant women in the state of Paraná, Brazil. Clinics 2026; 81 doi: 10.1016/j.clinsp.2026.100978
|
| 44 |
Paul Targett-Adams, Steeve Boulant, Mark W. Douglas, John McLauchlan. Lipid Metabolism and HCV Infection. Viruses 2010; 2(5) doi: 10.3390/v2051195
|
| 45 |
Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis. The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease. Journal of Viral Hepatitis 2018; 25(S3) doi: 10.1111/jvh.13005
|
| 46 |
Maria Stepanova, Fasiha Kanwal, Hashem B. El-Serag, Zobair M. Younossi. Insurance Status and Treatment Candidacy of Hepatitis C Patients: Analysis of Population-Based Data From the United States Δσ. Hepatology 2011; 53(3) doi: 10.1002/hep.24131
|
| 47 |
Udayan Chatterji, Michael Bobardt, Andrew Tai, Malcolm Wood, Philippe A. Gallay. Cyclophilin and NS5A Inhibitors, but Not Other Anti-Hepatitis C Virus (HCV) Agents, Preclude HCV-Mediated Formation of Double-Membrane-Vesicle Viral Factories. Antimicrobial Agents and Chemotherapy 2015; 59(5) doi: 10.1128/AAC.04958-14
|
| 48 |
Seyed Moayed Alavian. Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis C. Journal of Skin and Stem Cell 2014; 1(1) doi: 10.17795/jssc16639
|
| 49 |
Müge Toygar Deniz, Sıla Akhan, Murat Sayan, Gülden Sönmez Tamer, Emel Azak. Evaluation of HCV-Core Antigen in Diagnosis of Chronic Hepatitis C Patients under Direct-Acting Antiviral Treatment. Viral Hepatitis Journal 2022; 28(1) doi: 10.4274/vhd.galenos.2022.2021-3-2
|
| 50 |
Korra Bhanu Teja, Sridivya Bhagavatula, Aishwarya Bhatta, Shilpa J. Tomar. Emerging Human Viral Diseases, Volume II. 2024; doi: 10.1007/978-981-97-4480-0_20
|
| 51 |
Stephanie E. Perrett, Noel Craine, Marion Lyons. Developing blood borne virus services across prisons in Wales, UK. International Journal of Prisoner Health 2013; 9(1) doi: 10.1108/17449201311310788
|
| 52 |
Sandhya Sharma, Emmanuel Thomas, Massimo Caputi, Waseem Asghar. RT-LAMP-Based Molecular Diagnostic Set-Up for Rapid Hepatitis C Virus Testing. Biosensors 2022; 12(5) doi: 10.3390/bios12050298
|
| 53 |
Shilpi Bisht, Neeraj Bisht, Bishwajeet Pandey, Vedant Patil, Sonalika Srivastava, Anshul Srivastava. Optimizing HCV Diagnosis and Hospital Resource Management Using Machine Learning Techniques. 2024 3rd Edition of IEEE Delhi Section Flagship Conference (DELCON) 2024; doi: 10.1109/DELCON64804.2024.10866596
|
| 54 |
Liang-Jen Wang, Shuo-Wei Chen, Chih-Ken Chen, Cho-Li Yen, Jia-Jang Chang, Tsung-Shih Lee, Ching-Jung Liu, Li-Wei Chen, Rong-Nan Chien. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C. BMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1135-8
|
| 55 |
Chang Ho Lee, Seung Ryul Han, Seong‐Wook Lee. Therapeutic applications of group I intron‐based trans‐splicing ribozymes. WIREs RNA 2018; 9(3) doi: 10.1002/wrna.1466
|
| 56 |
Fiona Fonseca, Bijal Kulkarni, Meenal Hastak, Vinay Kumaran, Vibha Varma, Sorabh Kapoor. An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western India. Annals of Hepatology 2018; 17(3) doi: 10.5604/01.3001.0011.7387
|
| 57 |
Safak Kaya, Selcuk Aksoz, Birol Baysal, Nurettin Ay, Ramazan Danis. Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patients. Infectious Diseases 2015; 47(9) doi: 10.3109/23744235.2015.1034769
|
| 58 |
Mary E. Mackesy-Amiti, Lorna Finnegan, Lawrence J. Ouellet, Elizabeth T. Golub, Holly Hagan, Sharon M. Hudson, Mary H. Latka, Richard S. Garfein. Peer-Education Intervention to Reduce Injection Risk Behaviors Benefits High-Risk Young Injection Drug Users: A Latent Transition Analysis of the CIDUS 3/DUIT Study. AIDS and Behavior 2013; 17(6) doi: 10.1007/s10461-012-0373-0
|
| 59 |
Daniel Fuster, Arantza Sanvisens, Ferran Bolao, Inmaculada Rivas, Jordi Tor, Robert Muga. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World Journal of Hepatology 2016; 8(31): 1295-1308 doi: 10.4254/wjh.v8.i31.1295
|
| 60 |
Pierre van Damme, Koen Van Herck, Peter Michielsen, Sven Francque, Daniel Shouval. Oxford Textbook of Public Health. 2009; doi: 10.1093/med/9780199218707.003.0073
|
| 61 |
Dimitrios Vassilopoulos, Leonard H Calabrese. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Current Opinion in Rheumatology 2007; 19(6) doi: 10.1097/BOR.0b013e3282f05b63
|
| 62 |
Anuj Sharma, Sharanjit Kaur, Neeraj Sharma. PERCUTANEOUS ROUTE AS A RISK FACTOR FOR SEROPOSITIVITY OF HEPATITIS C VIRUS INFECTION. Journal of Evolution of Medical and Dental Sciences 2015; 4(05) doi: 10.14260/jemds/2015/121
|
| 63 |
Syed‐Mohammed Jafri, Stuart C. Gordon. Epidemiology of Hepatitis C. Clinical Liver Disease 2018; 12(5) doi: 10.1002/cld.783
|
| 64 |
Mohamed Elbadry, Noha Eltaweel. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00008-1
|
| 65 |
Ivan Gentile, Maria Aurora Carleo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia. The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus. Expert Opinion on Investigational Drugs 2010; 19(1) doi: 10.1517/13543780903501505
|
| 66 |
Céline Miroux, Thibaut Vausselin, Nadira Delhem. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opinion on Biological Therapy 2010; 10(11) doi: 10.1517/14712598.2010.529125
|
| 67 |
Nazira El-Hage, Seth M. Dever, Sylvia Fitting, Tasrif Ahmed, Kurt F. Hauser. HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host Defenses. Journal of Virology 2011; 85(22) doi: 10.1128/JVI.05239-11
|
| 68 |
Farzin Khorvash, Behrooz Ataei, Zahra Baghersad, Zahra Boroumandfar. Effectiveness of the Educational-Supportive Program to Improve the Quality of Life Among Patients with Hepatitis C virus (HCV): A Quasi-Experimental Study. Jundishapur Journal of Health Sciences 2022; 14(2) doi: 10.5812/jjhs-121626
|
| 69 |
Feifei Lei, Xu Lei, Rugui Li, Huabing Tan. Microcystin-LR in peripheral circulation worsens the prognosis partly through oxidative stress in patients with hepatocellular carcinoma. Clinical and Experimental Medicine 2019; 19(2) doi: 10.1007/s10238-019-00550-1
|
| 70 |
Liliane Hobeika, Monica Srivastava, Mai Vo, Marie D. Philipneri, David S. Brink, Nadia Wasi, Krista L. Lentine. Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infection. CEN Case Reports 2012; 1(1) doi: 10.1007/s13730-012-0008-3
|
| 71 |
Yousra A Mohamoud, Ghina R Mumtaz, Suzanne Riome, DeWolfe Miller, Laith J Abu-Raddad. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-288
|
| 72 |
Sepideh Nasimzadeh, Azarakhsh Azaran, Shahram Jalilian, Manoochehr Makvandi, Seyed Saeid Seyedian, Bijan keikhaei, Fateme Jahangiri Mehr. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran. Archives of Virology 2021; 166(10) doi: 10.1007/s00705-021-05126-7
|
| 73 |
Garrick K. Wilson, Michelle J. Farquhar, Luke Meredith, Anil Dhawan, Ragai Mitry, Peter Balfe, Jane A. McKeating. Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection.
Journal of General Virology
2015; 96(6) doi: 10.1099/vir.0.000085
|
| 74 |
Ling Kong, Walter Cardona Maya, Maria E Moreno-Fernandez, Gang Ma, Mohamed T Shata, Kenneth E Sherman, Claire Chougnet, Jason T Blackard. Low-level HIV infection of hepatocytes. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-157
|
| 75 |
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
|
| 76 |
John McLauchlan. Hepatitis C virus: viral proteins on the move. Biochemical Society Transactions 2009; 37(5) doi: 10.1042/BST0370986
|
| 77 |
Rasha Youssef Hagag, Ahmed Fawzy Selim, Omneya Darrag, Hassan Zied, Mohamed Sabry Aboelnasr. Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; doi: 10.2147/DMSO.S354023
|
| 78 |
. 2019; doi: 10.70675/b4a39be6z00d7z4b3cz9968z89b543ec74a1
|
| 79 |
F. Ramalho. Polimorfismos Genéticos da IL28B e a Terapêutica da Hepatite C. Revista Portuguesa de Doenças Infecciosas (RPDI) 2012; 8(2) doi: 10.65332/rpdi.v8.217
|
| 80 |
M.S. Kupka, M. Franz, K. Friese. Hepatitis, HIV und Kinderwunsch. Der Gynäkologe 2007; 40(10) doi: 10.1007/s00129-007-2047-y
|
| 81 |
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Ala I. Sharara. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients. Current Hepatitis Reports 2012; 11(4) doi: 10.1007/s11901-012-0147-1
|
| 82 |
A. Salmon-Rousseau, E. Piednoir, V. Cattoir, A. de La Blanchardière. Hajj-associated infections. Médecine et Maladies Infectieuses 2016; 46(7) doi: 10.1016/j.medmal.2016.04.002
|
| 83 |
Mehtap Tınazlı, Meryem Güvenir, Aslı Aykaç, Kaya Süer. Hepatitis C virus infection among patients admitted to a rheumatology ward in northern Cyprus. The Egyptian Rheumatologist 2017; 39(4) doi: 10.1016/j.ejr.2017.04.014
|
| 84 |
Karima Chaabna, Silva P. Kouyoumjian, Laith J. Abu-Raddad, Jason Blackard. Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(2) doi: 10.1371/journal.pone.0149966
|
| 85 |
Yasser M. Gohary, Amin M.A. El-Baky. Straight-erected hair in hepatitis C male patients treated with pegylated interferon and ribavirin. Journal of the Egyptian Womenʼs Dermatologic Society 2018; 15(2) doi: 10.1097/01.EWX.0000532147.57931.38
|
| 86 |
Ranil Gunewardene, Lisa Lampe, Ralf Ilchef. Prevalence of Hepatitis C in Two Inpatient Psychiatry Populations. Australasian Psychiatry 2010; 18(4) doi: 10.3109/10398561003763273
|
| 87 |
Claro Yu, Denali Boon, Shannon L. McDonald, Timothy G. Myers, Keiko Tomioka, Hanh Nguyen, Ronald E. Engle, Sugantha Govindarajan, Suzanne U. Emerson, Robert H. Purcell. Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and Differences. Journal of Virology 2010; 84(21) doi: 10.1128/JVI.01205-10
|
| 88 |
Zobair M Younossi, Aybike Birerdinc, Mike Estep, Maria Stepanova, Arian Afendy, Ancha Baranova. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Journal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-25
|
| 89 |
Jonghoon Kang, Erin Kang, Matthew L. Cowan, Manuel Orozco. Temporal development of research publications on SARS-CoV-2 and COVID-19. F1000Research 2022; 10 doi: 10.12688/f1000research.42122.2
|
| 90 |
Chien-Jen Chen, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Hui-Chi Chen, Yin-Chu Chien, San-Lin You. Viruses and Human Cancer. Recent Results in Cancer Research 2014; 193 doi: 10.1007/978-3-642-38965-8_2
|
| 91 |
Erika Castro, Elena Roger. Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs. World Journal of Virology 2016; 5(2): 68-72 doi: 10.5501/wjv.v5.i2.68
|
| 92 |
Daniela Manuc, Carmen Monica Preda, Irina Sandra, Cristian Baicus, Razvan Cerban, Ileana Constantinescu, Andrei Ovidiu Olteanu, Cosmin Alexandru Ciora, Teodora Manuc, Daniela Elena Chiriac, Andreea Elena Chifulescu, Mircea Diculescu, Cristian Tieranu, Lucian Negreanu, Gabriela Oprea-Calin, Mircea Manuc. Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma. Journal of Medicine and Life 2020; 13(1) doi: 10.25122/jml-2019-0076
|
| 93 |
Samar Samir Youssef, Eman Abd El- Razek Abbas, Asmaa Mostafa, Moataza Hassan Omran, Ahmed Barakat, Sameh Mohamed Seif. IL28Brs 12979860 Predicts Response to Treatment in Egyptian Hepatitis C Virus Genotype 4 Patients and Alpha Fetoprotein Increases Its Predictive Strength. Journal of Interferon & Cytokine Research 2014; 34(7) doi: 10.1089/jir.2013.0115
|
| 94 |
Ye Yu, Jing-feng Jing, Xian-kun Tong, Pei-lan He, Yuan-chao Li, You-hong Hu, Wei Tang, Jian-ping Zuo. Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease. Acta Pharmacologica Sinica 2014; 35(8) doi: 10.1038/aps.2014.55
|
| 95 |
Zobair M. Younossi, Dolores Limongi, Maria Stepanova, Mariaelena Pierobon, Arian Afendy, Rohini Mehta, Ancha Baranova, Lance. Liotta, Emanuel. Petricoin. Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV). Journal of Proteome Research 2011; 10(2) doi: 10.1021/pr100923u
|
| 96 |
Zeeshan Qamar, Faheem Anwar, Raiz Ahmad, Ihteshamul Haq, Mohsina haq, Arbab Muhammad Kashif Khan, Rafiq Hussain, Abd ullah, Zeeshan Shahzad, Ibrar Ahmad, Muhammad Salman Munir Malik, Muhammad Kamran khan, Jawad Khan. Prevalence of Hepatitis C virus and determination of its genotypes in subjects of Tehsil Daggar District Buner, KP, Pakistan. Clinical Epidemiology and Global Health 2021; 12 doi: 10.1016/j.cegh.2021.100809
|
| 97 |
İlkay Küçükgüzel, Gökhan Satılmış, K.R. Gurukumar, Amartya Basu, Esra Tatar, Daniel B. Nichols, Tanaji T. Talele, Neerja Kaushik-Basu. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. European Journal of Medicinal Chemistry 2013; 69 doi: 10.1016/j.ejmech.2013.08.043
|
| 98 |
Thangavel Megala, Thangaraj Nandha Gopal, Manickasundaram Siva Pradeep, Muthurathinam Sivabalan, Arunachalam Yasotha. Dynamics of re-infection in a Hepatitis B Virus epidemic model with constant vaccination and preventive measures. Journal of Applied Mathematics and Computing 2025; 71(4) doi: 10.1007/s12190-025-02431-1
|
| 99 |
Djadé I. Soumana, Nese Kurt Yilmaz, Kristina L. Prachanronarong, Cihan Aydin, Akbar Ali, Celia A. Schiffer. Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172. ACS Chemical Biology 2016; 11(4) doi: 10.1021/acschembio.5b00647
|
| 100 |
Marie-Josée Massariol, Songping Zhao, Martin Marquis, Diane Thibeault, Peter W. White. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3–NS4A proteins. Biochemical and Biophysical Research Communications 2010; 391(1) doi: 10.1016/j.bbrc.2009.11.122
|
| 101 |
Mun Hyuk Seong, Ho Kil, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Byung Hak Kang, Sook-Hyang Jeong. Clinical and epidemiological features of hepatitis C virus infection in South Korea: A prospective, multicenter cohort study. Journal of Medical Virology 2013; 85(10) doi: 10.1002/jmv.23661
|
| 102 |
Marian Major, Alexander Gutfraind, Louis Shekhtman, Qingwen Cui, Alla Kachko, Scott J. Cotler, Behzad Hajarizadeh, Rachel Sacks-Davis, Kimberly Page, Basmattee Boodram, Harel Dahari. Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Science Translational Medicine 2018; 10(449) doi: 10.1126/scitranslmed.aao4496
|
| 103 |
Soriane de Souza-Cruz, Marilú Barbieri Victória, Andréa Monteiro Tarragô, Allyson Guimarães da Costa, João Paulo Diniz Pimentel, Ericka Florêncio Pires, Lorene de Paula Araújo, Jordana Grazziela Coelho-dos-Reis, Matheus de Souza Gomes, Laurence Rodrigues Amaral, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Flamir da Silva Victória, Adriana Malheiro. Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10. BMC Microbiology 2016; 16(1) doi: 10.1186/s12866-015-0610-6
|
| 104 |
George Papatheodoridis, Angelos Hatzakis. Public health issues of hepatitis C virus infection. Best Practice & Research Clinical Gastroenterology 2012; 26(4) doi: 10.1016/j.bpg.2012.09.012
|
| 105 |
Maryam L. Famouri, Stacey A. Shaw, Assel Terlikbayeva, Louisa Gilbert, Tim Hunt, Yelena Rozental, Nabila El-Bassel. Partner notification among HCV-positive couples who inject drugs. Journal of Substance Use 2016; 21(1) doi: 10.3109/14659891.2014.960015
|
| 106 |
Fabrizio Fabrizi, Vivek Dixit, Paul Martin, Piergiorgio Messa. The Evidence-Based Epidemiology of HCV-Associated Kidney Disease. The International Journal of Artificial Organs 2012; 35(9) doi: 10.1177/039139881203500901
|
| 107 |
Claudia Roeder, Sabine Jordan, Julian Schulze zur Wiesch, Heike Pfeiffer-Vornkahl, Dietrich Hueppe, Stefan Mauss, Elmar Zehnter, Sabine Stoll, Ulrich Alshuth, Ansgar W Lohse, Stefan Lueth. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection. World Journal of Gastroenterology 2014; 20(31): 10984-10993 doi: 10.3748/wjg.v20.i31.10984
|
| 108 |
O. Ndiaye, J. Gozlan, H. Diop‐Ndiaye, A.S. Sall, S. Chapelain, A. Leprêtre, M. Maynart, M. Gueye, G Lo, M. Thiam, I. Ba, K. Lacombe, P.M. Girard, S. Mboup, C.T. Kane. Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal. Journal of Medical Virology 2017; 89(3) doi: 10.1002/jmv.24460
|
| 109 |
Shamim Saleha, Anwar Kamal, Farman Ullah, Nasar Khan, Asif Mahmood, Sanaullah Khan. Prevalence of Hepatitis C Virus Genotypes in District Bannu, Khyber Pakhtunkhwa, Pakistan. Hepatitis Research and Treatment 2014; 2014 doi: 10.1155/2014/165826
|
| 110 |
Shingo Iwasa, Naoko Satoh, Hayato Irokawa, Junichi Kikuchi, Jun Okawa, Masataka Nomoto, Gi-Wook Hwang, Akira Naganuma, Shusuke Kuge. Hepatitis C virus core can induce lipid droplet formation in a yeast model system. Fundamental Toxicological Sciences 2016; 3(1) doi: 10.2131/fts.3.13
|
| 111 |
Salwa Sabet, Marina A. George, Haidan M. El-Shorbagy, Heba Bassiony, Khaled Y. Farroh, Tareq Youssef, Taher A. Salaheldin, Abhijit De. Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0181723
|
| 112 |
Masahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection. Journal of Medical Virology 2017; 89(3) doi: 10.1002/jmv.24663
|
| 113 |
Nancy Agmon-Levin, Maya Ram, Ori Barzilai, Bat sheva Porat-Katz, Ronit Parikman, Carlo Selmi, M. Eric Gershwin, Juan-Manuel Anaya, Pierre Youinou, Nicola Bizzaro, Angela Tincani, Athanasios G. Tzioufas, Ricard Cervera, Ljudmila Stojanovich, Javier Martin, Miguel Angel Gonzalez-Gay, Gabriele Valentini, Miri Blank, Marielle SanMarco, Blaž Rozman, Stefano Bombardieri, Salvatore De Vita, Yehuda Shoenfeld. Prevalence of hepatitis C serum antibody in autoimmune diseases. Journal of Autoimmunity 2009; 32(3-4) doi: 10.1016/j.jaut.2009.02.017
|
| 114 |
Ijaz Ali, Sanaullah Khan, Sobia Attaullah, Shahid Niaz Khan, Jabbar Khan, Sami Siraj, Aqib Iqbal, Zahoor A Swati, Muhammad Idrees. Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-258
|
| 115 |
J Trinks, M L Hulaniuk, M Caputo, L Burgos Pratx, V Ré, L Fortuny, A Pontoriero, A Frías, O Torres, F Nuñez, A Gadano, D Corach, D Flichman. Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population. The Pharmacogenomics Journal 2014; 14(6) doi: 10.1038/tpj.2014.20
|
| 116 |
Portulaca oleraceaL. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease. Viral Immunology 2015; 28(5) doi: 10.1089/vim.2014.0079
|
| 117 |
Florian R. Fritzsche, Manfred Dietel, Wilko Weichert, Ann-Christin Buckendahl. Cut-resistant protective gloves in pathology—effective and cost-effective. Virchows Archiv 2008; 452(3) doi: 10.1007/s00428-008-0576-y
|
| 118 |
Atkinson G. Longmire, Seth Sims, Inna Rytsareva, David S. Campo, Pavel Skums, Zoya Dimitrova, Sumathi Ramachandran, Magdalena Medrzycki, Hong Thai, Lilia Ganova-Raeva, Yulin Lin, Lili T. Punkova, Amanda Sue, Massimo Mirabito, Silver Wang, Robin Tracy, Victor Bolet, Thom Sukalac, Chris Lynberg, Yury Khudyakov. GHOST: global hepatitis outbreak and surveillance technology. BMC Genomics 2017; 18(S10) doi: 10.1186/s12864-017-4268-3
|
| 119 |
. 2010; doi: 10.70675/5d87b0c8z76fdz4a4dza6dazac08a74af507
|
| 120 |
Seyed Moayed Alavian, Seyed Hossein Aalaei-Andabili. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis. Hepatitis Monthly 2012; 12(4) doi: 10.5812/hepatmon.6050
|
| 121 |
Roghayeh Teimourpour, Zahra Meshkat, Aida Gholoubi, Hosein Nomani, Sina Rostami. Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System. Jundishapur Journal of Microbiology 2015; 8(5) doi: 10.5812/jjm.8(5)2015.19279
|
| 122 |
Weidong Hu, Ping’an Wang, Chuanjun Song, Zhenliang Pan, Qiang Wang, Xiaohe Guo, Xuejun Yu, Zhenhua Shen, Shuyang Wang, Junbiao Chang. Synthesis and anti-HCV activity of a new 2′-deoxy-2′-fluoro-2′-C-methyl nucleoside analogue. Bioorganic & Medicinal Chemistry Letters 2010; 20(24) doi: 10.1016/j.bmcl.2010.10.076
|
| 123 |
Nathan A. Cannon, Maureen J. Donlin, Xiaofeng Fan, Rajeev Aurora, John E. Tavis, Sheila Mary Bowyer. Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy. PLoS ONE 2008; 3(5) doi: 10.1371/journal.pone.0002123
|
| 124 |
Lucia Flores-Contreras, Ana S Sandoval-Rodríguez, Mayra G Mena-Enriquez, Silvia Lucano-Landeros, Inmaculada Arellano-Olivera, Arnulfo Álvarez-Álvarez, M Guadalupe Sanchez-Parada, Juan Armendáriz-Borunda. Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-131
|
| 125 |
Resat Ozaras, Veysel Tahan. Acute hepatitis C: prevention and treatment. Expert Review of Anti-infective Therapy 2009; 7(3) doi: 10.1586/eri.09.8
|
| 126 |
Jae Young Jang, Raymond T. Chung. Chronic Hepatitis C. Gut and Liver 2011; 5(2) doi: 10.5009/gnl.2011.5.2.117
|
| 127 |
Samar Samir Youssef, Ahmed Mohamed Fahmy, Moataza Hassan Omran, Amr Saad Mohamed, Mohamed Ali El Desouki, Mostafa K. El-Awady. In VitroInhibition of Hepatitis C Virus by Antisense Oligonucleotides in PBMC Compared to Hepatoma Cells. BioMed Research International 2014; 2014 doi: 10.1155/2014/196712
|
| 128 |
Carmen L R Lopes, Sheila A Teles, Márcia P Espírito-Santo, Elisabete Lampe, Fabiana P Rodrigues, Ana Rita C Motta-Castro, Thaís A Marinho, Nádia R Reis, Ágabo M C Silva, Regina M B Martins. Prevalência, fatores de risco e genótipos da hepatite C entre usuários de drogas. Revista de Saúde Pública 2009; 43(suppl 1) doi: 10.1590/S0034-89102009000800008
|
| 129 |
Sahar EL Hadad, Hesa Al-Hamdan, Sabah Linjawi, Yury E Khudyakov. Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia. PLOS ONE 2017; 12(5) doi: 10.1371/journal.pone.0178225
|
| 130 |
John Halliday, Paul Klenerman, Eleanor Barnes. Vaccination for hepatitis C virus: closing in on an evasive target. Expert Review of Vaccines 2011; 10(5) doi: 10.1586/erv.11.55
|
| 131 |
Assessment of Hepatitis C Virus Prevalence in Patients Attending the Hematology Department of a Tertiary Care Hospital. PAIN, JOINTS, SPINE 2026; 16(5S) doi: 10.1922/pjs.16.3.2026.1114
|
| 132 |
. 2013; doi: 10.70675/6dc6e41ez97edz4f2bz9169z5446b968d69b
|
| 133 |
Otávio M. Espíndola, Alexandre G. Vizzoni, Elisabeth Lampe, Maria José Andrada-Serpa, Abelardo Q.C. Araújo, Ana Claudia C. Leite. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes. International Journal of Infectious Diseases 2017; 57 doi: 10.1016/j.ijid.2017.01.037
|
| 134 |
Elrashdy M. Redwan, Abdullah A. Aljadawi, Vladimir N. Uversky. Intrinsic disorder angle of the HCV co-infection and super-infection with other hepatitis viruses. Computers in Biology and Medicine 2025; 196 doi: 10.1016/j.compbiomed.2025.110811
|
| 135 |
Nicholas A. Meanwell, John F. Kadow, Paul M. Scola. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry 2009; 44 doi: 10.1016/S0065-7743(09)04420-0
|
| 136 |
Lindsay A. Petty, Jennifer L. Steinbeck, Kenneth Pursell, Donald M. Jensen. Human Immunodeficiency Virus and Coinfection with Hepatitis B and C. Infectious Disease Clinics of North America 2014; 28(3) doi: 10.1016/j.idc.2014.05.005
|
| 137 |
Pavel Skums, Zoya Dimitrova, David S Campo, Gilberto Vaughan, Livia Rossi, Joseph C Forbi, Jonny Yokosawa, Alex Zelikovsky, Yury Khudyakov. Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinformatics 2012; 13(S10) doi: 10.1186/1471-2105-13-S10-S6
|
| 138 |
Guangming Chen, Hongyu Ren, Nanjing Zhang, William Lennox, Anthony Turpoff, Steven Paget, Chunshi Li, Neil Almstead, F. George Njoroge, Zhengxian Gu, Jason Graci, Stephen P. Jung, Joseph Colacino, Fred Lahser, Xin Zhao, Marla Weetall, Amin Nomeir, Gary M. Karp. 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B. Bioorganic & Medicinal Chemistry Letters 2015; 25(4) doi: 10.1016/j.bmcl.2014.12.093
|
| 139 |
Robert Flisiak, Saya V. Feinman, Maciej Jablkowski, Andrzej Horban, Wieslaw Kryczka, Małgorzata Pawlowska, Jenny E. Heathcote, Giuseppe Mazzella, Carmen Vandelli, Valérie Nicolas-Métral, Pierre Grosgurin, Jorge S. Liz, Pietro Scalfaro, Hervé Porchet, Raf Crabbé. The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #. Hepatology 2009; 49(5) doi: 10.1002/hep.22835
|
| 140 |
Lauren Tal Grinspan, Elizabeth C. Verna. Liver Anesthesiology and Critical Care Medicine. 2018; doi: 10.1007/978-3-319-64298-7_2
|
| 141 |
Anita Netyő, Gabriella Lengyel, János Fehér. Intrafamilial hepatitis C virus infection. Orvosi Hetilap 2008; 149(11) doi: 10.1556/oh.2008.28333
|
| 142 |
Ivana Talić Drlje, Božo Šušak, Siniša Skočibušić, Borka Tutiš, Sanja Jakovac, Jurica Arapović. Sociodemographic characteristics, risk factors and genotype distribution of hepatitis C virus in Bosnia and Herzegovina: Single center experience. Clinical Epidemiology and Global Health 2025; 31 doi: 10.1016/j.cegh.2024.101845
|
| 143 |
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold. Bioorganic & Medicinal Chemistry Letters 2018; 28(5) doi: 10.1016/j.bmcl.2018.01.029
|
| 144 |
Ching-Chih Hu, Cheng-Hao Weng, Chih-Lang Lin, Hui-Ching Tien, Yen-Lin Kuo, Cheng-Hung Chien, Cho-Li Yen, Chun-Yen Lin, Rong-Nan Chien. Predictors of Changes in Hemoglobin Levels in Patients with Chronic Hepatitis C Treated with Ribavirin Plus Pegylated Interferon-α. Renal Failure 2012; 34(4) doi: 10.3109/0886022X.2011.650562
|
| 145 |
Dimitrios Paraskevis, Dora C. Stylianou, Johana Hezka, Zachariah Stern, Martha Oikonomopoulou, Ioannis Mamais, Chrysanthos Georgiou, Natasa Savvopoulou, Kyriakos L. Veresies, Tina Pavlou, Argyris Argyriou, Elena Zarouna, Leondios G. Kostrikis. HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46552-7
|
| 146 |
Birke Bartosch, Jean Dubuisson. Recent Advances in Hepatitis C Virus Cell Entry. Viruses 2010; 2(3) doi: 10.3390/v2030692
|
| 147 |
Emma R. Miller, Jan M. Moore, Peng Bi. Harm Reduction Behind Bars. Sage Open 2013; 3(3) doi: 10.1177/2158244013494209
|
| 148 |
Mustafa Altindis, Tuba Dal, Isin Akyar, Onur Karatuna, Selma Gokahmetoglu, Seda Tezcan Ulger, Canan Kulah, Berrin Uzun, Aslı Gamze Şener, Mehmet Ozdemir, Sibel Aydogan, Mert Ahmet Kuskucu, Kenan Midilli, Baris Otlu, Mustafa Kemal Celen, Kurtulus Buruk, Huseyin Guducuoglu. Six-year distribution pattern of hepatitis C virus in Turkey: a multicentre study. Biotechnology & Biotechnological Equipment 2016; 30(2) doi: 10.1080/13102818.2015.1093430
|
| 149 |
Poupak Fallahi, Silvia Martina Ferrari, Ugo Politti, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli. Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection. International Journal of Endocrinology 2014; 2014 doi: 10.1155/2014/935131
|
| 150 |
Simona Bota, Ioan Sporea, Roxana Şirli, Alina Popescu, Adriana Maria Neghină, Mirela Dănilă, Mihnea Străin. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review. World Journal of Hepatology 2013; 5(3): 120-126 doi: 10.4254/wjh.v5.i3.120
|
| 151 |
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore. Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology 2013; 10(9) doi: 10.1038/nrgastro.2013.107
|
| 152 |
Gaby S. Steba, Sylvie M. Koekkoek, Michael W. T. Tanck, Joost W. Vanhommerig, Jan T. M. van der Meer, David Kwa, Kees Brinkman, Maria Prins, Ben Berkhout, Georgios Pollakis, Richard Molenkamp, Janke Schinkel, William A. Paxton. SNP rs688 within the low‐density lipoprotein receptor (LDL‐R) gene associates with HCV susceptibility. Liver International 2019; 39(3) doi: 10.1111/liv.13978
|
| 153 |
Dorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, Sandra Ciesek, Martina Friesland, Eva Herrmann, Mirjam B. Zeisel, Thomas F. Baumert, Zhen-yong Keck, Steven K. H. Foung, Eve-Isabelle Pécheur, Thomas Pietschmann. Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes. Journal of Virology 2010; 84(11) doi: 10.1128/JVI.02200-09
|
| 154 |
Giody Bartolomei, Recep Emrah Cevik, Alessandro Marcello. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes.
Journal of General Virology
2011; 92(9) doi: 10.1099/vir.0.032706-0
|
| 155 |
Federico Alejandro Di Lello, Adrián Alejandro Farias, Andrés Carlos Alberto Culasso, Paula Soledad Pérez, María Belén Pisano, Marta Silvia Contigiani, Rodolfo Héctor Campos, Viviana Elizabeth Ré. Changing epidemiology of hepatitis C virus genotypes in the central region of Argentina. Archives of Virology 2015; 160(4) doi: 10.1007/s00705-015-2390-6
|
| 156 |
Peiyuan Wang, Byoung-Kwon Chun, Suguna Rachakonda, Jinfa Du, Noshena Khan, Junxing Shi, Wojciech Stec, Darryl Cleary, Bruce S. Ross, Michael J. Sofia. An Efficient and Diastereoselective Synthesis of PSI-6130: A Clinically Efficacious Inhibitor of HCV NS5B Polymerase. The Journal of Organic Chemistry 2009; 74(17) doi: 10.1021/jo901345j
|
| 157 |
Carlos Santos, Alexanda Reis, Cintia Vilhena dos Santos, Cristine Damas, Mariliza Henrique Silva, Mônica Valverde Viana, Maria Lucia Ferraz, Dimas Carnauba, Fabiane El-Far, Fernando Serra, Ricardo Sobhie Diaz. The use of real-time PCR to detect hepatitis C virus RNA in dried blood spots from Brazilian patients infected chronically. Journal of Virological Methods 2012; 179(1) doi: 10.1016/j.jviromet.2011.06.012
|
| 158 |
Norah J. Shire, Kenneth E. Sherman. Epidemiology of Hepatitis C Virus. Gastroenterology Clinics of North America 2015; 44(4) doi: 10.1016/j.gtc.2015.07.002
|
| 159 |
|
| 160 |
|
| 161 |
E. Kågström, A. Lannergård, J. El Khosht, P. Lörelius, J. Månflod, S. Strömdahl. Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden. Harm Reduction Journal 2023; 20(1) doi: 10.1186/s12954-023-00806-w
|
| 162 |
Aristide Mounchili Njifon, Abdou Fatawou Modiyinji, Chavely Gwladys Monamele, Pretty Rose Mbouyap, Laure Ngono, Paul Alain Tagnouokam-Ngoupo, Simon Frederic Lissock, Martin Ridole Zekeng, Jean Paul Assam Assam, Richard Njouom. A decade-long retrospective study of hepatitis C virus genetic diversity in Cameroon, 2013–2023: presence of a high proportion of unsubtypable and putative recombinant HCV strains. Archives of Virology 2024; 169(10) doi: 10.1007/s00705-024-06124-1
|
| 163 |
Aldemir B Oliveira-Filho, Adriana SC Pimenta, Márcia FM Rojas, Márcia CM Chagas, José Ângelo B Crescente, Deborah M Crespo, José Alexandre R Lemos. Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Memórias do Instituto Oswaldo Cruz 2010; 105(1) doi: 10.1590/S0074-02762010000100016
|
| 164 |
Gaby S. Steba, Sylvie M. Koekkoek, Maria Prins, Kees Brinkman, David Kwa, Jan T.M. van der Meer, Marc van der Valk, Richard Molenkamp, Georgios Pollakis, Janke Schinkel, William A. Paxton. Bile-salt stimulated lipase polymorphisms do not associate with HCV susceptibility. Virus Research 2019; 274 doi: 10.1016/j.virusres.2019.197715
|
| 165 |
Partha Roy, Anubha Patel, Kavita Lole, R.M. Gupta, Arun Kumar, S. Hazra. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India. Medical Journal Armed Forces India 2019; 75(1) doi: 10.1016/j.mjafi.2018.08.001
|
| 166 |
Loubna Jouan, Pierre Melançon, Ian-Gaël Rodrigue-Gervais, Valérie-Ann Raymond, Subajini Selliah, Geneviève Boucher, Marc Bilodeau, Nathalie Grandvaux, Daniel Lamarre. Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease. Journal of Hepatology 2010; 52(2) doi: 10.1016/j.jhep.2009.11.011
|
| 167 |
Suman Thakur, Rose V. Goncalves. The State of the Globe: The Global Challenge of Hepatitis B and C Coinfection. Journal of Global Infectious Diseases 2024; 16(4) doi: 10.4103/jgid.jgid_219_24
|
| 168 |
Prevalence of hepatitis C virus (HCV) genotype in general population of Peshawar District Khyber Pakhtunkhwa (KP), Pakistan. International Journal of Biosciences (IJB) 2019; doi: 10.12692/ijb/14.6.171-178
|
| 169 |
Zeinab Ashour, Rasha Shahin, Zeinab Ali-Eldin, Mohamed El-Shayeb, Tarek El-Tayeb, Salwa Bakr. Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00501-4
|
| 170 |
Chapter 9: Infection-related glomerulonephritis. Kidney International Supplements 2012; 2(2) doi: 10.1038/kisup.2012.22
|
| 171 |
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall. Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?. World Journal of Gastroenterology 2008; 14(43): 6627-6631 doi: 10.3748/wjg.14.6627
|
| 172 |
Yalin Liao, Esmail El-Fakkarany, Bo Lönnerdal, Elrashdy M. Redwan. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
Journal of Medical Microbiology
2012; 61(3) doi: 10.1099/jmm.0.033894-0
|
| 173 |
Koen Van Herck, A. Vorsters, P. Van Damme. Prevention of viral hepatitis (B and C) reassessed. Best Practice & Research Clinical Gastroenterology 2008; 22(6) doi: 10.1016/j.bpg.2008.11.008
|
| 174 |
Debasis Das, Jian Hong, Shu-Hui Chen, Guangyi Wang, Leonid Beigelman, Scott D. Seiwert, Brad O. Buckman. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry 2011; 19(16) doi: 10.1016/j.bmc.2011.06.079
|
| 175 |
Juliane Doerrbecker, Martina Friesland, Sandra Ciesek, Thomas J. Erichsen, Pedro Mateu-Gelabert, Jörg Steinmann, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann. Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces. The Journal of Infectious Diseases 2011; 204(12) doi: 10.1093/infdis/jir535
|
| 176 |
Barbara Bertisch, Fabio Giudici, Francesco Negro, Darius Moradpour, Beat Müllhaupt, Alberto Moriggia, Janne Estill, Olivia Keiser, Yury E Khudyakov. Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0155464
|
| 177 |
Mithaq Sabeeh Khudur Al-Nassary, Batool Mutar Mahdi. Study of Hepatitis C Virus Detection Assays. Annals of Medicine and Surgery 2018; 36 doi: 10.1016/j.amsu.2018.10.002
|
| 178 |
. 2018; doi: 10.70675/e8471e84za264z4a46z9d2dz0a24e58297b5
|
| 179 |
HAU HASSAN, A RIASAT, T ZIA, S ISHAQ, A ULLAH. CLASSIFICATION, PREVALENCE AND TREATMENT OF HEPACVIRIUS C. Journal of Physical, Biomedical and Biological Sciences 2024; 2025(1) doi: 10.64013/jpbab.v2024i1.33
|
| 180 |
Qingxia Han, Chunlian Xu, Chunchen Wu, Wenbo Zhu, Rongge Yang, Xinwen Chen. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Research 2009; 145(1) doi: 10.1016/j.virusres.2009.06.005
|
| 181 |
Victoria L. Demetriou, David A.M.C. van de Vijver, Johana Hezka, Leondios G. Kostrikis. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. Journal of Medical Virology 2010; 82(2) doi: 10.1002/jmv.21690
|
| 182 |
Maha A. Sultan, Maha M. Abou El-Alamin, Alastair W. Wark, Marwa M. Azab. Stability-indicating micellar enhanced spectro-fluorometric determination of Daclatasvir in its tablet and spiked human plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2019; 211 doi: 10.1016/j.saa.2018.11.023
|
| 183 |
Lindsay G Carter, John A D'Orazio, Kevin J Pearson. Resveratrol and cancer: focus on in vivo evidence. Endocrine-Related Cancer 2014; 21(3) doi: 10.1530/ERC-13-0171
|
| 184 |
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiology of hepatitis C virus infection. Revista da Associação Médica Brasileira 2011; 57(1) doi: 10.1016/S0104-4230(11)70024-0
|
| 185 |
Thomas Astell-Burt, Robin Flowerdew, Paul J. Boyle, John F. Dillon. Does geographic access to primary healthcare influence the detection of hepatitis C?. Social Science & Medicine 2011; 72(9) doi: 10.1016/j.socscimed.2011.02.015
|
| 186 |
Fei Kong, Yu Pan, Xiumei Chi, Xiaomei Wang, Linjiao Chen, Juan Lv, Haibo Sun, Ruihong Wu, Jinglan Jin, Ge Yu, Zhenhua Ma, Yang Wang, Xinxing Huang, Hua Li, Yang Bai, Jing Jia, Gerald Y. Minuk, Jin Zhong, Bing Sun, Jing Jiang, Junqi Niu. Factors Associated with Spontaneous Clearance of Hepatitis C Virus in Chinese Population. BioMed Research International 2014; 2014 doi: 10.1155/2014/527030
|
| 187 |
Alessandra Mangia, Maria Ripoli. Insulin resistance, steatosis and hepatitis C virus. Hepatology International 2013; 7(S2) doi: 10.1007/s12072-013-9460-1
|
| 188 |
Claudia Suellen Ferro de Oliveira, Adenielson Vilar e Silva, Kemper Nunes dos Santos, Amanda Alves Fecury, Marcella Kelly Costa de Almeida, Adriana Prado Fernandes, Carlos Araújo da Costa, Andrei Silva Freitas, Tereza Cristina de Oliveira Corvelo, Luisa Caricio Martins. Hepatitis B and C virus infection among Brazilian Amazon riparians. Revista da Sociedade Brasileira de Medicina Tropical 2011; 44(5) doi: 10.1590/S0037-86822011000500003
|
| 189 |
Sobia Kanwal, Tariq Mahmood. Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan. Hepatitis Monthly 2012; 12(6) doi: 10.5812/hepatmon.6184
|
| 190 |
Xiaoyong Zhang, Anke Kraft, Ruth Broering, Joerg F Schlaak, Ulf Dittmer, Mengji Lu. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Expert Opinion on Drug Discovery 2012; 7(7) doi: 10.1517/17460441.2012.689281
|
| 191 |
David Timm KVITKO, Gisele Alsina Nader BASTOS, Maria Eugênia Bresolin PINTO. PREVALENCE OF RISK FACTORS FOR HEPATITIS C AND ASSOCIATED FACTORS: a population-based study in southern Brazil. Arquivos de Gastroenterologia 2013; 50(2) doi: 10.1590/S0004-28032013000200020
|
| 192 |
Fabio Curcio, Giuseppina Villano, Salvatore Masucci, Marinella Plenzik, Ciro Veneruso, Giuseppe De Rosa. Epidemiological Survey of Hepatitis C Virus Infection in a Cohort of Patients From a Ser.T in Naples, Italy. Journal of Addiction Medicine 2011; 5(1) doi: 10.1097/ADM.0b013e3181d131e0
|
| 193 |
Fatma Abdallah, Gehad Mohamed, Mohsen Ibrahim, Mokhtar El Tarabily. Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4. The American Journal of the Medical Sciences 2018; 355(5) doi: 10.1016/j.amjms.2017.12.016
|
| 194 |
Gabor Lendvai, Katalin Jármay, Gizella Karácsony, Tünde Halász, Ilona Kovalszky, Kornélia Baghy, Tibor Wittmann, Zsuzsa Schaff, András Kiss. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World Journal of Gastroenterology 2014; 20(41): 15343-15350 doi: 10.3748/wjg.v20.i41.15343
|
| 195 |
Jung-Chen Ho, Meng-Lun Hsieh, Po-Heng Chuang, Vivian Chia-Rong Hsieh. Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Value in Health Regional Issues 2018; 15 doi: 10.1016/j.vhri.2017.12.012
|
| 196 |
Mohammed Omer Mohammed, Asan Baram Hasan, Fenk Bakir Maarouf. Epidemiological Study of Hepatitis B, C and HIV Cases among the Foreigners Visiting Sulaimani City from 2013 Through 2016. Kurdistan Journal of Applied Research 2019; doi: 10.24017/science.2019.ICHMS.23
|
| 197 |
Judith I. Tsui, Stephen C. Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E. Chaisson, Natalia Gnatienko, Jeffrey H. Samet. Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg. Hepatology, Medicine and Policy 2016; 1(1) doi: 10.1186/s41124-016-0020-x
|
| 198 |
A CLINICAL MANIFESTATION OF HEPATITIS C AMONG THE POPULATION OF HYDERABAD, PAKISTAN. Pakistan Journal of Biotechnology 2023; 20(02) doi: 10.34016/pjbt.2023.20.02.785
|
| 199 |
Jessica A. Briscoe, Sandra M. Quezada. Telemanagement of Inflammatory Bowel Disease. 2016; doi: 10.1007/978-3-319-22285-1_2
|
| 200 |
Aldemir Branco de Oliveira-Filho, Adriana do Socorro Coelho Pimenta, Márcia de Fátima Maciel Rojas, Márcia Cristina Munhoz Chagas, Deborah Maia Crespo, José Ângelo Barletta Crescente, José Alexandre Rodrigues de Lemos. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cadernos de Saúde Pública 2010; 26(4) doi: 10.1590/S0102-311X2010000400025
|
| 201 |
Christoph T. Berger, Arthur Y. Kim. IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment. Infectious Disease Clinics of North America 2012; 26(4) doi: 10.1016/j.idc.2012.08.010
|
| 202 |
Guoping Xu, Yungang Zhu, Huijia Liu, Yingying Liu, Xuening Zhang. Long Non-Coding RNA KCNQ1OT1 Promotes Progression of Hepatocellular Carcinoma by miR-148a-3p/IGF1R Axis. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820980117
|
| 203 |
Noreen Akhtar, Muhammad Bilal, Muhammad Rizwan, Muhammad Asif Khan, Aurangzeb Khan. Genotypes of Hepatitis C Virus in Relapsed and Non-respondent Patients and their Response to Anti-Viral Therapy in District Mardan, Khyber Pakhtunkhawa, Pakistan. Asian Pacific Journal of Cancer Prevention 2015; 16(3) doi: 10.7314/APJCP.2015.16.3.1037
|
| 204 |
Yan-Feng Pan, Yan Zheng, Tao Qin, Lei Feng, Qian Zhang, Xiao-Gong Ping, Yan-Ting Pan, Xiao-Ping Wang, Li Bai, Hua-Hua Li. Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion. Experimental and Therapeutic Medicine 2016; 12(5) doi: 10.3892/etm.2016.3792
|
| 205 |
Satomi Mizuno, Sachiko Ono, Hideo Yasunaga, Hirotaro Iwase. Factors associated with methamphetamine use in Japanese people who died of unnatural causes: Analysis using forensic autopsy reports. Forensic Science International 2021; 327 doi: 10.1016/j.forsciint.2021.110946
|
| 206 |
Mark Aziz. Which of the direct acting anti-viral agents is the better drug in terms of efficacy, cost and safety, Boceprevir or Telaprevir?. Medical Science and Discovery 2019; doi: 10.17546/msd.501220
|
| 207 |
Ricardo Andrade Carmo, Lorenza Nogueira Campos, Ana Paula Souto Melo, Mark Drew Crosland Guimarães. Hepatitis C among patients with mental illness in Brazil: an analysis of associated factors. General Hospital Psychiatry 2013; 35(2) doi: 10.1016/j.genhosppsych.2012.11.005
|
| 208 |
Sadaf Badar, Bushra Khubaib, Muhammad Idrees, Abrar Hussain, Zunaira Awan, Sadia Butt, Samia Afzal, Madeeha Akram, Zareen Fatima, Mahwish Aftab, Sana Saleem, Sara Munir, Bisma Rauff, Mahrukh Naudhani, Liaquat Ali, Muhammaad Ali, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1) doi: 10.5812/kowsar.1735143X.4295
|
| 209 |
Mohammad A. Ansari, Mohammad Irshad, Sanjay Kumar Agarwal, Kunzang Chosdol. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products. European Journal of Gastroenterology & Hepatology 2013; 25(7) doi: 10.1097/MEG.0b013e32835eb9b9
|
| 210 |
Nabiha Faisal, Khalid Mumtaz, Max Marquez, Eberhard L. Renner, Leslie B. Lilly. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation. Hepatology International 2015; 9(1) doi: 10.1007/s12072-014-9589-6
|
| 211 |
Hiroyoshi Doi, Shiroh Tanoue, David E. Kaplan. Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clinical Immunology 2014; 150(2) doi: 10.1016/j.clim.2013.12.001
|
| 212 |
Lance D. Presser, Steven McRae, Gulam Waris, Ching-Ping Tseng. Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0056367
|
| 213 |
Lenka Benova, Yousra A. Mohamoud, Clara Calvert, Laith J. Abu-Raddad. Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis. Clinical Infectious Diseases 2014; 59(6) doi: 10.1093/cid/ciu447
|
| 214 |
Sobia Kanwal, Tariq Mahmood. Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatment. Virology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-171
|
| 215 |
Mei-Hing Ng, Jen-Yu Chou, Ta-Jen Chang, Pei-Chin Lee, Wen-Chuan Shao, Tsang-Yaw Lin, Vincent Chin-Hung Chen, Michael Gossop. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addictive Behaviors 2013; 38(4) doi: 10.1016/j.addbeh.2013.01.010
|
| 216 |
Hong-Min Ni, Jessica A. Williams, Hua Yang, Ying-Hong Shi, Jia Fan, Wen-Xing Ding. Targeting autophagy for the treatment of liver diseases. Pharmacological Research 2012; 66(6) doi: 10.1016/j.phrs.2012.07.003
|
| 217 |
A ALI, A ULLAH, S KIRBAG. COMPARATIVE ANALYSIS OF ANTIVIRAL THERAPIES IN CHRONIC HCV PATIENTS: CLINICAL OUTCOMES AND TREATMENT IMPLICATIONS. Bulletin of Biological and Allied Sciences Research 2026; 2026(1) doi: 10.64013/bbasr.v2026i1.136
|
| 218 |
Annagiulia Gramenzi, Fabio Conti, Calogero Cammà, Antonio Grieco, Antonino Picciotto, Caterina Furlan, Domenico Romagno, Paolo Costa, Maria Rendina, Fausto Ancarani, Maria Chiaramonte, Gabriella Verucchi, Antonio Craxì, Mauro Bernardi, Pietro Andreone. Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver. Digestive and Liver Disease 2012; 44(8) doi: 10.1016/j.dld.2012.03.009
|
| 219 |
Magdy Amin El Serafy, Abdel Meguid Kassem, Heba Omar, Mohammad Shaaban Mahfouz, Maissa El Said EL Raziky. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis. Arab Journal of Gastroenterology 2017; 18(2) doi: 10.1016/j.ajg.2017.05.005
|
| 220 |
Perdita Backes, Doris Quinkert, Simon Reiss, Marco Binder, Margarita Zayas, Ursula Rescher, Volker Gerke, Ralf Bartenschlager, Volker Lohmann. Role of Annexin A2 in the Production of Infectious Hepatitis C Virus Particles. Journal of Virology 2010; 84(11) doi: 10.1128/JVI.02343-09
|
| 221 |
Ana Shulla, Glenn Randall. Hepatitis C virus—host interactions, replication, and viral assembly. Current Opinion in Virology 2012; 2(6) doi: 10.1016/j.coviro.2012.09.013
|
| 222 |
Antonio Craxì, Carlo Federico Perno, Mauro Viganò, Francesca Ceccherini-Silberstein, Salvatore Petta, Alessio Aghemo, Alfredo Alberti, Pietro Andreone, Massimo Andreoni, Stefano Bonora, Maurizia Rossana Brunetto, Savino Bruno, Nicola Caporaso, Antonio Chirianni, Alessia Ciancio, Elisabetta Degasperi, Giovanni Di Perri, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Adriano Pellicelli, Massimo Puoti, Giovanni Raimondo, Gloria Taliani, Erica Villa, Anna Linda Zignego. From current status to optimization of HCV treatment: Recommendations from an expert panel. Digestive and Liver Disease 2016; 48(9) doi: 10.1016/j.dld.2016.06.004
|
| 223 |
Huan-You Lin, Tzu-Cheng Chang, Shang-Tzen Chang. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa. Journal of Traditional and Complementary Medicine 2018; 8(4) doi: 10.1016/j.jtcme.2018.05.002
|
| 224 |
Nese Kurt Yilmaz, Ronald Swanstrom, Celia A. Schiffer. Improving Viral Protease Inhibitors to Counter Drug Resistance. Trends in Microbiology 2016; 24(7) doi: 10.1016/j.tim.2016.03.010
|
| 225 |
Francisco Barrera M, Alejandro Soza. Shortened therapy for genotype 1 hepatitis C virus. The final answer?. Annals of Hepatology 2010; 9(1) doi: 10.1016/S1665-2681(19)31692-8
|
| 226 |
James Lara, Robert M. Wohlhueter, Zoya Dimitrova, Yury E. Khudyakov. Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Bioinformatics 2008; 24(17) doi: 10.1093/bioinformatics/btn339
|
| 227 |
Rania A. Tohme, Scott D. Holmberg. Is Sexual Contact a Major Mode of Hepatitis C Virus Transmission?. Hepatology 2010; 52(4) doi: 10.1002/hep.23808
|
| 228 |
Chang Ho Lee, Soo-Han Lee, Ji Hyun Kim, Yook-Hwan Noh, Gyu-Jeong Noh, Seong-Wook Lee. Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein. Molecular Therapy - Nucleic Acids 2015; 4 doi: 10.1038/mtna.2015.30
|
| 229 |
A Paez Jimenez, N Sharaf Eldin, F Rimlinger, M El-Daly, H El-Hariri, M El-Hoseiny, A Mohsen, A Mostafa, E Delarocque-Astagneau, M Abdel-Hamid, A Fontanet, M K Mohamed, V Thiers. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 2010; 59(11) doi: 10.1136/gut.2009.194266
|
| 230 |
C.‐C. Hu, C.‐L. Lin, Y.‐L. Kuo, C.‐H. Chien, S.‐W. Chen, C.‐L. Yen, C.‐Y. Lin, R.‐N. Chien. Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2013; 37(1) doi: 10.1111/apt.12112
|
| 231 |
Kerui Cai, Tieling Li, Ling Guo, Haifeng Guo, Wei Zhu, Lei Yan, Fujuan Li. RETRACTED: Long non-coding RNA LINC00467 regulates hepatocellular carcinoma progression by modulating miR-9-5p/PPARA expression. Open Biology 2019; 9(9) doi: 10.1098/rsob.190074
|
| 232 |
Jennifer Ng, Jennifer Wu. Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.7635
|
| 233 |
Jason T. Blackard, Ling Kong, Angela Lombardi, Dirk Homann, Sara Salehi Hammerstad, Yaron Tomer. A preliminary analysis of hepatitis C virus in pancreatic islet cells. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0905-3
|
| 234 |
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey. World Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
|
| 235 |
Mayura M. Desai, Bin Gong, Tehsheng Chan, Robert A. Davey, Lynn Soong, Andrey A. Kolokoltsov, Jiaren Sun. Differential, Type I Interferon-Mediated Autophagic Trafficking of Hepatitis C Virus Proteins in Mouse Liver. Gastroenterology 2011; 141(2) doi: 10.1053/j.gastro.2011.04.060
|
| 236 |
Eike Steinmann, Thomas Pietschmann. Hepatitis C Virus P7—A Viroporin Crucial for Virus Assembly and an Emerging Target for Antiviral Therapy. Viruses 2010; 2(9) doi: 10.3390/v2092078
|
| 237 |
Basmattee Boodram, Anna L. Hotton, Louis Shekhtman, Alexander Gutfraind, Harel Dahari. High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members. Journal of Urban Health 2018; 95(1) doi: 10.1007/s11524-017-0185-7
|
| 238 |
Tatiana Kuznetsova, Tatjana Tallo, Vadim Brjalin, Irina Reshetnjak, Riina Salupere, Ljudmilla Priimagi, Olga Katargina, Maria Smirnova, Juris Jansons, Valentina Tefanova. Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14481
|
| 239 |
Talita de A. Fernandes, Dinesh Manvar, Jorge L.O. Domingos, Amartya Basu, Daniel Brian Nichols, Neerja Kaushik-Basu, Paulo R.R. Costa. 5-Carba-pterocarpens: A new scaffold with anti-HCV activity. European Journal of Medicinal Chemistry 2016; 112 doi: 10.1016/j.ejmech.2016.02.010
|
| 240 |
Maria Victoria Preciado, Pamela Valva, Alejandro Escobar-Gutierrez, Paula Rahal, Karina Ruiz-Tovar, Lilian Yamasaki, Carlos Vazquez-Chacon, Armando Martinez-Guarneros, Juan Carlos Carpio-Pedroza, Salvador Fonseca-Coronado, Mayra Cruz-Rivera. Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy. World Journal of Gastroenterology 2014; 20(43): 15992-16013 doi: 10.3748/wjg.v20.i43.15992
|
| 241 |
Jennifer R. Havens, Michelle R. Lofwall, Simon D. W. Frost, Carrie B. Oser, Carl G. Leukefeld, Richard A. Crosby. Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users. American Journal of Public Health 2013; 103(1) doi: 10.2105/AJPH.2012.300874
|
| 242 |
Ndiémé Ndongo, Pascale Berthillon, Pierre Pradat, Claude Vieux, Isabelle Bordes, Françoise Berby, Marianne Maynard, Fabien Zoulim, Christian Trépo, Marie-Anne Petit. Association of Anti-E1E2 Antibodies with Spontaneous Recovery or Sustained Viral Response to Therapy in Patients Infected with Hepatitis C Virus. Hepatology 2010; 52(5) doi: 10.1002/hep.23862
|
| 243 |
Ching-Chih Hu, Cheng-Hao Weng, Man-Chin Hua, Pei-Hung Chang, Chih-Lang Lin, Yen-Ting Chen, Cheng-Hung Chien, Shu-Ting Lin, Rong-Nan Chien. New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research 2020; 40(2) doi: 10.1089/jir.2019.0103
|
| 244 |
Farzin Roohvand, Niloufar Kossari. Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design. Expert Opinion on Therapeutic Patents 2011; 21(12) doi: 10.1517/13543776.2011.630662
|
| 245 |
David S. Campo, Ha-Jung Roh, Brian L. Pearlman, Daniel S. Fierer, Sumathi Ramachandran, Gilberto Vaughan, Andrew Hinds, Zoya Dimitrova, Pavel Skums, Yury Khudyakov. Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus. Cellular and Molecular Gastroenterology and Hepatology 2016; 2(5) doi: 10.1016/j.jcmgh.2016.05.012
|
| 246 |
Roger Detels, Quarraisha Abdool Karim, Fran Baum, Liming Li, Alastair H. Leyland, Ehud Zigmond, Daniel Shouval. Oxford Textbook of Global Public Health. 2021; doi: 10.1093/med/9780198816805.003.0074
|
| 247 |
|
| 248 |
Vassiliki Papaevangelou, Marianna Varsami, Vassilios Papadakis, Aglaia Zellos, Agapi Parcharidou, Sophia Papargyri, Ourania Karentzou, Nina Manolaki, Eleftheria Roma, Sophia Polychronopoulou. HEPATITIS C TREATMENT CONCOMITANT TO CHEMOTHERAPY AS “SALVAGE” THERAPY IN CHILDREN WITH HEMATOLOGIC MALIGNANCIES. Pediatric Infectious Disease Journal 2010; 29(3) doi: 10.1097/INF.0b013e3181c2115a
|
| 249 |
Hong-Xin Piao, Ai-Ting Yang, Ya-Meng Sun, Yuan-Yuan Kong, Xiao-Ning Wu, Ying-Zhe Zhang, Bo Ding, Bao-En Wang, Ji-Dong Jia, Hong You, Matthew Law. Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in China. PLoS ONE 2014; 9(1) doi: 10.1371/journal.pone.0086190
|
| 250 |
Richard A. Giovane, Kevin deWeber, Uziel Sauceda, Davide Bianchi. Blood-Borne Infection Prevention in Combat Sports: Position Statement of the Association of Ringside Physicians. Clinical Journal of Sport Medicine 2026; 36(2) doi: 10.1097/JSM.0000000000001350
|
| 251 |
Brenda L. Fredericksen, Michael Gale. Cellular Signaling and Innate Immune Responses to RNA Virus Infections. 2014; doi: 10.1128/9781555815561.ch20
|
| 252 |
Kimberly A. Dowd, Dale M. Netski, Xiao–Hong Wang, Andrea L. Cox, Stuart C. Ray. Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus. Gastroenterology 2009; 136(7) doi: 10.1053/j.gastro.2009.02.080
|
| 253 |
Mayra Cruz-Rivera, Juan Carlos Carpio-Pedroza, Alejandro Escobar-Gutiérrez, Daniela Lozano, Arely Vergara-Castaneda, Pilar Rivera-Osorio, Armando Martinez-Guarneros, Carlos A. Vazquez Chacon, Salvador Fonseca-Coronado, Gilberto Vaughan. Rapid Hepatitis C Virus Divergence among Chronically Infected Individuals. Journal of Clinical Microbiology 2013; 51(2) doi: 10.1128/JCM.03042-12
|
| 254 |
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li, Hongpeng Zhang. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis. International Immunopharmacology 2016; 40 doi: 10.1016/j.intimp.2016.09.015
|
| 255 |
Lenka Benova, Susanne F. Awad, F. DeWolfe Miller, Laith J. Abu‐Raddad. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015; 61(3) doi: 10.1002/hep.27596
|
| 256 |
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis C. The Lancet Infectious Diseases 2009; 9(2) doi: 10.1016/S1473-3099(09)70020-9
|
| 257 |
Amar Deep, Suchit Swaroop, Durgesh Dubey, Atul Rawat, Ajay Verma, Bikash Baisya, Rashmi Parihar, Amit Goel, Sumit Rungta. The metabolic fingerprint of chronic hepatitis C progression: Metabolome shifts and cutting‐edge diagnostic options. Journal of Molecular Recognition 2024; 37(1) doi: 10.1002/jmr.3066
|
| 258 |
S. Ciesek, H. Wedemeyer. Immunosuppression, liver injury and post‐transplant HCV recurrence. Journal of Viral Hepatitis 2012; 19(1) doi: 10.1111/j.1365-2893.2011.01548.x
|
| 259 |
Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun. Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B Carriers. Medicine 2014; 93(20) doi: 10.1097/MD.0000000000000091
|
| 260 |
Abdulrazzaq Bahaulddin Mohammed, Blnd Ibrahim Mohammed, Tariq Hammed Amin. Association Between Hepatitis C Virus Infections and Toll-Like Receptor 3 Gene Polymorphism, Erbil City. Medical Journal of Babylon 2021; 18(3) doi: 10.4103/MJBL.MJBL_28_21
|
| 261 |
Guanghui Cheng, Gongwei Yang, Xifeng Sun, Qian Xin, Yueze Li, Chen Zong, Feng Long, Shiliang Zhang. Association between the telomerase rs2736100_CC genotype and a lower risk of chronic hepatitis C in Chinese males. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11351-z
|
| 262 |
Allan Peres-da-Silva, Adilson José de Almeida, Elisabeth Lampe. Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs. Memórias do Instituto Oswaldo Cruz 2012; 107(2) doi: 10.1590/S0074-02762012000200016
|
| 263 |
Kathie-Anne Walters, Michael G. Katze. Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?. Antiviral Research 2009; 81(3) doi: 10.1016/j.antiviral.2008.12.005
|
| 264 |
Noha Mohamed Hosni Shaheen, Amin Roshdy Soliman, Sahier Omar El-Khashab, Mariam Onsy Farag Hanna. HLA DRB1 Alleles and Hepatitis C Virus Infection in Chronic Kidney Disease Patients. Renal Failure 2013; 35(3) doi: 10.3109/0886022X.2012.761038
|
| 265 |
Livia Rossi, Alejandro Escobar-Gutierrez, Paula Rahal. Advanced Molecular Surveillance of Hepatitis C Virus. Viruses 2015; 7(3) doi: 10.3390/v7031153
|
| 266 |
Serpil MIZRAKÇI, Mukerrem GUVEN, Sevil ALKAN. Seroprevalence of Hepatitis B and Hepatitis C in Inpatients for Alcohol and Drug Addiction Treatment in the Psychiatry Clinic of a Private Hospital. Journal of Biotechnology and Strategic Health Research 2022; 6(1) doi: 10.34084/bshr.1031398
|
| 267 |
Justin C. Strickland, Michele Staton, Carl G. Leukefeld, Carrie B. Oser, J. Matthew Webster. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system. International Journal of Prisoner Health 2018; 14(2) doi: 10.1108/IJPH-03-2017-0012
|
| 268 |
Jeroen Witteveldt, Marion Martin-Gans, Peter Simmonds. Enhancement of the Replication of Hepatitis C Virus Replicons of Genotypes 1 to 4 by Manipulation of CpG and UpA Dinucleotide Frequencies and Use of Cell Lines Expressing SECL14L2 for Antiviral Resistance Testing. Antimicrobial Agents and Chemotherapy 2016; 60(5) doi: 10.1128/AAC.02932-15
|
| 269 |
David S. Campo, Yury Khudyakov. Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions. Infection, Genetics and Evolution 2018; 63 doi: 10.1016/j.meegid.2018.05.028
|
| 270 |
Michael Houghton. The long and winding road leading to the identification of the hepatitis C virus. Journal of Hepatology 2009; 51(5) doi: 10.1016/j.jhep.2009.08.004
|
| 271 |
Mohammad Motaghi, Kazem Ghaffari, Mahroo Mansori, Ali Ghasemi. Comparative Study on the Effect of Vitamin D Deficiency on Platelet Indices in COVID‐19 and Hepatitis C Patients; an Observational Comparative Study. Health Science Reports 2026; 9(3) doi: 10.1002/hsr2.71945
|
| 272 |
Saba Khan, Arpit Bhargava, Neelam Pathak, Kewal. K. Maudar, Subodh Varshney, Pradyumna K. Mishra. Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections. Indian Journal of Clinical Biochemistry 2011; 26(2) doi: 10.1007/s12291-010-0098-7
|
| 273 |
Camille Raynes‐Greenow, Suzanne Polis, Elizabeth Elliott, Winita Hardikar, Alison Kesson, John Kaldor, Cheryl A Jones. Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five years. Journal of Paediatrics and Child Health 2015; 51(11) doi: 10.1111/jpc.12904
|
| 274 |
Ibrahim M. Sayed, Sayed F. Abdelwahab. Is Hepatitis E Virus a Neglected or Emerging Pathogen in Egypt?. Pathogens 2022; 11(11) doi: 10.3390/pathogens11111337
|
| 275 |
Samia Afzal, Muhammad Idrees, Muhammad Ali, Muhammad Ilyas, Abrar Hussain, Madiha Akram, Sadia Butt, Sana Saleem, Irshadur Rehman, Liaqat Ali, Muhammad Shahid. Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approach. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-71
|
| 276 |
Mahwish Khan, Shah Jahan, Saba Khaliq, Bushra Ijaz, Waqar Ahmad, Baila Samreen, Sajida Hassan. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Archives of Virology 2010; 155(11) doi: 10.1007/s00705-010-0797-7
|
| 277 |
Milton W Taylor, Takuma Tsukahara, Jeanette N McClintick, Howard J Edenberg, Paul Kwo. Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment. Journal of Translational Medicine 2008; 6(1) doi: 10.1186/1479-5876-6-66
|
| 278 |
Nikolaus Jilg, Wenyu Lin, Jian Hong, Esperance A. Schaefer, David Wolski, James Meixong, Kaku Goto, Cynthia Brisac, Pattranuch Chusri, Dahlene N. Fusco, Stephane Chevaliez, Jay Luther, Kattareeya Kumthip, Thomas J. Urban, Lee F. Peng, Georg M. Lauer, Raymond T. Chung. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology 2014; 59(4) doi: 10.1002/hep.26653
|
| 279 |
Samir Rouabhia, Mourad Sadelaoud, Karima Chaabna-Mokrane, Wided Toumi, Ludovico Abenavoli. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study. World Journal of Hepatology 2013; 5(7): 393-397 doi: 10.4254/wjh.v5.i7.393
|
| 280 |
Marcel W. Keddeas, Ossama A. Ahmed, Hisham Samy, AbdElaziz Mahmoud, Maha A. El-Tony. Risk assessment of hepatitis C virus seroconversion in haemodialysis patients and units at Sohag. Egyptian Liver Journal 2014; 4(1) doi: 10.1097/01.ELX.0000440961.86687.60
|
| 281 |
Tae-Won KIM, Jong-Hwan LIM, In-Bae SONG, Sang-Jin PARK, Jae-Won YANG, Jung Cheul SHIN, Joo-Won SUH, Hwa-Young SON, Eun-Sang CHO, Myoung-Seok KIM, Sang-Wook LEE, Jong-Woo KIM, Hyo-In YUN. Hepatoprotective and Anti-Hepatitis C Viral Activity of Platycodon grandiflorum Extract on Carbon Tetrachloride-Induced Acute Hepatic Injury in Mice. Journal of Nutritional Science and Vitaminology 2012; 58(3) doi: 10.3177/jnsv.58.187
|
| 282 |
. 2011; doi: 10.70675/1feecd7cz252fz4236z9debz9803b0b34d2e
|
| 283 |
Jun Tao, Jun Liang, Hui Zhang, Lijian Pei, Han-zhu Qian, Matthew C. Chambers, Yan Jiang, Yao Xiao, Jason Blackard. The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China. PLOS ONE 2015; 10(10) doi: 10.1371/journal.pone.0140263
|
| 284 |
Alexander Tarr, Tanvi Khera, Kathrin Hueging, Julie Sheldon, Eike Steinmann, Thomas Pietschmann, Richard Brown. Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design. Viruses 2015; 7(7) doi: 10.3390/v7072809
|
| 285 |
Feng Ni, Smitha Kota, Virginia Takahashi, A. Donny Strosberg, John K. Snyder. Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents. Bioorganic & Medicinal Chemistry Letters 2011; 21(8) doi: 10.1016/j.bmcl.2011.03.014
|
| 286 |
Bader Faiyaz Zuberi, Faisal Faiyaz Zuberi, Sajjad Ali Memon, Muhammad Hafeez Qureshi, Sheikh Zafar Ali, Salahuddin Afsar. Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population. World Journal of Gastroenterology 2008; 14(14): 2218-2221 doi: 10.3748/wjg.14.2218
|
| 287 |
Xiaofei Gao, Qian Cui, Xiang Shi, Jing Su, Zhihang Peng, Xin Chen, Na Lei, Keqin Ding, Lu Wang, Rongbin Yu, Ning Wang. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infectious Diseases 2011; 11(1) doi: 10.1186/1471-2334-11-88
|
| 288 |
Chun-Hung Tseng, Chih-Hsin Muo, Chung Y. Hsu, Chia-Hung Kao. Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection. Medicine 2015; 94(46) doi: 10.1097/MD.0000000000002132
|
| 289 |
Djadé I. Soumana, Akbar Ali, Celia A. Schiffer. Structural Analysis of Asunaprevir Resistance in HCV
NS3/4A Protease. ACS Chemical Biology 2014; 9(11) doi: 10.1021/cb5006118
|
| 290 |
Michel Ventura, Lucie Martin, Chloé Jaubert, Marie-Line Andréola, Cyril Masante. Hepatitis C virus intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence. Journal of General Virology 2017; 98(4) doi: 10.1099/jgv.0.000719
|
| 291 |
Diego M Flichman, Jorgelina L Blejer, Beatriz I Livellara, Viviana E Re, Sonia Bartoli, Juan A Bustos, Claudia P Ansola, Susana Hidalgo, Martin E Cerda, Alicia E Levin, Adriana Huenul, Victoria Riboldi, Elena MC Treviño, Horacio J Salamone, Felix A Nuñez, Robert J Fernández, Juan F Reybaud, Rodolfo H Campos. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-218
|
| 292 |
Umit Yasemin Sert, Yaprak Engin-Ustun, Sibel Saygan, A. Seval Ozgu-Erdinc. Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Status in the Pregnancy. Infectious Diseases in Clinical Practice 2021; 29(2) doi: 10.1097/IPC.0000000000000951
|
| 293 |
Helen S. Te, Donald M. Jensen. Epidemiology of Hepatitis B and C Viruses: A Global Overview. Clinics in Liver Disease 2010; 14(1) doi: 10.1016/j.cld.2009.11.009
|
| 294 |
Volker Meier, Giuliano Ramadori. Hepatitis C virus virology and new treatment targets. Expert Review of Anti-infective Therapy 2009; 7(3) doi: 10.1586/eri.09.12
|
| 295 |
Guiying Cao, Jue Liu, Min Liu. Associations of hepatitis B and C in women aged 15–49 years with neonatal preterm birth in 66 high‐income countries, 1990–2019. International Journal of Gynecology & Obstetrics 2024; 164(1) doi: 10.1002/ijgo.14957
|
| 296 |
Mohamed Abd Elaziz, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong. Quantitative Structure-Activity Relationship Model for HCVNS5B inhibitors based on an Antlion Optimizer-Adaptive Neuro-Fuzzy Inference System. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-19122-y
|
| 297 |
Jin Yang, Yunquan Zhang, Lisha Luo, Runtang Meng, Chuanhua Yu. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis. International Journal of Environmental Research and Public Health 2018; 15(1) doi: 10.3390/ijerph15010170
|
| 298 |
Yun Zhou, Ying Zhang, Zhiqiang Yao, Jonathan Patrick Moorman, Zhansheng Jia. Dendritic cell‐based immunity and vaccination against hepatitis C virus infection. Immunology 2012; 136(4) doi: 10.1111/j.1365-2567.2012.03590.x
|
| 299 |
Wei-Chun Chen, Chin-Kai Tseng, Yen-Hsu Chen, Chun-Kuang Lin, Shih-hsien Hsu, Shen-Nien Wang, Jin-Ching Lee, Stephen J Polyak. HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway. PLOS ONE 2015; 10(7) doi: 10.1371/journal.pone.0133264
|
| 300 |
Jasmine Riviere Marcelin, Lynda A. Szczech, Stacey Rizza. Core Concepts in Parenchymal Kidney Disease. 2014; doi: 10.1007/978-1-4614-8166-9_13
|
| 301 |
M. L. SHIFFMAN, P. POCKROS, J. G. MCHUTCHISON, E. R. SCHIFF, M. MORRIS, G. BURGESS. Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2010; 31(9) doi: 10.1111/j.1365-2036.2010.04264.x
|
| 302 |
Barbara Zanini, Loredana Covolo, Francesco Donato, Alberto Lanzini. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: Meta-analysis of prospective studies. Clinical Therapeutics 2010; 32(13) doi: 10.1016/S0149-2918(11)00021-X
|
| 303 |
Megan G. Hofmeister, Jennifer R. Havens, April M. Young. Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs. The Journal of Primary Prevention 2017; 38(5) doi: 10.1007/s10935-017-0483-6
|
| 304 |
Sania Amr, Emily A Iarocci, Ghada R Nasr, Doa’a Saleh, Jan Blancato, Kirti Shetty, Christopher A Loffredo. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-893
|
| 305 |
David S. Campo, June Zhang, Sumathi Ramachandran, Yury Khudyakov. Transmissibility of intra-host hepatitis C virus variants. BMC Genomics 2017; 18(S10) doi: 10.1186/s12864-017-4267-4
|
| 306 |
Margaret Robinson, Yang Tian, Nikos Pagratis, William E. Delaney. Screening of Hepatitis C Virus Inhibitors Using Genotype 1a HCV Replicon Cell Lines. Current Protocols in Microbiology 2011; 22(1) doi: 10.1002/9780471729259.mc1707s22
|
| 307 |
Li Yen Goh, Tim Card, Andrew W. Fogarty, Tricia M. McKeever. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: A population based study from the NHANES III database. Respiratory Medicine 2014; 108(12) doi: 10.1016/j.rmed.2014.10.006
|
| 308 |
Martina Volarevic, Robert Smolic, Catherine H Wu, George Y Wu. Potential role of RNAi in the treatment of HCV infection. Expert Review of Anti-infective Therapy 2007; 5(5) doi: 10.1586/14787210.5.5.823
|
| 309 |
Brett Hoffman, Qiang Liu. Hepatitis C viral protein translation: mechanisms and implications in developing antivirals. Liver International 2011; 31(10) doi: 10.1111/j.1478-3231.2011.02543.x
|
| 310 |
Ibrahim Slimane, Ghazala Nazir, Juan J. Nieto, Faheem Yaqoob. Mathematical analysis of Hepatitis C Virus infection model in the framework of non-local and non-singular kernel fractional derivative. International Journal of Biomathematics 2023; 16(01) doi: 10.1142/S1793524522500644
|
| 311 |
Massimo Andreoni, Sergio Babudieri, Savino Bruno, Massimo Colombo, Anna L. Zignego, Vito Di Marco, Giovanni Di Perri, Carlo F. Perno, Massimo Puoti, Gloria Taliani, Erica Villa, Antonio Craxì. Current and future challenges in HCV: insights from an Italian experts panel. Infection 2018; 46(2) doi: 10.1007/s15010-017-1093-1
|
| 312 |
Zobair M. Younossi, Ancha Baranova, Arian Afendy, Rochelle Collantes, Maria Stepanova, Ganiraju Manyam, Anita Bakshi, Christopher L. Sigua, Joanne P. Chan, Ayuko A. Iverson, Christopher D. Santini, Sheng‐Yung P. Chang. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†. Hepatology 2009; 49(3) doi: 10.1002/hep.22729
|
| 313 |
Udayan Chatterji, Michael Bobardt, Lana Schaffer, Malcolm Wood, Philippe A. Gallay, Birke Bartosch. Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0159511
|
| 314 |
Jin‐Ching Lee, Chin‐Kai Tseng, Kung‐Chia Young, Hung‐Yu Sun, Shainn‐Wei Wang, Wei‐Chun Chen, Chun‐Kuang Lin, Yu‐Hsuan Wu. Andrographolide exerts anti‐hepatitis C virus activity by up‐regulating haeme oxygenase‐1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. British Journal of Pharmacology 2014; 171(1) doi: 10.1111/bph.12440
|
| 315 |
Geraldo Duarte, Paula Pezzuto, Tiago Dahrug Barros, Gláucio Mosimann Junior, Flor Ernestina Martinez-Espinosa. Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis. Revista da Sociedade Brasileira de Medicina Tropical 2021; 54( suppl 1) doi: 10.1590/0037-8682-834-2020
|
| 316 |
Mark V. Thomas, Glena Jarboe, Robert Q. Frazer. Infection Control in the Dental Office. Dental Clinics of North America 2008; 52(3) doi: 10.1016/j.cden.2008.02.002
|
| 317 |
Dalia Elsayed Metawlly, Ahmed Noby Amer, Hanan Mostafa Mostafa, Gamal El Din Elsawaf, Ola Abd El Kader. Low cost detection of hepatitis C virus RNA in HCV infected patients by SYBR Green I real-time PCR. Alexandria Journal of Medicine 2018; 54(4) doi: 10.1016/j.ajme.2017.11.004
|
| 318 |
Masakuni Tateyama, Hiroshi Yatsuhashi, Naota Taura, Yasuhide Motoyoshi, Shinya Nagaoka, Kenji Yanagi, Seigo Abiru, Koji Yano, Atsumasa Komori, Kiyoshi Migita, Minoru Nakamura, Hiroyasu Nagahama, Yutaka Sasaki, Yuzo Miyakawa, Hiromi Ishibashi. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. Journal of Gastroenterology 2011; 46(1) doi: 10.1007/s00535-010-0293-6
|
| 319 |
S. K. Basnayake, P. J. Easterbrook. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. Journal of Viral Hepatitis 2016; 23(7) doi: 10.1111/jvh.12519
|
| 320 |
I. V. Astrakhantseva, D. S. Campo, A. Araujo, C.-G Teo, Y. Khudyakov, S. Kamili. Variation in physicochemical properties of the hypervariable region 1 during acute and chronic stages of hepatitis C virus infection. 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; doi: 10.1109/BIBMW.2011.6112357
|
| 321 |
Z.A. Randriamanantany, D.H. Rajaonatahina, F.É. Razafimanantsoa, M.T. Rasamindrakotroka, R. Andriamahenina, F.B. Rasoarilalaomanarivo, S.P. Hanitriniala, F.R. Herisoa, O.A. Rakoto-Alson, A. Rasamindrakotroka. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009. Transfusion Clinique et Biologique 2012; 19(2) doi: 10.1016/j.tracli.2011.10.004
|
| 322 |
Anissa Chouikha, Marwa Khedhiri, Hatem Triki, Walid Hammemi, Amel Sadraoui, Henda Touzi, Ahlem Ben Yahia, Amel Chtourou, Saba Gargouri, Lamia Feki Ben Rajah, Hela Hakim Karray, Henda Triki. Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study. Archives of Virology 2021; 166(2) doi: 10.1007/s00705-020-04918-7
|
| 323 |
|
| 324 |
Alison B. Jazwinski, Andrew J. Muir. Emerging Therapies in Hepatitis C: Dawn of the Era of the Direct-Acting Antivirals. Gastroenterology Clinics of North America 2011; 40(3) doi: 10.1016/j.gtc.2011.06.005
|
| 325 |
Ana Matošević, Anita Bosak. Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents. Archives of Industrial Hygiene and Toxicology 2020; 71(4) doi: 10.2478/aiht-2020-71-3466
|
| 326 |
Shu Nishikori, Kenji Takemoto, Shinji Kamisuki, Syo Nakajima, Kouji Kuramochi, Senko Tsukuda, Masashi Iwamoto, Yuri Katayama, Takahiro Suzuki, Susumu Kobayashi, Koichi Watashi, Fumio Sugawara. Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei. Journal of Natural Products 2016; 79(2) doi: 10.1021/acs.jnatprod.5b00555
|
| 327 |
Snawar Hussain, Naina Barretto, Susan L Uprichard. New hepatitis C virus drug discovery strategies and model systems. Expert Opinion on Drug Discovery 2012; 7(9) doi: 10.1517/17460441.2012.711312
|
| 328 |
Rohan J. Meshram, Rajesh N. Gacche. Effective epitope identification employing phylogenetic, mutational variability, sequence entropy, and correlated mutation analysis targeting NS5B protein of hepatitis C virus: from bioinformatics to therapeutics. Journal of Molecular Recognition 2015; 28(8) doi: 10.1002/jmr.2466
|
| 329 |
Perrine Roux, Jean‐Marie Le Gall, Marie Debrus, Camélia Protopopescu, Khadim Ndiaye, Baptiste Demoulin, Caroline Lions, Aurelie Haas, Marion Mora, Bruno Spire, Marie Suzan‐Monti, Maria Patrizia Carrieri. Innovative community‐based educational face‐to‐face intervention to reduce HIV, hepatitis C virus and other blood‐borne infectious risks in difficult‐to‐reach people who inject drugs: results from the ANRS–AERLI intervention study. Addiction 2016; 111(1) doi: 10.1111/add.13089
|
| 330 |
Yanli Zeng, Wei Li, Jingtao Li, Junjie Wang, Bin Zhou, Jian Zhang, Shuwen Liu, Yingsong Wu, Jinlin Hou, Yuanping Zhou. Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C. Archives of Virology 2012; 157(6) doi: 10.1007/s00705-012-1283-1
|
| 331 |
Chuanliang Han, Meijia Li, Naem Haihambo, Yu Cao, Xixi Zhao, Nicholas S. Duesbery. Enlightenment on oscillatory properties of 23 class B notifiable infectious diseases in the mainland of China from 2004 to 2020. PLOS ONE 2021; 16(6) doi: 10.1371/journal.pone.0252803
|
| 332 |
Jean Marie Ntaganda, Mahamat Saleh Daoussa Haggar, Benjamin Mampassi. Fuzzy Logic Strategy for Solving an Optimal Control Problem of Therapeutic Hepatitis C Virus Dynamics. Open Journal of Applied Sciences 2015; 5(09) doi: 10.4236/ojapps.2015.59051
|
| 333 |
Kairi Mansberg, Karin Kull, Riina Salupere, Tiina Prükk, Benno Margus, Toomas Kariis, Triin Remmel, Külliki Suurmaa, Kristi Ott, Krista Jaago, Jelena Šmidt. A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia. Medicina 2018; 54(1) doi: 10.3390/medicina54010009
|
| 334 |
Paul Y. Kwo. Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection. Therapeutic Advances in Gastroenterology 2012; 5(3) doi: 10.1177/1756283X11436317
|
| 335 |
|
| 336 |
Danielle Scher, Enes Kanlic, Julia Bader, Melchor Ortiz, Amr Abdelgawad. Hepatitis C Viral Infection as an Associated Risk Factor for Necrotizing Fasciitis. Orthopedics 2012; 35(4) doi: 10.3928/01477447-20120327-43
|
| 337 |
Adriana Sánchez-García, Clara Patricia Ríos-Ibarra, Ana Rosa Rincón-Sánchez, Rocío Ortiz-López, Aurora Garza-Juárez, Jesús Morlett-Chávez, Herminia Martínez-Rodríguez, Ana María Rivas-Estilla. Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid. Annals of Hepatology 2013; 12(5) doi: 10.1016/S1665-2681(19)31313-4
|
| 338 |
V A Malov, E A Ubeeva, I P Ubeeva, S M Nikolaev, K T Umbetova. Treatment of chronic viral hepatitis C with direct acting antiviral agent: review. Terapevticheskii arkhiv 2019; 91(11) doi: 10.26442/00403660.2019.11.000307
|
| 339 |
Hassan A. Al-Shamahy, Sami Sultan Ahmed Abdu. Genotyping of Hepatitis C Virus (HCV) in Infected Patients from Yemen. European Journal of Basic Medical Sciences 2013; 3(4) doi: 10.15197/sabad.2.3.15
|
| 340 |
Abdulmumini Yakubu, Bello Hali, Abubakar Sadiq Maiyaki. Prevalence and Risk Factors for Hepatitis C Virus Co-infection among Human Immunodeficiency Virus-Infected Patients and Effect of Hepatitis C Virus Infection on Acquired Immunodeficiency Syndrome Cases at Baseline. Annals of African Medicine 2021; 20(4) doi: 10.4103/aam.aam_65_20
|
| 341 |
Mo Guan, Wenbo Wang, Xiaoqing Liu, Yimin Tong, Yuan Liu, Hao Ren, Shiying Zhu, Jean Dubuisson, Thomas F. Baumert, Yongzhe Zhu, Haoran Peng, Laure Aurelian, Ping Zhao, Zhongtian Qi. Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune Evasion. Journal of Biological Chemistry 2012; 287(42) doi: 10.1074/jbc.M112.382341
|
| 342 |
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana. Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI. Revista Colombiana de Gastroenterología 2019; 34(3) doi: 10.22516/25007440.322
|
| 343 |
Dita Broz, Lawrence J. Ouellet. Prevalence and Correlates of Former Injection Drug Use Among Young Noninjecting Heroin Users in Chicago. Substance Use & Misuse 2010; 45(12) doi: 10.3109/10826081003682875
|
| 344 |
Issifou Yaya, Perrine Roux, Fabienne Marcellin, Linda Wittkop, Laure Esterle, Bruno Spire, Stéphanie Dominguez, Boni Armand Elegbe, Lionel Piroth, Philippe Sogni, Dominique Salmon-Ceron, Maria Patrizia Carrieri, Yury E. Khudyakov. Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients. PLOS ONE 2018; 13(7) doi: 10.1371/journal.pone.0199874
|
| 345 |
Karim Si-Tayeb, Jean-Charles Duclos-Vallée, Marie-Anne Petit. Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal. Journal of Hepatology 2012; 57(3) doi: 10.1016/j.jhep.2012.04.012
|
| 346 |
Volker Lohmann. Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development. Medical Microbiology and Immunology 2019; 208(1) doi: 10.1007/s00430-018-0566-x
|
| 347 |
Xi Chen. Commercial plasma donation and individual health in impoverished rural China. Health Economics Review 2014; 4(1) doi: 10.1186/s13561-014-0030-6
|
| 348 |
Markus S. Kupka. Reproduktionsmedizin. Springer Reference Medizin 2019; doi: 10.1007/978-3-662-55601-6_42-2
|
| 349 |
Amna H.A. Ibrahim, Hermane Mambili Mamboundou. Mathematical model of immune response to Hepatitis C virus (HCV) disease. Partial Differential Equations in Applied Mathematics 2025; 16 doi: 10.1016/j.padiff.2025.101275
|
| 350 |
Daniel Fuster, Jordi Tor, Celestino Rey-Joly, Robert Muga. Interacciones patogénicas entre alcohol y hepatitis C. Medicina Clínica 2012; 138(14) doi: 10.1016/j.medcli.2011.04.019
|
| 351 |
Ivo Ditah, Badr Al Bawardy, Humberto C Gonzalez, Behnam Saberi, Callistus Ditah, Patrick S Kamath, Michael Charlton. Lack of Health Insurance Limits the Benefits of Hepatitis C Virus Screening: Insights from the National Health and Nutrition Examination Hepatitis C Follow-Up Study. American Journal of Gastroenterology 2015; 110(8) doi: 10.1038/ajg.2015.31
|
| 352 |
Dinesh Manvar, Talita de A. Fernandes, Jorge L.O. Domingos, Erdenechimeg Baljinnyam, Amartya Basu, Eurides F.T. Junior, Paulo R.R. Costa, Neerja Kaushik-Basu. Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitors. European Journal of Medicinal Chemistry 2015; 93 doi: 10.1016/j.ejmech.2015.01.057
|
| 353 |
Hamed Delam, Ahmadreza Eidi, Zahra Keshtkaran, Alireza Shahedi, Omid Soufi, Behzad Rezaei, Mohammad-Rafi Bazrafshan. Changing the Epidemiology and Pattern of Hepatitis B and C in the South of Fars Province, Southern Iran: 2015 - 2021. Jundishapur Journal of Chronic Disease Care 2023; 12(3) doi: 10.5812/jjcdc-137658
|
| 354 |
Felicidade Mota Pereira, Maria Alice Sant'ana Zarife, Eliana Almeida Gomes Reis, Mitermayer G. Reis. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(1) doi: 10.1590/0037-8682-0222-2013
|
| 355 |
William Botelho de Brito, Maria Alice Freitas Queiroz, Ednelza da Silva Graça Amoras, Sandra Souza Lima, Simone Regina Souza da Silva Conde, Eduardo José Melo dos Santos, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. The TGFB1 -509C/T polymorphism and elevated TGF-β1 levels are associated with chronic hepatitis C and cirrhosis. Immunobiology 2020; 225(5) doi: 10.1016/j.imbio.2020.152002
|
| 356 |
Filippo Ansaldi, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Giancarlo Icardi. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World Journal of Gastroenterology 2014; 20(29): 9633-9652 doi: 10.3748/wjg.v20.i29.9633
|
| 357 |
Mirjam Kretzschmar, Lucas Wiessing. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. AIDS 2008; 22(13) doi: 10.1097/QAD.0b013e3282ff6265
|
| 358 |
Raf Crabbé, Grégoire Vuagniaux, Jean-Maurice Dumont, Valérie Nicolas-Métral, Judith Marfurt, Laura Novaroli. An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C. Expert Opinion on Investigational Drugs 2009; 18(2) doi: 10.1517/13543780802651583
|
| 359 |
Stephanie Pfaender, Stephanie Walter, Daniel Todt, Patrick Behrendt, Juliane Doerrbecker, Benno Wölk, Michael Engelmann, Ute Gravemann, Axel Seltsam, Joerg Steinmann, Peter D. Burbelo, Frank Klawonn, Karsten Feige, Thomas Pietschmann, Jessika-M. V. Cavalleri, Eike Steinmann. Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure.
Journal of General Virology
2015; 96(9) doi: 10.1099/vir.0.000208
|
| 360 |
Shafquat M. Rafiq, Harunor Rashid, Elizabeth Haworth, Robert Booy. Hazards of hepatitis at the Hajj. Travel Medicine and Infectious Disease 2009; 7(4) doi: 10.1016/j.tmaid.2008.09.008
|
| 361 |
Liesl M. Hagan, Ana Kasradze, Stephanie J. Salyer, Amiran Gamkrelidze, Maia Alkhazashvili, Gvantsa Chanturia, Nazibrola Chitadze, Roena Sukhiashvili, Marina Shakhnazarova, Steven Russell, Curtis Blanton, Giorgi Kuchukhidze, Davit Baliashvili, Susan Hariri, Stephen Ko, Paata Imnadze, Jan Drobeniuc, Juliette Morgan, Francisco Averhoff. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination. BMC Public Health 2019; 19(S3) doi: 10.1186/s12889-019-6784-3
|
| 362 |
|
| 363 |
Brunel M. Angounda, Serge O. Mokono, Ngala Itoua-Ngaporo, Jourdain B. Nziengue M’vouala, Jile F. Mimiesse, Clausina M. Ahoui Apendi, Gabriel Ahombo, Blaise I. Atipo Ibara, Jean Rosaire Ibara. Prevalence of Hepatitis C Virus Infection and Risk Factors among Pregnant Women in Pointe Noire, Republic of Congo. Journal of Biosciences and Medicines 2019; 7(08) doi: 10.4236/jbm.2019.78007
|
| 364 |
Ming-Ju Hsieh, Mu-Kuan Chen, Chih-Jung Chen, Ming-Chang Hsieh, Yu-Sheng Lo, Yi-Ching Chuang, Hui-Ling Chiou, Shun-Fa Yang. Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells. Phytomedicine 2016; 23(4) doi: 10.1016/j.phymed.2016.01.005
|
| 365 |
L. I Nikolaeva, E. A Leybman, G. V Sapronov, A. N Yudin. Liver cirrhosis and hepatocellular carcinoma in patients with chronic viral hepatitis c: some epidemiologic and molecular-genetic aspects. Epidemiology and Infectious Diseases 2014; 19(2) doi: 10.17816/EID40788
|
| 366 |
T P Rozina, T M Ignatova, S V Fastovets, E E Starostina, L M Samokhodskaia, T N Krasnova. The first experience of non-interferon therapy of HCV infection in patients with Wilson-Konovalov’s disease. Terapevticheskii arkhiv 2018; 90(11) doi: 10.26442/terarkh201890114-78
|
| 367 |
Feng Qu, Su-Jun Zheng, Cai-Sheng Wu, Zhi-Xin Jia, Jin-Lan Zhang, Zhong-Ping Duan. Lipidomic profiling of plasma in patients with chronic hepatitis C infection. Analytical and Bioanalytical Chemistry 2014; 406(2) doi: 10.1007/s00216-013-7479-8
|
| 368 |
Basmattee Boodram, Ronald C. Hershow, Scott J. Cotler, Lawrence J. Ouellet. Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users. Drug and Alcohol Dependence 2011; 119(3) doi: 10.1016/j.drugalcdep.2011.06.005
|
| 369 |
Helen Caldwell. Preventing, identifying and treating hepatitis C. Nursing Standard 2019; 34(1) doi: 10.7748/ns.2018.e11321
|
| 370 |
Jiaye Long, Kai Cui, Du Wang, Shuxin Qin, Zhong Li. Burden of Hepatocellular Carcinoma and Its Underlying Etiologies in China, 1990-2021: Findings From the Global Burden of Disease Study 2021. Cancer Control 2024; 31 doi: 10.1177/10732748241310573
|
| 371 |
Safa Machraoui, Abdelmalek Hakmaoui, Khaoula Errafii, Mehdi Knidiri, Lamiaa Essaadouni, Khadija Krati, Brahim Admou. HLA Class I (A and B) Allele Polymorphism in a Moroccan Population Infected with Hepatitis C Virus. Current Issues in Molecular Biology 2024; 46(12) doi: 10.3390/cimb46120842
|
| 372 |
Ruben Hernaez, Hsin-Chieh Yeh, Mariana Lazo, Hui-Ming Chung, James P. Hamilton, Ayman Koteish, James J. Potter, Frederick L. Brancati, Jeanne M. Clark. Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study. Hepatology International 2013; 7(4) doi: 10.1007/s12072-013-9476-6
|
| 373 |
B. E. Pickett, R. Striker, E. J. Lefkowitz. Evidence for separation of HCV subtype 1a into two distinct clades. Journal of Viral Hepatitis 2011; 18(9) doi: 10.1111/j.1365-2893.2010.01342.x
|
| 374 |
Felicidade Mota Pereira, Maria da Conceição Chagas de Almeida, Fred Luciano Neves Santos, Roberto Perez Carreiro, Bernardo Galvão-Castro, Maria Fernanda Rios Grassi, William M. Switzer. Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil. PLOS ONE 2020; 15(7) doi: 10.1371/journal.pone.0223087
|
| 375 |
A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina. Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation 2023; 13(4) doi: 10.30895/1991-2919-2023-499
|
| 376 |
Yuan‐Ming Lee, Huang‐Jie Lin, Yen‐Ju Chen, Cheng‐Ming Lee, Sheng‐Fan Wang, Kai‐Yuan Chang, Tzu‐Lang Chen, Hsin‐Fu Liu, Yi‐Ming Arthur Chen. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full‐length sequences of two new subtype 6w strains and a recombinant form_2b6w. Journal of Medical Virology 2010; 82(1) doi: 10.1002/jmv.21658
|
| 377 |
Laura Pacini, Rita Graziani, Linda Bartholomew, Raffaele De Francesco, Giacomo Paonessa.
Naturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are
trans
-Packaged In Vitro To Generate Infectious Defective Particles
. Journal of Virology 2009; 83(18) doi: 10.1128/JVI.00308-09
|
| 378 |
Celeste Reker, K.M. Islam. Risk factors associated with high prevalence rates of hepatitis C infection in Egypt. International Journal of Infectious Diseases 2014; 25 doi: 10.1016/j.ijid.2014.02.003
|
| 379 |
Z. Dimitrova, D. S. Campo, S. Ramachandran, G. Vaughan, L. Ganova-Raeva, Y. Lin, J. C. Forbi, G. Xia, P. Skums, B. Pearlman, Y. Khudyakov. Assessments of intra- and inter-host diversity of hepatitis C virus using Next Generation Sequencing and Mass spectrometry. 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; doi: 10.1109/BIBMW.2011.6112358
|
| 380 |
Dmitry K. Lvov, Sergey V. Alkhovsky, Oleg Petrovich Zhirnov. 130th anniversary of virology. Problems of Virology 2022; 67(5) doi: 10.36233/0507-4088-140
|
| 381 |
Markus S. Kupka. Reproduktionsmedizin. Springer Reference Medizin 2020; doi: 10.1007/978-3-662-57636-6_42
|
| 382 |
Robert B. Hood, William C. Miller, Abigail Shoben, Randall E. Harris, Alison H. Norris, Gbenga Olorunfemi. Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States. PLOS ONE 2023; 18(10) doi: 10.1371/journal.pone.0291994
|
| 383 |
Bassam Bernieh. Viral hepatitis in hemodialysis: An update. Journal of Translational Internal Medicine 2015; 3(3) doi: 10.1515/jtim-2015-0018
|
| 384 |
E. Crouchet, R. Saad, C. Affolter-Zbaraszczuk, J. Ogier, T. F. Baumert, C. Schuster, F. Meyer. Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection. Journal of Materials Chemistry B 2017; 5(4) doi: 10.1039/C6TB01718E
|
| 385 |
Roland Remenyi, Hangfei Qi, Sheng-Yao Su, Zugen Chen, Nicholas C. Wu, Vaithilingaraja Arumugaswami, Shawna Truong, Virginia Chu, Tamar Stokelman, Hung-Hao Lo, C. Anders Olson, Ting-Ting Wu, Shu-Hwa Chen, Chung-Yen Lin, Ren Sun, Peter Palese. A Comprehensive Functional Map of the Hepatitis C Virus Genome Provides a Resource for Probing Viral Proteins. mBio 2014; 5(5) doi: 10.1128/mBio.01469-14
|
| 386 |
Małgorzata Zdrodowska, Anna Kasperczuk, Agnieszka Dardzińska-Głębocka. Selected feature selection methods for classifying patients with Hepatitis C. Procedia Computer Science 2023; 225 doi: 10.1016/j.procs.2023.10.366
|
| 387 |
. 2011; doi: 10.70675/d8c05805z1edfz42d2zb167zbb86786ada47
|
| 388 |
A. Birerdinc, A. Afendy, M. Stepanova, I. Younossi, G. Manyam, A. Baranova, Z. M. Younossi. Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C. Journal of Viral Hepatitis 2010; 17(10) doi: 10.1111/j.1365-2893.2009.01235.x
|
| 389 |
Lindsay A. Uribe, Peter Bacchetti, Nicholas Gelman, Esteban Burchard, Mark Fitch, Marc Hellerstein, Mandana Khalili. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Alcoholism: Clinical and Experimental Research 2018; 42(3) doi: 10.1111/acer.13576
|
| 390 |
Michael Houghton. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunological Reviews 2011; 239(1) doi: 10.1111/j.1600-065X.2010.00977.x
|
| 391 |
Marina Matas, Antònia Picornell, Carmen Cifuentes, Antoni Payeras, Antoni Bassa, Francesc Homar, Fernando González-Candelas, F. Xavier López-Labrador, Andrés Moya, Maria M. Ramon, José A. Castro. Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients. Infection, Genetics and Evolution 2013; 13 doi: 10.1016/j.meegid.2012.10.020
|
| 392 |
Xiao-Min Wu, Cheng Jin, Yuan-Long Gu, Wu-Qiang Chen, Mao-Qun Zhu, Shuo Zhang, Zhen Zhang. <p>Gluconokinase IDNK Promotes Cell Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S234055
|
| 393 |
Mohamed Emam, Mohamed I. Radwan, Mohamed M. Refaey, Noha E. Shaheen, Safaa Abd-ElMoez, Marian A. Gerges. Prevalence of hepatitis C virus in an elderly population in rural areas of Sharkia governorate, Egypt. Egyptian Liver Journal 2015; 5(2) doi: 10.1097/01.ELX.0000463678.53334.c7
|
| 394 |
Ya-pei Wang, Shu-wen Yang, Fan Jia, Wei Wang, Xue Xu, Yi-xuan Wang, Jing-feng Bi, Bo-an Li, Vera Tesic. Effect of concentration, temperature, and time on the stability of hepatitis C virus nucleic acid in serum. Microbiology Spectrum 2024; 12(10) doi: 10.1128/spectrum.00769-24
|
| 395 |
Mudassar Imran, Hassan Rafique, Adnan Khan, Tufail Malik. A model of bi-mode transmission dynamics of hepatitis C with optimal control. Theory in Biosciences 2014; 133(2) doi: 10.1007/s12064-013-0197-0
|
| 396 |
Nidhi Vaid, Katherine M. Langan, Richard J. Maude. Post‐exposure prophylaxis in resource‐poor settings: review and recommendations for pre‐departure risk assessment and planning for expatriate healthcare workers. Tropical Medicine & International Health 2013; 18(5) doi: 10.1111/tmi.12080
|
| 397 |
Sarwat Mahmud, Vajiheh Akbarzadeh, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18296-9
|
| 398 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_164
|
| 399 |
Sk Md Mosaddek Hossain, Sumanta Ray, Tabassum Sultana Tannee, Anirban Mukhopadhyay. Analyzing Prognosis Characteristics of Hepatitis C using a Biclustering Based Approach. Procedia Computer Science 2017; 115 doi: 10.1016/j.procs.2017.09.136
|
| 400 |
Gerald Friedland. Infectious Disease Comorbidities Adversely Affecting Substance Users With HIV: Hepatitis C and Tuberculosis. JAIDS Journal of Acquired Immune Deficiency Syndromes 2010; 55(Supplement 1) doi: 10.1097/QAI.0b013e3181f9c0b6
|
| 401 |
Wenlian Li, Hongzong Si, Yang Li, Cuizhu Ge, Fucheng Song, Xiuting Ma, Yunbo Duan, Honglin Zhai. 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase. Journal of Molecular Structure 2016; 1117 doi: 10.1016/j.molstruc.2016.03.073
|
| 402 |
Edgar Turner Overton, Judith A. Aberg. HIV and Liver Disease. 2012; doi: 10.1007/978-1-4419-1712-6_17
|
| 403 |
Juan Cristina, Ricardo Recarey. Identification of MicroRNA-Like Molecules Derived from the Antigenome RNA of Hepatitis C Virus: A Bioinformatics Approach. Natural Science 2016; 8(04) doi: 10.4236/ns.2016.84021
|
| 404 |
Azza Masoud Abdelbaky Ahmed, Hanan Abdelftah Temerk, Hamdi Ramdan Galal, Shamardan Ezzeldin S. Bazeed, Serageldeen Sultan. The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper Egypt. VirusDisease 2020; 31(3) doi: 10.1007/s13337-020-00589-9
|
| 405 |
R. Ingle, A.K. Chaya, S. Chavan, S. Taklikar, S. Baveja. A study of seroprevalence and the associated risk factors of hepatitis C at a tertiary care hospital in Mumbai. Clinical Epidemiology and Global Health 2023; 23 doi: 10.1016/j.cegh.2023.101356
|
| 406 |
Philippe Roingeard, Marion Depla. The birth and life of lipid droplets: learning from the hepatitis C virus. Biology of the Cell 2011; 103(5) doi: 10.1042/BC20100119
|
| 407 |
Jia‐Horng Kao, Ming‐Lung Yu, Cheng‐Yuan Peng, Jeong Heo, Chi‐Jen Chu, Ting‐Tsung Chang, Youn‐Jae Lee, Tsung‐Hui Hu, Ki Tae Yoon, Seung Woon Paik, Young Suk Lim, Sang Hoon Ahn, Vasily Isakov, Fiona McPhee, Wenhua Hu, Eugene Scott Swenson, Philip D Yin, Michelle Treitel. Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1. Journal of Gastroenterology and Hepatology 2017; 32(12) doi: 10.1111/jgh.13796
|
| 408 |
Nicolas Khatmi, Lionel Dany, Khadim Ndiaye, Patrizia Carrieri, Daniela Rojas Castro, Perrine Roux. Impact of an educational intervention on risks associated with drug injection, and on psychosocial factors (PSF) involved in initiating and maintaining new health behaviors over time. Addictive Behaviors 2018; 87 doi: 10.1016/j.addbeh.2018.07.007
|
| 409 |
Elena Zocca, Silva Seraceni, Teresa Cafaro, Tamara Emanuela Cervone, Laura Cardarelli, Massimiliano Valisi, Isabella Polidori, Massimo Pieri, Flaminia Tomassetti, Francesco Broccolo. Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach. Diagnostics 2024; 14(6) doi: 10.3390/diagnostics14060570
|
| 410 |
Jessica Liu, Hwai-I Yang, Mei-Hsuan Lee, Wan-Lun Hsu, Hui-Chi Chen, Chien-Jen Chen. Infection and Cancer: Bi-Directorial Interactions. 2015; doi: 10.1007/978-3-319-20669-1_3
|
| 411 |
Javier Briceño, Ruben Ciria, María Pleguezuelo, Manuel de la Mata, Jordi Muntané, Álvaro Naranjo, Juan Sánchez-Hidalgo, Trinidad Marchal, Sebastián Rufián, Pedro López-Cillero. Impact of Donor Graft Steatosis on Overall Outcome and Viral Recurrence After Liver Transplantation for Hepatitis C Virus Cirrhosis. Liver Transplantation 2009; 15(1) doi: 10.1002/lt.21566
|
| 412 |
Joseph S. Doyle, Rachel Sacks-Davis, Margaret E. Hellard. Acute Hepatitis C Infection: New Approaches to Surveillance, Treatment and Prevention. Current Hepatitis Reports 2012; 11(4) doi: 10.1007/s11901-012-0143-5
|
| 413 |
Garima Jindal, Dibyendu Mondal, Arieh Warshel. Exploring the Drug Resistance of HCV Protease. The Journal of Physical Chemistry B 2017; 121(28) doi: 10.1021/acs.jpcb.7b04562
|
| 414 |
Z. M. Younossi, M. Stepanova, F. Nader, Z. Younossi, E. Elsheikh. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Alimentary Pharmacology & Therapeutics 2013; 37(6) doi: 10.1111/apt.12234
|
| 415 |
Kenji Ikeda, Yasuji Arase, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada. Necessities of Interferon Therapy in Elderly Patients with Chronic Hepatitis C. The American Journal of Medicine 2009; 122(5) doi: 10.1016/j.amjmed.2008.09.045
|
| 416 |
Anuli Nwaohiri, Sarah Schillie, Marc Bulterys, Athena P. Kourtis. Hepatitis C virus infection in children: How do we prevent it and how do we treat it?. Expert Review of Anti-infective Therapy 2018; 16(9) doi: 10.1080/14787210.2018.1509707
|
| 417 |
Jian Cao, Dawei Li. Searching for human oncoviruses: Histories, challenges, and opportunities. Journal of Cellular Biochemistry 2018; 119(6) doi: 10.1002/jcb.26717
|
| 418 |
Joseph Kluck, Rose M. O’Flynn, David E. Kaplan, Kyong-Mi Chang. Evaluation of the Significance of Pretreatment Liver Biopsy and Baseline Mental Health Disorder Diagnosis on Hepatitis C Treatment Completion Rates at a Veterans Affairs Medical Center. Hepatitis Research and Treatment 2013; 2013 doi: 10.1155/2013/653976
|
| 419 |
Livia Maria Gonçalves Rossi, Alejandro Escobar-Gutierrez, Paula Rahal. Multiregion deep sequencing of hepatitis C virus: An improved approach for genetic relatedness studies. Infection, Genetics and Evolution 2016; 38 doi: 10.1016/j.meegid.2015.12.020
|
| 420 |
Silvia Bassani Schuch-Goi, Juliana Nichterwitz Scherer, Felix Henrique Paim Kessler, Anne Orgler Sordi, Flavio Pechansky, Lisia von Diemen. Hepatitis C: clinical and biological features related to different forms of cocaine use. Trends in Psychiatry and Psychotherapy 2017; 39(4) doi: 10.1590/2237-6089-2016-0076
|
| 421 |
Fiona McPhee, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kasuaki Chayama, Yoshiiku Kawakami, Min Lung Yu, Sang Hoon Ahn, Hiroki Ishikawa, Rafia Bhore, Nannan Zhou, Dennis Hernandez, Patricia Mendez, Hiromitsu Kumada. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms. Advances in Therapy 2015; 32(7) doi: 10.1007/s12325-015-0221-5
|
| 422 |
Zohreh Sharifi, Mahmood Mahmoodian Shooshtari, Fahimeh Rangbar Kermani. Identification of HCV genotypes in HCV infected blood donors. Indian Journal of Microbiology 2010; 50(3) doi: 10.1007/s12088-010-0059-0
|
| 423 |
Francisca Sosa-Jurado, Verónica L Hernández-Galindo, Daniel Meléndez-Mena, Miguel A Mendoza-Torres, Fernando J Martínez-Arroniz, Verónica Vallejo-Ruiz, Julio Reyes-Leyva, Gerardo Santos-López. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-72
|
| 424 |
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
|
| 425 |
Lillian Gelberg, Marjorie J. Robertson, Lisa Arangua, Barbara D. Leake, Gerald Sumner, Ardis Moe, Ronald M. Andersen, Hal Morgenstern, Adeline Nyamathi. Prevalence, Distribution, and Correlates of Hepatitis C Virus Infection among Homeless Adults in Los Angeles. Public Health Reports® 2012; 127(4) doi: 10.1177/003335491212700409
|
| 426 |
V. T. Ivashkin, V. P. Chulanov, N. A. Mamonova, M. V. Maevskaya, M. S. Zharkova, I. N. Tikhonov, P. O. Bogomolov, E. V. Volchkova, A. S. Dmitriev, O. O. Znojko, E. A. Klimova, K. V. Kozlov, I. E. Kravchenko, E. Yu. Malinnikova, R. V. Maslennikov, M. I. Mikhailov, K. E. Novak, I. G. Nikitin, V. E. Syutkin, E. V. Esaulenko, A. A. Sheptulin, E. N. Shirokova, N. D. Yushchuk. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(1) doi: 10.22416/1382-4376-2023-33-1-84-124
|
| 427 |
Monem Makki Alshok. Clinical Study on Hepatitis C Virus Infection in Babylon, Iraq. Medical Journal of Babylon 2025; 22(3) doi: 10.4103/MJBL.MJBL_1691_23
|
| 428 |
Maria Teresa Catanese, Helenia Ansuini, Rita Graziani, Thierry Huby, Martine Moreau, Jonathan K. Ball, Giacomo Paonessa, Charles M. Rice, Riccardo Cortese, Alessandra Vitelli, Alfredo Nicosia. Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants. Journal of Virology 2010; 84(1) doi: 10.1128/JVI.02199-08
|
| 429 |
Jeffrey N. T. Squire, Michaelann George, Zakirah Allain, Oghenowede Eyawo. Infectious medical waste (IMW) and disease transmission: A critical public health challenge in Africa and the global implications – A systematic review. Journal of Public Health Research 2026; 15(3) doi: 10.1177/22799036261470478
|
| 430 |
Atika Mansoor, Lubna Ali, Noor-ul Sabah, Asraf Hussain Hashmi, Mohammad Haroon Khan, Syed Ali Raza Kazmi, Nafees Ahmad, Saima Siddiqi, Khalid Mehmood Khan. Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-352
|
| 431 |
Cristiana Luiza Rădoi, Elena-Iuliana-Anamaria Berbecaru, Anca-Maria Istrate-Ofițeru, Rodica Daniela Nagy, Roxana Cristina Drăgușin, Razvan Grigoraș Căpitănescu, Marian Valentin Zorilă, Lucian George Zorilă, Dominic Gabriel Iliescu. Intrauterine Transmission of Hepatitis C Virus Concomitant with Isolated Severe Fetal Ascites. Pathogens 2022; 11(11) doi: 10.3390/pathogens11111335
|
| 432 |
Riyad Edan Abed, Ali N. Salman, Awatif H. Issa, Moatasem Al-Salih. HCV infection epidemiology in Thi Qar Province, Southern Iraq, from 2005 to 2021. PHYSICAL MESOMECHANICS OF CONDENSED MATTER: Physical Principles of Multiscale Structure Formation and the Mechanisms of Nonlinear Behavior: MESO2022 2023; 2899 doi: 10.1063/5.0157021
|
| 433 |
Markus S. Kupka. Reproduktionsmedizin. Springer Reference Medizin 2019; doi: 10.1007/978-3-662-55601-6_42-1
|
| 434 |
Afaf M. Abdallah, Asmaa O. Atalla, Taher El-Demerdash Attia, El Sayed A.-R. El-Kafas. Seroprevalence and risk factors of hepatitis C virus infection in a rural area in Gharbia Governorate (Quotour District). Tanta Medical Journal 2022; 50(3) doi: 10.4103/tmj.tmj_139_20
|
| 435 |
XIAO-HUA JIANG, YU-TAO XIE, BO JIANG, MENG-YING TANG, TAO MA, HUA PENG. Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAs. Molecular Medicine Reports 2015; 12(2) doi: 10.3892/mmr.2015.3571
|
| 436 |
Antoine Abou Rached, Selim Abou Kheir, Jowana Saba, Walid Ammar. Epidemiology of hepatitis B and hepatitis C in Lebanon. Arab Journal of Gastroenterology 2016; 17(1) doi: 10.1016/j.ajg.2016.01.002
|
| 437 |
Maria A. Sorbera, Michelle L. Friedman, Rebecca Cope. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment. Journal of Pharmacy Practice 2017; 30(3) doi: 10.1177/0897190016632128
|
| 438 |
Salvador Fonseca-Coronado, Gilberto Vaughan, Mayra Yolanda Cruz-Rivera, Juan Carlos Carpio-Pedroza, Karina Ruiz-Tovar, Juan Alberto Ruiz-Pacheco, Alejandro Escobar-Gutiérrez. Interleukin-28B Genotyping by Melt-Mismatch Amplification Mutation Assay PCR Analysis Using Single Nucleotide Polymorphisms rs12979860 and rs8099917, a Useful Tool for Prediction of Therapy Response in Hepatitis C Patients. Journal of Clinical Microbiology 2011; 49(7) doi: 10.1128/JCM.00877-11
|
| 439 |
Mengping Liu, Maria Tuttle, Min Gao, Julie A. Lemm. Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major Genotypes. Antimicrobial Agents and Chemotherapy 2014; 58(12) doi: 10.1128/AAC.03851-14
|
| 440 |
Sunil Gupta, Scott A. Read, Nicholas A. Shackel, Lionel Hebbard, Jacob George, Golo Ahlenstiel. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus. Cells 2019; 8(6) doi: 10.3390/cells8060603
|
| 441 |
Chin-Kai Tseng, Sung-Po Hsu, Chun-Kuang Lin, Yu-Hsuan Wu, Jin-Ching Lee, Kung-Chia Young. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells. Antiviral Research 2017; 146 doi: 10.1016/j.antiviral.2017.09.010
|
| 442 |
Sudheesh Raveendran, Zhiyan Lu. A short review on early HCC: MRI findings and pathological diagnosis. Radiology of Infectious Diseases 2018; 5(2) doi: 10.1016/j.jrid.2017.08.008
|
| 443 |
Michael C. Sneller, Zonghui Hu, Carol A. Langford. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitis. Arthritis & Rheumatism 2012; 64(3) doi: 10.1002/art.34322
|
| 444 |
Hafsa Aziz, Abida Raza, Javaid Irfan. Optimum predictors of therapeutic outcome in HCV patients in Pakistan. Journal of Medical Virology 2016; 88(1) doi: 10.1002/jmv.24305
|
| 445 |
Siamak Salehi, Oliver D. Tavabie, Suman Verma, Mark J. W. McPhail, Farzin Farzaneh, William Bernal, Krish Menon, Kosh Agarwal, Varuna R. Aluvihare. Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation. Liver Transplantation 2020; 26(6) doi: 10.1002/lt.25781
|
| 446 |
Matthew S. Paulson, Huiling Yang, I-hung Shih, Joy Y. Feng, Eric M. Mabery, Margaret F. Robinson, Weidong Zhong, William E. Delaney. Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. Antiviral Research 2009; 83(2) doi: 10.1016/j.antiviral.2009.04.003
|
| 447 |
Karin Nielsen, Hester J. Scheffer, M. Petrousjka van den Tol, Anders Nilsson. Irreversible Electroporation in Clinical Practice. 2018; doi: 10.1007/978-3-319-55113-5_10
|
| 448 |
V. Bekker, S. J. Chanock, M. Yeager, A. A. Hutchinson, T. von Hahn, S. Chen, N. Xiao, M. Dotrang, M. Brown, M. P. Busch, B. R. Edlin, C. M. Rice, T. R. O’Brien. Genetic variation inCLDN1and susceptibility to hepatitis C virus infection. Journal of Viral Hepatitis 2010; 17(3) doi: 10.1111/j.1365-2893.2009.01166.x
|
| 449 |
Salvador Fonseca-Coronado, Alejandro Escobar-Gutiérrez, Karina Ruiz-Tovar, Mayra Yolanda Cruz-Rivera, Pilar Rivera-Osorio, Mauricio Vazquez-Pichardo, Juan Carlos Carpio-Pedroza, Juan Alberto Ruíz-Pacheco, Fernando Cazares, Gilberto Vaughan. Specific Detection of Naturally Occurring Hepatitis C Virus Mutants with Resistance to Telaprevir and Boceprevir (Protease Inhibitors) among Treatment-Naïve Infected Individuals. Journal of Clinical Microbiology 2012; 50(2) doi: 10.1128/JCM.05842-11
|
| 450 |
Fabian Elgner, Huimei Ren, Regina Medvedev, Daniela Ploen, Kiyoshi Himmelsbach, Klaus Boller, Eberhard Hildt, J.-H. J. Ou. The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus. Journal of Virology 2016; 90(24) doi: 10.1128/JVI.01053-16
|
| 451 |
Aya Mostafa, Sylvia M. Taylor, Mai El-Daly, Mostafa El Hoseiny, Iman Bakr, Naglaa Arafa, Valérie Thiers, François Rimlinger, Mohamed Abdel-Hamid, Arnaud Fontanet, Mostafa K. Mohamed. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver International 2010; 30(4) doi: 10.1111/j.1478-3231.2009.02204.x
|
| 452 |
Jessica Proulx, Maria Ghaly, In-Woo Park, Kathleen Borgmann. HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers. Biomedicines 2022; 10(4) doi: 10.3390/biomedicines10040768
|
| 453 |
Mona H. Ismail. Beyond genotype‐4: Direct‐acting antiviral agents in patients with chronic hepatitis C infection from the Eastern Province of Saudi Arabia. Health Science Reports 2024; 7(1) doi: 10.1002/hsr2.1795
|
| 454 |
Joanna Bladowska, Brygida Knysz, Anna Zimny, Krzysztof Małyszczak, Anna Kołtowska, Paweł Szewczyk, Jacek Gąsiorowski, Michał Furdal, Marek J. Sąsiadek, Linda Chao. Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive Patients. PLoS ONE 2014; 9(7) doi: 10.1371/journal.pone.0102214
|
| 455 |
F. Nascimento, E. Borba, A. Philipi, A.C. Guimarães, R. Boff, P. Spada, A. Coitinho, C. Funchal, C. Dani. Leitura A Influência da Composição Corporal e Idade no Perfil Hepático e Prostático de Homens do Município de Flores da Cunha/RS. Ciência em Movimento - Biociências e Saúde 2013; 15(30) doi: 10.15602/1983-9480/cmbs.v15n30p9-16
|
| 456 |
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in Portugal. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
|
| 457 |
Charles S. Chasela, Patrick Wall, Jan Drobeniuc, Caroline C. King, Eyasu Teshale, Mina C. Hosseinipour, Sascha R. Ellington, Mary Codd, Denise J. Jamieson, Rodney J. Knight, Patricia Fitzpatrick, Athena P. Kourtis, Irving F. Hoffman, Dumbani Kayira, Noel Mumba, Deborah D. Kamwendo, Francis Martinson, William Powderly, Charles van der Horst, Saleem Kamili. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: The BAN study. Journal of Clinical Virology 2012; 54(4) doi: 10.1016/j.jcv.2012.05.003
|
| 458 |
Andrew T. Maynard, Christopher D. Roberts. Quantifying, Visualizing, and Monitoring Lead Optimization. Journal of Medicinal Chemistry 2016; 59(9) doi: 10.1021/acs.jmedchem.5b00948
|
| 459 |
Silmara Rodrigues Machado, Edison Roberto Parise, Luciana de Carvalho. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. The Brazilian Journal of Infectious Diseases 2014; 18(2) doi: 10.1016/j.bjid.2013.09.001
|
| 460 |
Daniel Fuster, Judith I. Tsui, Debbie M. Cheng, Emily K. Quinn, Carly Bridden, David Nunes, Howard Libman, Richard Saitz, Jeffrey H. Samet. Impact of Lifetime Alcohol Use on Liver Fibrosis in a Population of HIV-Infected Patients With and Without Hepatitis C Coinfection. Alcoholism: Clinical and Experimental Research 2013; 37(9) doi: 10.1111/acer.12129
|
| 461 |
Hiam Chemaitelly, Laith J. Abu-Raddad, F. DeWolfe Miller, Ravi Jhaveri. An Apparent Lack of Epidemiologic Association between Hepatitis C Virus Knowledge and the Prevalence of Hepatitis C Infection in a National Survey in Egypt. PLoS ONE 2013; 8(7) doi: 10.1371/journal.pone.0069803
|
| 462 |
Vikas Saxena, Chao-Kuen Lai, Ti-Chun Chao, King-Song Jeng, Michael M. C. Lai. Annexin A2 Is Involved in the Formation of Hepatitis C Virus Replication Complex on the Lipid Raft. Journal of Virology 2012; 86(8) doi: 10.1128/JVI.06327-11
|
| 463 |
Zachariah Madaki, Nurettin Abacioglu, A. G. Usman, Neda Taner, Ahmet. O. Sehirli, S. I. Abba. Novel Hybridized Computational Paradigms Integrated with Five Stand-Alone Algorithms for Clinical Prediction of HCV Status among Patients: A Data-Driven Technique. Life 2022; 13(1) doi: 10.3390/life13010079
|
| 464 |
Ponni V. Perumalswami, Robert S. Klein. Viral Infections of Humans. 2014; doi: 10.1007/978-1-4899-7448-8_33
|
| 465 |
Sanaa M. Kamal. Acute Hepatitis C: A Systematic Review.. The American Journal of Gastroenterology 2008; 103(5) doi: 10.1111/j.1572-0241.2008.01825.x
|
| 466 |
Kenneth E. Sherman. Thymosin α 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences 2010; 1194(1) doi: 10.1111/j.1749-6632.2010.05460.x
|
| 467 |
Nehal Shukla, Anastasia Angelopoulou, Rania Hodhod. Non-Invasive Diagnosis of Liver Fibrosis in Chronic Hepatitis C using Mathematical Modeling and Simulation. Electronics 2022; 11(8) doi: 10.3390/electronics11081260
|
| 468 |
Paul Y Kwo, Maaz B. Badshah. Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature. Current Gastroenterology Reports 2015; 17(10) doi: 10.1007/s11894-015-0462-0
|
| 469 |
I. A. Chekmazov, I. O. Ivanikov, G. V. Sapronov, N. Ch. Kirillova, N. N. Vinogradova. Liver cancer: etiology, pathogenesis, results of long-term clinical and epidemiological observation. Dokazatel'naya gastroenterologiya 2019; 8(1) doi: 10.17116/dokgastro201980115
|
| 470 |
Aécio Flávio Meirelles de Souza, Fábio Heleno de Lima Pace, Júlio Maria Fonseca Chebli, Lincoln Eduardo Villela Vieira de Castro Ferreira. Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?. Arquivos Brasileiros de Endocrinologia & Metabologia 2011; 55(6) doi: 10.1590/S0004-27302011000600008
|
| 471 |
Julie Blaising, Eve-Isabelle Pécheur. Lipids ‒ A key for hepatitis C virus entry and a potential target for antiviral strategies. Biochimie 2013; 95(1) doi: 10.1016/j.biochi.2012.07.016
|
| 472 |
Partha K. Chandra, Lili Bao, Kyoungsub Song, Fatma M. Aboulnasr, Darren P. Baker, Nathan Shores, William C. Wimley, Shuanghu Liu, Curt H. Hagedorn, Serge Y. Fuchs, Tong Wu, Luis A. Balart, Srikanta Dash. HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling. The American Journal of Pathology 2014; 184(1) doi: 10.1016/j.ajpath.2013.10.005
|
| 473 |
James N. Laditka, Sarah B. Laditka, Janice C. Probst. Health care access in rural areas: Evidence that hospitalization for ambulatory care-sensitive conditions in the United States may increase with the level of rurality. Health & Place 2009; 15(3) doi: 10.1016/j.healthplace.2008.12.007
|
| 474 |
P. Skums, D. S. Campo, Z. Dimitrova, G. Vaughan, D. T. Lau, Y. Khudyakov. Modelling differential interferon resistance of HCV quasispecies. 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; doi: 10.1109/BIBMW.2011.6112367
|
| 475 |
Hassan Ayaz, Faisal Ahmad, Sajjad Ahmad, Qaiser Arfan, Abdullah F. Alasmari, Farhan Siddique, Bushra Rehman, Adnan Zeb, Sergio Crovella, Syed Shujait Ali, Yasir Waheed, Muhammad Suleman. Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 2025; 43(13) doi: 10.1080/07391102.2024.2326197
|
| 476 |
Stephanie Jiménez Irausquin, Austin L. Hughes. Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b. Virus Research 2010; 147(2) doi: 10.1016/j.virusres.2009.11.001
|
| 477 |
Mohamed A. Daw, Aghnaya A. Dau. Hepatitis C Virus in Arab World: A State of Concern. The Scientific World Journal 2012; 2012 doi: 10.1100/2012/719494
|
| 478 |
Jianquan Li, Ke Men, Yali Yang, Duan Li. Dynamical analysis on a chronic hepatitis C virus infection model with immune response. Journal of Theoretical Biology 2015; 365 doi: 10.1016/j.jtbi.2014.10.039
|
| 479 |
Ciniso Sylvester Shabangu, Wen-Hsiu Su, Chia-Yang Li, Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Shu-Chi Wang. Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04925-1
|
| 480 |
Soraya Abad, Almudena Vega, Eduardo Hernández, Evangelina Mérida, Patricia de Sequera, Marta Albalate, Nicolás Macías, Monica Milla, Juan M. López-Gómez. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4. American Journal of Nephrology 2017; 45(3) doi: 10.1159/000454819
|
| 481 |
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in Scotland. Journal of Public Health and Epidemiology 2018; 10(7) doi: 10.5897/JPHE2018.1031
|
| 482 |
Noah Hoffman, Misha Roshal. Lennette's Laboratory Diagnosis of Viral Infections. Infectious Disease and Therapy 2010; doi: 10.3109/9781420084962.005
|
| 483 |
D. Silver, G. Karnik, A. Osinusi, R. Silk, L. Stabinski, L. Doonquah, S. Henn, G. Teferi, H. Masur, S. Kottilil, D. Fishbein. Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans. Clinical Infectious Diseases 2013; 56(9) doi: 10.1093/cid/cit037
|
| 484 |
|
| 485 |
Anne Frentzen, Kathrin Hüging, Julia Bitzegeio, Martina Friesland, Sibylle Haid, Juliane Gentzsch, Markus Hoffmann, Dirk Lindemann, Gert Zimmer, Florian Zielecki, Friedemann Weber, Eike Steinmann, Thomas Pietschmann, Charles M. Rice. Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell Lines. PLoS Pathogens 2011; 7(4) doi: 10.1371/journal.ppat.1002029
|
| 486 |
Caleb Kesse Firempong, Hui Yun Zhang, Yan Wang, Jingjing Chen, Xia Cao, Wenwen Deng, Jie Zhou, Qiang Wang, Shan-Shan Tong, Jiangnan Yu, Ximing Xu. Segetoside I, a plant-derived bisdesmosidic saponin, induces apoptosis in human hepatoma cells in vitro and inhibits tumor growth in vivo. Pharmacological Research 2016; 110 doi: 10.1016/j.phrs.2016.04.032
|
| 487 |
Hiam Chemaitelly, Sarwat Mahmud, Ahmad Masoud Rahmani, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis. International Journal of Infectious Diseases 2015; 40 doi: 10.1016/j.ijid.2015.09.011
|
| 488 |
Amedeo Lonardo, Luigi Elio Adinolfi, Salvatore Petta, Antonio Craxì, Paola Loria. Hepatitis C and diabetes: the inevitable coincidence?. Expert Review of Anti-infective Therapy 2009; 7(3) doi: 10.1586/eri.09.3
|
| 489 |
Janaina Cristiana de Oliveira Crispim, Tarsia Giabardo Alves Silva, Francisco José Dutra Souto, Fernanda Fernandes Souza, Carmen Lucia Bassi, Christiane Pienna Soares, Sérgio Zucoloto, Philippe Moreau, Ana de Lourdes Candolo Martinelli, Eduardo Antonio Donadi. Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection. Human Immunology 2012; 73(3) doi: 10.1016/j.humimm.2011.12.004
|
| 490 |
Jiaren Sun, Gaurav Chaturvedi, Steven A. Weinman. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5 doi: 10.1007/978-1-4419-7107-4_38
|
| 491 |
Tae Hyeong Kim, Seong-Wook Lee. Generation of hepatitis C virus–resistant liver cells by genome editing–mediated stable expression of RNA aptamer. Molecular Therapy Methods & Clinical Development 2023; 31 doi: 10.1016/j.omtm.2023.101151
|
| 492 |
Jama M. Darling, Stanley M. Lemon, Michael W. Fried. Schiff's Diseases of the Liver. 2011; doi: 10.1002/9781119950509.ch25
|
| 493 |
A.C.G. Jardim, Z. Igloi, J.F. Shimizu, V.A.F.F.M. Santos, L.G. Felippe, B.F. Mazzeu, Y. Amako, M. Furlan, M. Harris, P. Rahal. Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro. Antiviral Research 2015; 115 doi: 10.1016/j.antiviral.2014.12.018
|
| 494 |
Chunfu Wang, Haichang Huang, Lourdes Valera, Jin-Hua Sun, Donald R. O'Boyle, Peter T. Nower, Lingling Jia, Dike Qiu, Xin Huang, Aneela Altaf, Min Gao, Robert A. Fridell. Hepatitis C Virus RNA Elimination and Development of Resistance in Replicon Cells Treated with BMS-790052. Antimicrobial Agents and Chemotherapy 2012; 56(3) doi: 10.1128/AAC.05977-11
|
| 495 |
Ashraf Elbahrawy, Ahmed Elwassief, Abdallah Mahmoud Abdallah, Arafat Kasem, Sadek Mostafa, Khaled Makboul, Mohamed Salah Ali, Ahmed Alashker, Ahmed Maher Eliwa, Hossam Shahbah, Mohamed Abdellah Othman, Mohamed Hanafy Morsy, Mohamed Ali Abdelbaseer, Hafez Abdelhafeez. Hepatitis C virus exposure rate among health-care workers in rural Lower Egypt governorates. Journal of Translational Internal Medicine 2017; 5(3) doi: 10.1515/jtim-2017-0024
|
| 496 |
Tim J Benstead, Colin H Chalk, Natalie E Parks, Tim J Benstead. Cochrane Database of Systematic Reviews. 2013; doi: 10.1002/14651858.CD010404
|
| 497 |
Jessica Taaffe, David Wilson. Mobilising a global response to hepatitis: Lessons learned from the HIV movement. Global Public Health 2018; 13(4) doi: 10.1080/17441692.2016.1233989
|
| 498 |
Alejandro Escobar-Gutiérrez, Hugo Soudeyns, Ariane Larouche, Juan Carlos Carpio-Pedroza, Armando Martinez-Guarneros, Carlos A. Vazquez-Chacon, Salvador Fonseca-Coronado, Lilian H.T. Yamasaki, Karina Ruiz-Tovar, Mayra Cruz-Rivera. Vertical transmission of hepatitis C virus: A tale of multiple outcomes. Infection, Genetics and Evolution 2013; 20 doi: 10.1016/j.meegid.2013.10.005
|
| 499 |
Jennifer E. Layden, Richard O. Phillips, Shirley Owusu-Ofori, Fred Stephen Sarfo, Stephanie Kliethermes, Nallely Mora, Dorcas Owusu, Kenrad Nelson, Ohene Opare-Sem, Lara Dugas, Amy Luke, David Shoham, Joseph C. Forbi, Yury E. Khudyakov, Richard S. Cooper. High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways. Clinical Infectious Diseases 2015; 60(7) doi: 10.1093/cid/ciu965
|
| 500 |
Chien-Jen Chen, San-Lin You, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Hui-Chi Chen, Yun-Yuan Chen, Jessica Liu, Hui-Han Hu, Yu-Ju Lin, Yu-Ju Chu, Yen-Tsung Huang, Chun-Ju Chiang, Yin-Chu Chien. Viruses and Human Cancer. Recent Results in Cancer Research 2021; 217 doi: 10.1007/978-3-030-57362-1_2
|
| 501 |
Evangelos Cholongitas, Chrysoula Pipili, George Papatheodoridis. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World Journal of Gastroenterology 2015; 21(32): 9526-9533 doi: 10.3748/wjg.v21.i32.9526
|
| 502 |
Hirofumi Akari, Yuki Iwasaki, Tomoyuki Yoshida, Sayuki Iijima. Non‐human primate surrogate model of hepatitis C virus infection. Microbiology and Immunology 2009; 53(1) doi: 10.1111/j.1348-0421.2008.00087.x
|
| 503 |
Sergio Abrignani, Eva Reali, Michael Houghton, Raffaele De Francesco. Vaccines. 2013; doi: 10.1016/B978-1-4557-0090-5.00051-3
|
| 504 |
Kazeem Oare Okosun, Oluwole Daniel Makinde. Optimal control analysis of hepatitis C virus with acute and chronic stages in the presence of treatment and infected immigrants. International Journal of Biomathematics 2014; 7(02) doi: 10.1142/S1793524514500193
|
| 505 |
Shaimaa B. Abdelaziz, Yasmine S. Galal, Amal S. Sedrak, Dina S. Shaheen. Association of Hepatitis C Virus Infection and Type 2 Diabetes in Egypt: A Hospital-Based Study. Journal of Diabetes Mellitus 2016; 6(01) doi: 10.4236/jdm.2016.61009
|
| 506 |
Bret Poat, Sidhartha Hazari, Partha K Chandra, Feyza Gunduz, Xavier Alvarez, Luis A Balart, Robert F Garry, Srikanta Dash. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-265
|
| 507 |
Poupak Fallahi, Silvia Martina Ferrari, Roberto Vita, Salvatore Benvenga, Alessandro Antonelli. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders. Reviews in Endocrine and Metabolic Disorders 2016; 17(4) doi: 10.1007/s11154-016-9361-4
|
| 508 |
|
| 509 |
Diego F. Cuadros, Adam J. Branscum, DeWolfe F. Miller, Laith J. Abu-Raddad. Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications. Hepatology 2014; 60(4) doi: 10.1002/hep.27248
|
| 510 |
Yifan Xing, Zeyu Wen, Jie Mei, Xinyi Huang, Shuangshuang Zhao, Jin Zhong, Yaming Jiu. Cytoskeletal Vimentin Directs Cell‐Cell Transmission of Hepatitis C Virus. Advanced Science 2025; 12(3) doi: 10.1002/advs.202408917
|
| 511 |
Julie Bruneau, Élise Roy, Nelson Arruda, Geng Zang, Didier Jutras‐Aswad. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street‐drug users. Addiction 2012; 107(7) doi: 10.1111/j.1360-0443.2012.03803.x
|
| 512 |
Marinus van Hulst, Cees Th. Smit Sibinga, Maarten J. Postma. Health economics of blood transfusion safety – focus on sub-Saharan Africa. Biologicals 2010; 38(1) doi: 10.1016/j.biologicals.2009.10.006
|
| 513 |
Anita Khokhar, Priyanka Sharma. Biotechnological Innovations for Environmental Bioremediation. 2022; doi: 10.1007/978-981-16-9001-3_28
|
| 514 |
Maiko Sakamoto, Steven Paul Woods, Michael Kolessar, Daniel Kriz, J. Renee Anderson, Hannah Olavarria, Anna W. Sasaki, Michael Chang, Kenneth D. Flora, Jennifer M. Loftis, Marilyn Huckans. Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C. Journal of NeuroVirology 2013; 19(5) doi: 10.1007/s13365-013-0196-4
|
| 515 |
Lambros Messinis, Panagiotis Papathanasopoulos. Is there a higher risk of neuropsychological impairment in HIV–HCV coinfected patients?. Neurology 2015; 84(3) doi: 10.1212/WNL.0000000000001169
|
| 516 |
Christine Meffre, Yann Le Strat, Elisabeth Delarocque‐Astagneau, Fréderic Dubois, Denise Antona, Jean‐Marie Lemasson, Josiane Warszawski, Josiane Steinmetz, Dominique Coste, Jean‐François Meyer, Sandrine Leiser, Jean‐Pierre Giordanella, René Gueguen, Jean‐Claude Desenclos. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology 2010; 82(4) doi: 10.1002/jmv.21734
|
| 517 |
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiologia da infecção pelo vírus da hepatite C. Revista da Associação Médica Brasileira 2011; 57(1) doi: 10.1590/S0104-42302011000100024
|
| 518 |
Mitchell L Shiffman, Yves Benhamou. Cure of HCV related liver disease. Liver International 2015; 35(s1) doi: 10.1111/liv.12734
|
| 519 |
Mohamed Abo El-Asrar, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Ahmed Mohamed Elshenity. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications. Blood Cells, Molecules, and Diseases 2016; 56(1) doi: 10.1016/j.bcmd.2015.09.006
|
| 520 |
David Goldberg, Ivo C. Ditah, Kia Saeian, Mona Lalehzari, Andrew Aronsohn, Emmanuel C. Gorospe, Michael Charlton. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology 2017; 152(5) doi: 10.1053/j.gastro.2017.01.003
|
| 521 |
Amira Mohsen, Adeline Bernier, Lenaig LeFouler, Elisabeth Delarocque‐Astagneau, Mai El‐Daly, Sherif El‐Kafrawy, Salwa El‐Mango, Mohamed Abdel‐Hamid, Mohsen Gadallah, Gamal Esmat, Mostafa K. Mohamed, Arnaud Fontanet. Hepatitis C virus acquisition among Egyptians: analysis of a 10‐year surveillance of acute hepatitis C. Tropical Medicine & International Health 2015; 20(1) doi: 10.1111/tmi.12410
|
| 522 |
M. Castells, G. Bello, S. Ifrán, S. Pereyra, S. Boschi, R. Uriarte, J. Cristina, R. Colina. Epidemic history of major genotypes of hepatitis C virus in Uruguay. Infection, Genetics and Evolution 2015; 32 doi: 10.1016/j.meegid.2015.03.021
|
| 523 |
Carrie Reed, Caleb Bliss, Sherri O. Stuver, Timothy Heeren, Sheila Tumilty, C. Robert Horsburgh, Jeffrey H. Samet, Deborah J. Cotton. Predictors of Active Injection Drug Use in a Cohort of Patients Infected With Hepatitis C Virus. American Journal of Public Health 2013; 103(1) doi: 10.2105/AJPH.2012.300819
|
| 524 |
Adela Paez Jimenez, Mostafa K. Mohamed, Noha Sharaf Eldin, Hasnaa Abou Seif, Said El Aidi, Yehia Sultan, Nasr Elsaid, Claire Rekacewicz, Mostafa El-Hoseiny, May El-Daly, Mohamed Abdel-Hamid, Arnaud Fontanet, Matthew Baylis. Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt. PLoS ONE 2009; 4(9) doi: 10.1371/journal.pone.0007193
|
| 525 |
Naoki Ogura, Yukiyo Toyonaga, Izuru Ando, Kunihiro Hirahara, Tsutomu Shibata, Gabriela Turcanu, Sudhakar Pai, Kan Yee, Barbara Gerhardt, Maribel Rodriguez-Torres, Toru Noguchi. Genotypic and Phenotypic Analyses of Hepatitis C Virus from Patients Treated with JTK-853 in a Three-Day Monotherapy. Antimicrobial Agents and Chemotherapy 2013; 57(1) doi: 10.1128/AAC.01432-12
|
| 526 |
Eric Tatara, Nicholson T. Collier, Jonathan Ozik, Alexander Gutfraind, Scott J. Cotler, Harel Dahari, Marian Major, Basmattee Boodram. Multi-Objective Model Exploration of Hepatitis C Elimination in an Agent-Based Model of People who Inject Drugs. 2019 Winter Simulation Conference (WSC) 2019; doi: 10.1109/WSC40007.2019.9004747
|
| 527 |
Clarice Souza Pinto, Regina Maria Bringel Martins, Sonia Maria Oliveira de Andrade, Alcione Cavalheiro Faro Stief, Roberto Dias de Oliveira, Ana Rita Coimbra Motta de Castro. Infecção pelo vírus da hepatite C em gestantes em Mato Grosso do Sul, 2005-2007. Revista de Saúde Pública 2011; 45(5) doi: 10.1590/S0034-89102011005000053
|
| 528 |
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifs. Bioorganic & Medicinal Chemistry Letters 2014; 24(24) doi: 10.1016/j.bmcl.2014.10.056
|
| 529 |
Patrick D. Wilkinson, Andrew W. Duncan. Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury. Seminars in Liver Disease 2021; 41(01) doi: 10.1055/s-0040-1719175
|
| 530 |
Izuru Ando, Tsuyoshi Adachi, Naoki Ogura, Yukiyo Toyonaga, Kazuyuki Sugimoto, Hiroyuki Abe, Masafumi Kamada, Toru Noguchi. Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrobial Agents and Chemotherapy 2012; 56(8) doi: 10.1128/AAC.00312-12
|
| 531 |
Victor Virlogeux, Pascale Berthillon, Isabelle Bordes, Sylvie Larrat, Stéphanie Crouy, Caroline Scholtès, Pierre Pradat, Marianne Maynard, Fabien Zoulim, Vincent Leroy, Isabelle Chemin, Christian Trépo, Marie-Anne Petit. Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy. Clinics and Research in Hepatology and Gastroenterology 2018; 42(4) doi: 10.1016/j.clinre.2018.02.002
|
| 532 |
M. M. G. Godoy, E. P. A. Lopes, R. O. Silva, F. Hallwass, L. C. A. Koury, I. M. Moura, S. M. C. Gonçalves, A. M. Simas. Hepatitis C virus infection diagnosis using metabonomics. Journal of Viral Hepatitis 2010; 17(12) doi: 10.1111/j.1365-2893.2009.01252.x
|
| 533 |
Mary Ellen Mackesy-Amiti, Joshua Falk, Carl Latkin, Maggie Kaufmann, Leslie Williams, Basmattee Boodram. Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior. Harm Reduction Journal 2022; 19(1) doi: 10.1186/s12954-022-00642-4
|
| 534 |
Suliman Qadir Afridi, Muhammad Nouman Zahid, Muhammad Zubair Shabbir, Zeenat Hussain, Nadia Mukhtar, Muhammad Yasin Tipu, Fareeha Akhtar, Tahir Yaqub. Prevalence of HCV genotypes in district Mardan. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-90
|
| 535 |
Jorge A. Soto, Nicolas M. S. Gálvez, Catalina A. Andrade, Gaspar A. Pacheco, Karen Bohmwald, Roslye V. Berrios, Susan M. Bueno, Alexis M. Kalergis. The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01513
|
| 536 |
Ravi Jhaveri, Samer S. El-Kamary. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2025; doi: 10.1016/B978-0-323-82763-8.00190-4
|
| 537 |
Chia-Chun Hung, El-Wui Loh, Tsung-Ming Hu, Hsien-Jane Chiu, Hung-Chieh Hsieh, Chin-Hong Chan, Tsuo-Hung Lan. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. Journal of the Chinese Medical Association 2012; 75(6) doi: 10.1016/j.jcma.2012.03.002
|
| 538 |
Rima Chaudhuri, Hyun Lee, Lena Truong, Jaime Torres, Kavankumar Patel, Michael E. Johnson. Identification of Non-Macrocyclic Small Molecule Inhibitors against the NS3/4A Serine Protease of Hepatitis C Virus through in Silico Screening. Journal of Chemical Information and Modeling 2012; 52(8) doi: 10.1021/ci300177p
|
| 539 |
Christina Greenaway, Ann Thu Ma, Lorie A. Kloda, Marina Klein, Sonya Cnossen, Guido Schwarzer, Ian Shrier, Jason Grebely. The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(11) doi: 10.1371/journal.pone.0141715
|
| 540 |
Inna Rytsareva, David S. Campo, Yueli Zheng, Seth Sims, Sharma V. Thankachan, Cansu Tetik, Jain Chirag, Sriram P. Chockalingam, Amanda Sue, Srinivas Aluru, Yury Khudyakov. Efficient detection of viral transmissions with Next-Generation Sequencing data. BMC Genomics 2017; 18(S4) doi: 10.1186/s12864-017-3732-4
|
| 541 |
Madeline C. Frost, Theresa E. Matson, Judith I. Tsui, Emily C. Williams. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV. Drug and Alcohol Dependence 2019; 194 doi: 10.1016/j.drugalcdep.2018.10.008
|
| 542 |
Jihene Bettaieb, Anissa Chouikha, Marwa Khedhiri, Ghassen Kharroubi, Malek Badreddine, Nabil Bel Hadj Hmida, Adel Gharbi, Walid Hammemi, Amel Sadraoui, Ahlem Ben Yahia, Zina Meddeb, Afif Ben Salah, Henda Triki. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study. Archives of Virology 2019; 164(9) doi: 10.1007/s00705-019-04308-8
|
| 543 |
R. K. Sterling, A. Kuo, V. K. Rustgi, M. S. Sulkowski, T. G. Stewart, J. M. Fenkel, H. El‐Genaidi, M. A. Mah'moud, G. M. Abraham, P. W. Stewart, L. Akushevich, D. R. Nelson, M. W. Fried, A. M. Di Bisceglie. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Alimentary Pharmacology & Therapeutics 2015; 41(7) doi: 10.1111/apt.13095
|
| 544 |
|
| 545 |
Maha Mahmoud Abou El-Alamin, Maha Abd Elrahman Sultan, Maha Hegazy, Alastair William Wark, Marwa Mohamed Azab. Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin. European Journal of Chemistry 2019; 10(4) doi: 10.5155/eurjchem.10.4.350-357.1899
|
| 546 |
Masahiro Ishikane, Koji Watanabe, Kunihisa Tsukada, Yuichi Nozaki, Mikio Yanase, Toru Igari, Naohiko Masaki, Yoshimi Kikuchi, Shinichi Oka, Hiroyuki Gatanaga, Golo Ahlenstiel. Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study. PLoS ONE 2014; 9(6) doi: 10.1371/journal.pone.0100517
|
| 547 |
Nik Howes, Sam Lattimore, William Lucien Irving, Brian James Thomson. Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment. Open Forum Infectious Diseases 2016; 3(1) doi: 10.1093/ofid/ofv218
|
| 548 |
T. C. R. AZEVEDO, N. A. FILGUEIRA, E. P. LOPES. Risk factors for hepatitis C virus infection in former Brazilian soccer players. Epidemiology and Infection 2012; 140(1) doi: 10.1017/S0950268811000458
|
| 549 |
Joanna Bladowska, Anna Zimny, Anna Kołtowska, Paweł Szewczyk, Brygida Knysz, Jacek Gąsiorowski, Michał Furdal, Marek J. Sąsiadek. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: Magnetic resonance spectroscopy and immunologic correlation. European Journal of Radiology 2013; 82(4) doi: 10.1016/j.ejrad.2012.11.029
|
| 550 |
Fred Leland McClure, Justin K. Niles, Harvey W. Kaufman, Jeffrey Gudin. Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence. Journal of Addiction Medicine 2019; 13(2) doi: 10.1097/ADM.0000000000000460
|
| 551 |
Silvia Portugal, Nyamekye Obeng-Adjei, Susan Moir, Peter D. Crompton, Susan K. Pierce. Atypical memory B cells in human chronic infectious diseases: An interim report. Cellular Immunology 2017; 321 doi: 10.1016/j.cellimm.2017.07.003
|
| 552 |
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Amir Ghorbanzadeh, Farzin Sadeghi. Association of HLA Class II Alleles with Outcome of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Hepatitis Monthly 2021; 21(7) doi: 10.5812/hepatmon.109493
|
| 553 |
Robert Flisiak, Waldemar Halota, Andrzej Horban, Jacek Juszczyk, Malgorzata Pawlowska, Krzysztof Simon. Prevalence and risk factors of HCV infection in Poland. European Journal of Gastroenterology & Hepatology 2011; 23(12) doi: 10.1097/MEG.0b013e32834d173c
|
| 554 |
Ryan J. Malonis, Jonathan R. Lai, Olivia Vergnolle. Peptide-Based Vaccines: Current Progress and Future Challenges. Chemical Reviews 2020; 120(6) doi: 10.1021/acs.chemrev.9b00472
|
| 555 |
Mohammed A. El Feki, Heba H. El Demellawy, Tamer Hifnawy. Prevalence and risk factors of hepatitis C virus and its association with diabetes mellitus in rural versus urban districts in the Beni-Suef Governorate, Egypt. Egyptian Liver Journal 2013; 3(2) doi: 10.1097/01.ELX.0000427104.13118.0e
|
| 556 |
Gisele Barreto Lopes Menezes, Fernanda Albuquerque Pereira, César Augusto Barros Duarte, Theomira Mauadie Azevedo Carmo, Hermes Pedreira da Silva Filho, Maria Alice Zarife, Marco Aurélio Krieger, Eliana Almeida Gomes Reis, Mitermayer G Reis. Hepatitis C virus quantification in serum and saliva of HCV-infected patients. Memórias do Instituto Oswaldo Cruz 2012; 107(5) doi: 10.1590/S0074-02762012000500016
|
| 557 |
Xi-Jing Qian, Yong-Zhe Zhu, Ping Zhao, Zhong-Tian Qi. Entry inhibitors: New advances in HCV treatment. Emerging Microbes & Infections 2016; 5(1) doi: 10.1038/emi.2016.3
|
| 558 |
Aritra Biswas, Debanjali Gupta, Kallol Saha, Kahini Sarkar, Rushna Firdaus, Provash Chandra Sadhukhan. Emerging new HCV strains among intravenous drug users and their route of transmission in the north eastern state of Mizoram, India. Molecular Phylogenetics and Evolution 2017; 116 doi: 10.1016/j.ympev.2017.09.006
|
| 559 |
J. Walker Gussler, David S. Campo, Zoya Dimitrova, Pavel Skums, Yury Khudyakov. Primary case inference in viral outbreaks through analysis of intra-host variant population. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04585-2
|
| 560 |
Zhengxian Gu, Jason D. Graci, Frederick C. Lahser, Jamie J. Breslin, Stephen P. Jung, James H. Crona, Patricia McMonagle, Ellen Xia, Shaotang Liu, Gary Karp, Jin Zhu, Song Huang, Amin Nomeir, Marla Weetall, Neil G. Almstead, Stuart W. Peltz, Xiao Tong, Robert Ralston, Joseph M. Colacino. Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy 2013; 57(7) doi: 10.1128/AAC.00527-13
|
| 561 |
Donald Gardenier, Angie Woody, Catherine Amory, Jeffrey J. Weiss. Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies. Archives of Psychiatric Nursing 2019; 33(4) doi: 10.1016/j.apnu.2019.02.001
|
| 562 |
Mohamed M. Al-Daydamony, El-Sayed M. Farag. CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig University Hospital. Indian Heart Journal 2016; 68(5) doi: 10.1016/j.ihj.2016.03.007
|
| 563 |
Hannes Hagström. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?. Current Hepatology Reports 2017; 16(2) doi: 10.1007/s11901-017-0343-0
|
| 564 |
Mary E. Mackesy-Amiti, Basmattee Boodram, Michael W. Spiller, Gabriela Paz-Bailey, Nikhil Prachand, Dita Broz. Injection-Related Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Across 20 US Cities. JAIDS Journal of Acquired Immune Deficiency Syndromes 2017; 75(3) doi: 10.1097/QAI.0000000000001406
|
| 565 |
Nano‐bio‐engineered silk matrix based devices for molecular bioanalysis. Biotechnology and Bioengineering 2022; 119(3) doi: 10.1002/bit.28021
|
| 566 |
Georgios Grammatikos, Cassandra B Jabara, Monazza Q Ahmad, Eva Herrmann, Stefan Zeuzem, Christoph Welsch. Genetic Background for Development of Resistance Mutations within the HCV Ns3 Protease–Helicase in Direct Acting Antiviral Naive Patients. Antiviral Therapy 2014; 19(5) doi: 10.3851/IMP2734
|
| 567 |
Paul K Nelson, Bradley M Mathers, Benjamin Cowie, Holly Hagan, Don Des Jarlais, Danielle Horyniak, Louisa Degenhardt. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet 2011; 378(9791) doi: 10.1016/S0140-6736(11)61097-0
|
| 568 |
MedhatK Shier, MohammadS El-Wetidy, HebatallahH Ali, MohammadM Al-Qattan. Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A. Saudi Journal of Gastroenterology 2016; 22(3) doi: 10.4103/1319-3767.182461
|
| 569 |
Zhenwei Shen, Xiaoxue Zhu, Hong Zhang, Hong Chen, Junqi Niu, Guiling Chen, Xiaojiao Li, Yanhua Ding. Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS‐331007 in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development 2019; 8(8) doi: 10.1002/cpdd.674
|
| 570 |
Aldemir B Oliveira-Filho, Leila Sawada, Laine C Pinto, Daiane Locks, Santana L Bahia, JairoA A Castro, Renata B Hermes, Igor Brasil-Costa, CarlosE M Amaral, José Alexandre R Lemos. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon. Virology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-38
|
| 571 |
Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert. Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2017; 29(1) doi: 10.1097/MEG.0000000000000757
|
| 572 |
Wieslaw M. Kazmierski, Andrew Maynard, Maosheng Duan, Sam Baskaran, Janos Botyanszki, Renae Crosby, Scott Dickerson, Matthew Tallant, Rick Grimes, Robert Hamatake, Martin Leivers, Christopher D. Roberts, Jill Walker. Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound. Journal of Medicinal Chemistry 2014; 57(5) doi: 10.1021/jm4013104
|
| 573 |
Janielle Mari S. Abadilla, Bor-Yann Chen, Mike Anthony D. Ganzon, Alvin R. Caparanga, Kristopher Ray S. Pamintuan, Lemmuel L. Tayo, Chung-Chuan Hsueh, Cheng-Yang Hsieh, Ling-Ling Yang, Po-Wei Tsai. Pharmacological Potential and Electrochemical Characteristics of Typha angustifolia Pollen. Plants 2024; 13(20) doi: 10.3390/plants13202857
|
| 574 |
Zaigham Abbas, Ghiasun Nabi Tayyab, Mustafa Qureshi, Mohammad Sadik Memon, Amna Subhan, Tanzila Shakir, Wasim Jafri, Saeed Hamid. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14146
|
| 575 |
Ednelza da Silva Graça Amoras, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Bárbara Brasil Santana, Geraldo Ishak, Marialva Tereza Ferreira de Araújo, Sâmia Demachki, Simone Regina Souza da Silva Conde, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, Matthaios Speletas. Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0156604
|
| 576 |
Allah Nawaz, Syed Faisal Zaidi, Khan Usmanghani, Irshad Ahmad. Concise review on the insight of hepatitis C. Journal of Taibah University Medical Sciences 2015; 10(2) doi: 10.1016/j.jtumed.2014.08.004
|
| 577 |
Basmattee Boodram, Mary-Ellen Mackesy-Amiti, Carl Latkin. The role of social networks and geography on risky injection behaviors of young persons who inject drugs. Drug and Alcohol Dependence 2015; 154 doi: 10.1016/j.drugalcdep.2015.06.042
|
| 578 |
Shakir Saleem, Md Adil Shaharyar, Mohammad Jawed Khusroo, Parwej Ahmad, Rais Ur Rahman, Kamran Ahmad, Md Jahangir Alam, Naif O Al-Harbi, Muzaffar Iqbal, Faisal Imam. Anticancer potential of rhamnocitrin 4′-β-d-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry 2013; 384(1-2) doi: 10.1007/s11010-013-1792-6
|
| 579 |
Anjum Ara, Deep Inder, Pawan Kumar, Kafil Akhtar. Knowledge, Attitude and Practices for HBV and HCV (Hepatitis B Virus and Hepatitis C Virus) among the Students of a Central University in South Delhi (India) and Strategies for Prevention of Disease. Journal of Integrated Health Sciences 2021; 9(1) doi: 10.4103/jihs.jihs_2_21
|
| 580 |
Kendall R. Van Keuren‐Jensen, Ivana Malenica, Amanda L. Courtright, Layla T. Ghaffari, Alex P. Starr, Raghu P. Metpally, Taylor A. Beecroft, Elizabeth W.J. Carlson, Jeffrey A. Kiefer, Paul J. Pockros, Jorge Rakela. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Liver International 2016; 36(3) doi: 10.1111/liv.12919
|
| 581 |
S. Karbanova, L. Cerveny, L. Jiraskova, R. Karahoda, M. Ceckova, Z. Ptackova, F. Staud. Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters. Biochemical Pharmacology 2019; 163 doi: 10.1016/j.bcp.2019.01.024
|
| 582 |
Feyza Gunduz, Chaithanya Mallikarjun, Luis A. Balart, Srikanta Dash. Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection. Experimental and Molecular Pathology 2014; 96(1) doi: 10.1016/j.yexmp.2013.10.016
|
| 583 |
Malgorzata Sidorkiewicz, Barbara Józwiak, Barbara Durys, Ewa Majda-Stanislawska, Anna Piekarska, Natalia Kosciuk, Jadwiga Ciechowicz, Ewa Majewska, Jacek Bartkowiak. Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. Virus Research 2009; 145(1) doi: 10.1016/j.virusres.2009.06.001
|
| 584 |
M. El‐Bendary, M. Neamatallah, G. Esmat, E. Kamel, H. Elalfy, T. Besheer, D. Eldeib, A.‐H. Eladl, M. El‐Setouhy, A.‐H. El‐Gilany, A. El‐Waseef. Associations of human leucocyte antigen class II‐DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family‐based study. Journal of Viral Hepatitis 2016; 23(12) doi: 10.1111/jvh.12573
|
| 585 |
Ye Chen, Alain Bopda-Waffo, Amartya Basu, Ramalingam Krishnan, Erica Silberstein, Deborah R Taylor, Tanaji T Talele, Payal Arora, Neerja Kaushik-Basu. Characterization of Aurintricarboxylic Acid as a Potent Hepatitis C Virus Replicase Inhibitor. Antiviral Chemistry and Chemotherapy 2009; 20(1) doi: 10.3851/IMP1286
|
| 586 |
Daniel Schmidt-Martin, Orla Crosbie, Elizabeth Kenny-Walsh, Liam J. Fanning. Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection.
Journal of General Virology
2015; 96(8) doi: 10.1099/vir.0.000149
|
| 587 |
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections. 2020; doi: 10.1007/978-3-030-02200-6_6
|
| 588 |
Magdalena Perić, Zinka Bošnjak, Bojan Šarkanj, Jerko Barbić, Arlen Antolović-Požgain, Nataša Ružman, Ivana Roksandić-Križan, Dubravka Vuković. Polymorphisms of Toll-like receptors 2 and 4 in chronically infected hepatitis C patients from north-east Croatia. Archives of Virology 2015; 160(1) doi: 10.1007/s00705-014-2283-0
|
| 589 |
Maemu Petronella Gededzha, M. Jeffrey Mphahlele, Jason T. Blackard, Selokela Gloria Selabe. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South Africans. Hepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.14248
|
| 590 |
Arturo Panduro, Sonia Roman, Anis Khan, Yasuhito Tanaka, Fuat Kurbanov, Erika Martinez-Lopez, Octavio Campollo, Zamira Hernandez-Nazara, Masashi Mizokami. Molecular epidemiology of hepatitis C virus genotypes in West Mexico. Virus Research 2010; 151(1) doi: 10.1016/j.virusres.2010.03.009
|
| 591 |
Hannes Hagström. Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 2017; 31(5) doi: 10.1016/j.bpg.2017.09.003
|
| 592 |
|
| 593 |
Yifan Xing, Ran Chen, Feng Li, Bin Xu, Lin Han, Chaolun Liu, Yimin Tong, Yaming Jiu, Jin Zhong, Guo-Chun Zhou. Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent. Virology 2023; 586 doi: 10.1016/j.virol.2023.07.012
|
| 594 |
Shingo Iwasa, Naoko Sato, Chao-Wen Wang, Yun-Hsin Cheng, Hayato Irokawa, Gi-Wook Hwang, Akira Naganuma, Shusuke Kuge, Clarissa Menezes Maya-Monteiro. The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model System. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0159324
|
| 595 |
Francesco Saverio Mennini, Paolo Sciattella, Claudia Simonelli, Andrea Marcellusi, Stefano Rosato, Loreta A. Kondili. Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy. Journal of Viral Hepatitis 2025; 32(2) doi: 10.1111/jvh.14061
|
| 596 |
. 2019; doi: 10.70675/b12babe9zc7c8z4bfdzb876zb57d9437825d
|
| 597 |
Fernanda Bernadelli Garcia, Gilberto de Araújo Pereira, Paulo Roberto Juliano Martins, Helio Moraes-Souza. Epidemiological profile of hepatitis C in blood donors at the Uberaba Regional Blood Center. Revista da Sociedade Brasileira de Medicina Tropical 2009; 42(1) doi: 10.1590/S0037-86822009000100001
|
| 598 |
Henry Namme Luma, Servais Albert Fiacre Bagnaka Eloumou, Agnes Malongue, Elvis Temfack, Dominique Noah Noah, Olivier Donfack-Sontsa, Ivo Che Ditah. Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon. International Journal of Infectious Diseases 2016; 45 doi: 10.1016/j.ijid.2016.02.013
|
| 599 |
Shazia Rafique, Muhammad Idrees, Muhammad Ilyas, Abrar Hussain, Muhammad Ali, Liaqat Ali, Sadia Butt, Samia Afzal, Irshad Ur Rehman, Sana Saleem. Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: Interferon Resistance analysis via Sequence Alignment. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-204
|
| 600 |
Vaithilingaraja Arumugaswami, Roland Remenyi, Vidhya Kanagavel, Eric Yiang Sue, Tuyet Ngoc Ho, Chang Liu, Vanessa Fontanes, Asim Dasgupta, Ren Sun, Donald E. Ganem. High-Resolution Functional Profiling of Hepatitis C Virus Genome. PLoS Pathogens 2008; 4(10) doi: 10.1371/journal.ppat.1000182
|
| 601 |
Françoise Stoll-Keller, Heidi Barth, Samira Fafi-Kremer, Mirjam B Zeisel, Thomas F Baumert. Development of hepatitis C virus vaccines: challenges and progress. Expert Review of Vaccines 2009; 8(3) doi: 10.1586/14760584.8.3.333
|
| 602 |
Laura Patrícia Viana Maia, Olindo Assis Martins‐Filho, Andréa Teixeira‐Carvalho, Elaine Speziali, Rolandro Vermhren, Edson Fonseca Lira, Tatiane Amabile Lima, Wornei Silva Braga, Kátia Luz Torres, Adriana Malheiro. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis. Journal of Medical Virology 2009; 81(7) doi: 10.1002/jmv.21521
|
| 603 |
Ling Lu, Chunhua Li, Yan Xu, Donald G. Murphy. Full-length genomes of 16 hepatitis C virus genotype 1 isolates representing subtypes 1c, 1d, 1e, 1g, 1h, 1i, 1j and 1k, and two new subtypes 1m and 1n, and four unclassified variants reveal ancestral relationships among subtypes.
Journal of General Virology
2014; 95(7) doi: 10.1099/vir.0.064980-0
|
| 604 |
Mauro Viganò, Carlo Federico Perno, Antonio Craxì, Alessio Aghemo, Alfredo Alberti, Pietro Andreone, Massimo Andreoni, Stefano Bonora, Maurizia Rossana Brunetto, Raffaele Bruno, Savino Bruno, Vincenza Calvaruso, Nicola Caporaso, Francesca Ceccherini-Silberstein, Valeria Cento, Alessia Ciancio, Piero Colombatto, Elisabetta Degasperi, Vito Di Marco, Giovanni Di Perri, Gianpiero D’offizi, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Adriano Pellicelli, Salvatore Petta, Sara Piovesan, Massimo Puoti, Giovanni Raimondo, Francesco Paolo Russo, Gloria Taliani, Ugo Trama, Erica Villa, Anna Linda Zignego. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel. Digestive and Liver Disease 2017; 49(7) doi: 10.1016/j.dld.2017.03.027
|
| 605 |
B. Zhang, R. Wang, K. Jiang, X. Fang, H. Li, N. Dang, T. Zhang, B. Zeng. Prevalence of positivity to antibodies to hepatitis C virus among volunteer blood donors in China: a meta-analysis. Public Health 2021; 199 doi: 10.1016/j.puhe.2021.07.011
|
| 606 |
Alice Russell, Nilay Hepgul, Naghmeh Nikkheslat, Alessandra Borsini, Zuzanna Zajkowska, Natalie Moll, Daniel Forton, Kosh Agarwal, Trudie Chalder, Valeria Mondelli, Matthew Hotopf, Anthony Cleare, Gabrielle Murphy, Graham Foster, Terry Wong, Gregor A. Schütze, Markus J. Schwarz, Neil Harrison, Patricia A. Zunszain, Carmine M. Pariante. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology 2019; 100 doi: 10.1016/j.psyneuen.2018.11.032
|
| 607 |
Adam Trickey, Hannah Fraser, Aaron G Lim, Amy Peacock, Samantha Colledge, Josephine G Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Matthew Hickman, Louisa Degenhardt, Margaret T May, Peter Vickerman. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. The Lancet Gastroenterology & Hepatology 2019; 4(6) doi: 10.1016/S2468-1253(19)30085-8
|
| 608 |
Vincenza Calvaruso, Marta Mazza, Piero L Almasio. Pegylated-interferon-α2ain clinical practice: how to manage patients suffering from side effects. Expert Opinion on Drug Safety 2011; 10(3) doi: 10.1517/14740338.2011.559161
|
| 609 |
Pankaj Puri, Anil C. Anand, Vivek A. Saraswat, Subrat K. Acharya, Radha K. Dhiman, Rakesh Aggarwal, Shivram P. Singh, Deepak Amarapurkar, Anil Arora, Mohinish Chhabra, Kamal Chetri, Gourdas Choudhuri, Vinod K. Dixit, Ajay Duseja, Ajay K. Jain, Dharmesh Kapoorz, Premashis Kar, Abraham Koshy, Ashish Kumar, Kaushal Madan, Sri P. Misra, Mohan V.G. Prasad, Aabha Nagral, Amarendra S. Puri, R. Jeyamani, Sanjiv Saigal, Shiv K. Sarin, Samir Shah, P.K. Sharma, Ajit Sood, Sandeep Thareja, Manav Wadhawan. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. Journal of Clinical and Experimental Hepatology 2014; 4(2) doi: 10.1016/j.jceh.2014.05.006
|
| 610 |
Barbara Zanini, Alberto Lanzini. Antiviral Treatment for Chronic Hepatitis C in Illicit drug Users: A Systematic Review. Antiviral Therapy 2009; 14(4) doi: 10.1177/135965350901400410
|
| 611 |
Jayendrakumar Patel, Preeti Sharma. Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodies. Archives of Virology 2020; 165(3) doi: 10.1007/s00705-019-04518-0
|
| 612 |
|
| 613 |
Smitha Kota, Virginia Takahashi, Feng Ni, John K. Snyder, A. Donny Strosberg, Gunnar F. Kaufmann. Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein. PLoS ONE 2012; 7(2) doi: 10.1371/journal.pone.0032207
|
| 614 |
Gretja Schnell, Yueh-Ming Loo, Joseph Marcotrigiano, Michael Gale, Karen L. Mossman. Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I. PLoS Pathogens 2012; 8(8) doi: 10.1371/journal.ppat.1002839
|
| 615 |
Jin-Ching Lee, Wei-Chun Chen, Shou-Fang Wu, Chin-kai Tseng, Ching-Yi Chiou, Fang-Rong Chang, Shih-hsien Hsu, Yang-Chang Wu. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral Research 2011; 89(1) doi: 10.1016/j.antiviral.2010.11.003
|
| 616 |
Alexander Gutfraind, Basmattee Boodram, Nikhil Prachand, Atesmachew Hailegiorgis, Harel Dahari, Marian E. Major, Lars Kaderali. Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections. PLOS ONE 2015; 10(9) doi: 10.1371/journal.pone.0137993
|
| 617 |
OV Churbakova, VG Akimkin, VV Pavlov, DV Pechkurov. Epidemiological Situation of Chronic Hepatitis C Virus Infection in Russia and the Samara Region. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2020; doi: 10.35627/2219-5238/2020-332-11-72-77
|
| 618 |
Sanaa M. Kamal, Ahmed M. Fouad. Hepatitis C in Developing Countries. 2018; doi: 10.1016/B978-0-12-803233-6.00014-X
|
| 619 |
Keshav Gandhi, Yash Vijay, Kimberly Page, Harel Dahari, Alexander Gutfraind. Challenges in coverage of future hepatitis C vaccines: Review and potential solutions. Vaccine 2025; 59 doi: 10.1016/j.vaccine.2025.127256
|
| 620 |
Nabeen C. Nayak, Deepali Jain, Nandini Vasdev, Hanni Gulwani, Sanjiv Saigal, Arvinder Soin. Etiologic types of end-stage chronic liver disease in adults. European Journal of Gastroenterology & Hepatology 2012; 24(10) doi: 10.1097/MEG.0b013e32835643f1
|
| 621 |
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses. World Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
|
| 622 |
Jia Yan, Ming Shu, Xiang Li, Hua Yu, Shuhuai Chen, Shujie Xie. Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma. Evolutionary Bioinformatics 2020; 16 doi: 10.1177/1176934320951571
|
| 623 |
MM Sohail, MG Yasin, S Ahmad. A phenomenological account of social sources, coping effects and relational role of social support in nursing among chronic patients with hepatitis. Journal of Research in Nursing 2018; 23(1) doi: 10.1177/1744987117736362
|
| 624 |
S. B. MATOS, A. L. S. R. JESUS, K. C. M. C. PEDROZA, H. R. S. SODRE, T. L. H. FERREIRA, F. W. M. LIMA. Prevalence of serological markers and risk factors for bloodborne pathogens in Salvador, Bahia state, Brazil. Epidemiology and Infection 2013; 141(1) doi: 10.1017/S0950268812000386
|
| 625 |
David S. Campo, Guo-Liang Xia, Zoya Dimitrova, Yulin Lin, Joseph C. Forbi, Lilia Ganova-Raeva, Lili Punkova, Sumathi Ramachandran, Hong Thai, Pavel Skums, Seth Sims, Inna Rytsareva, Gilberto Vaughan, Ha-Jung Roh, Michael A. Purdy, Amanda Sue, Yury Khudyakov. Accurate Genetic Detection of Hepatitis C Virus Transmissions in Outbreak Settings. Journal of Infectious Diseases 2016; 213(6) doi: 10.1093/infdis/jiv542
|
| 626 |
|
| 627 |
Ugo Fedeli, Enrico Grande, Francesco Grippo, Luisa Frova. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data. World Journal of Gastroenterology 2017; 23(10): 1866-1871 doi: 10.3748/wjg.v23.i10.1866
|
| 628 |
Alejandro Soza, Pilar Labbé, Marco Arrese, Arnoldo Riquelme, Francisco Barrera, Carlos Benítez, Alvaro Huete, M. Elvira Balcells, Jaime Labarca. Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin. Annals of Hepatology 2015; 14(1) doi: 10.1016/S1665-2681(19)30811-7
|
| 629 |
Jonghoon Kang, Erin Kang, Matthew L. Cowan, Manuel Orozco. Temporal development of research publications on SARS-CoV-2 and COVID-19. F1000Research 2021; 10 doi: 10.12688/f1000research.42122.1
|
| 630 |
Michael James Babineaux, Miriam J. Alter. Netter’s Infectious Diseases. 2012; doi: 10.1016/B978-1-4377-0126-5.00067-7
|
| 631 |
Maria Z. Sulbarán, Federico A. Di Lello, Yoneira Sulbarán, Clarisa Cosson, Carmen L. Loureiro, Héctor R. Rangel, Jean F. Cantaloube, Rodolfo H. Campos, Gonzalo Moratorio, Juan Cristina, Flor H. Pujol, Sheila Mary Bowyer. Genetic History of Hepatitis C Virus in Venezuela: High Diversity and Long Time of Evolution of HCV Genotype 2. PLoS ONE 2010; 5(12) doi: 10.1371/journal.pone.0014315
|
| 632 |
Waqas Alam, Hammad Ullah, Cristina Santarcangelo, Alessandro Di Minno, Haroon Khan, Maria Daglia, Carla Renata Arciola. Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22158014
|
| 633 |
Aparna Goel, Aijaz Ahmed, Imam Waked. Clinical Epidemiology of Chronic Liver Diseases. 2019; doi: 10.1007/978-3-319-94355-8_12
|
| 634 |
Thomas Astell-Burt, Robin Flowerdew, Paul Boyle, John Dillon. Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?. Social Science & Medicine 2012; 75(1) doi: 10.1016/j.socscimed.2012.02.046
|
| 635 |
Guangming Chen, Hongyu Ren, Anthony Turpoff, Alexander Arefolov, Richard Wilde, James Takasugi, Atiyya Khan, Neil Almstead, Zhengxian Gu, Takashi Komatsu, Connie Freund, Jamie Breslin, Joseph Colacino, Jean Hedrick, Marla Weetall, Gary M. Karp. Discovery of N-(4′-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication. Bioorganic & Medicinal Chemistry Letters 2013; 23(13) doi: 10.1016/j.bmcl.2013.04.050
|
| 636 |
Ahmed M. Abdulkareem, Basheer A. Al-Ofairi, Mansour Ali Al-Amrani, Marwan K. Saeed, Majed A. Al-Jahrani, Wadhah Hassan Edrees, Shiburaj Sugathan, Ansam Wadia Al-shameri, Ammar AL-Farga. Detection of Natural Killer and Natural Killer T Cells Responses among Patients with Chronic Hepatitis C Infections in Sana’a City-Yemen. Current Microbiology 2026; 83(10) doi: 10.1007/s00284-026-05117-4
|
| 637 |
Alison Jazwinski, Andrew Muir. IL28B: Implications for Clinical Practice. Current Hepatitis Reports 2012; 11(1) doi: 10.1007/s11901-011-0118-y
|
| 638 |
G. P. WATT, K. P. VATCHEVA, L. BERETTA, J. J. PAN, M. B. FALLON, J. B. McCORMICK, S. P. FISHER-HOCH. Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes. Epidemiology and Infection 2016; 144(2) doi: 10.1017/S0950268815001247
|
| 639 |
Cara S. Kosack, Sigrid Nick. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource‐constrained settings. Tropical Medicine & International Health 2016; 21(5) doi: 10.1111/tmi.12688
|
| 640 |
Chunhua Li, Richard Njouom, Jacques Pépin, Tatsunori Nakano, Phil Bennett, Oliver G. Pybus, Ling Lu. Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1.
Journal of General Virology
2013; 94(8) doi: 10.1099/vir.0.048835-0
|
| 641 |
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1) doi: 10.5812/hepatmon.4295
|
| 642 |
Jose A. Garcia-Rivera, Michael Bobardt, Udayan Chatterji, Sam Hopkins, Matthew A. Gregory, Barrie Wilkinson, Kai Lin, Philippe A. Gallay. Multiple Mutations in Hepatitis C Virus NS5A Domain II Are Required To Confer a Significant Level of Resistance to Alisporivir. Antimicrobial Agents and Chemotherapy 2012; 56(10) doi: 10.1128/AAC.00919-12
|
| 643 |
Simona Ruta, Costin Cernescu. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World Journal of Gastroenterology 2015; 21(38): 10811-10823 doi: 10.3748/wjg.v21.i38.10811
|
| 644 |
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitor. Bioorganic & Medicinal Chemistry Letters 2016; 26(18) doi: 10.1016/j.bmcl.2016.07.066
|
| 645 |
Omar D. Lopez, Van N. Nguyen, Denis R. St. Laurent, Makonen Belema, Michael H. Serrano-Wu, Jason T. Goodrich, Fukang Yang, Yuping Qiu, Amy S. Ripka, Peter T. Nower, Lourdes Valera, Mengping Liu, Donald R. O’Boyle, Jin-Hua Sun, Robert A. Fridell, Julie A. Lemm, Min Gao, Andrew C. Good, Nicholas A. Meanwell, Lawrence B. Snyder. HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters 2013; 23(3) doi: 10.1016/j.bmcl.2012.11.086
|
| 646 |
Aristide Mounchili-Njifon, Pretty Rosereine Mbouyap, Laure Ngono, Elizabeth Berinyuy Nsai, Annie Epote, Suzanne Belinga, Richard Njouom. Trends in the seroprevalence of hepatitis C viruses among patients received at the Centre Pasteur du Cameroun, with an indication of anti-HCV Ac serology from 2019 to 2024. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11498-x
|
| 647 |
Nasar Khan, Muhammad Akmal, Muhammad Hayat, Attahullah xx, Iqbal Ahmed, Kashif Rahim, Sadar Ali, Sulaiman Bahadar, Shamim Saleha. Geographic Distribution of Hepatitis C Virus Genotypes in Pakistan. Hepatitis Monthly 2014; 14(10) doi: 10.5812/hepatmon.20299
|
| 648 |
Shu‐Chi Wang, Jeng‐Fu Yang, Chao‐Ling Wang, Chung‐Feng Huang, Yu‐Yin Lin, Yi‐You Chen, Chung‐Ting Lo, Po‐Yen Lee, Kuan‐Ta Wu, Chia‐I. Lin, Meng‐Hsuan Hsieh, Hung‐Yi Chuang, Chi‐Kung Ho, Ming‐Lung Yu, Chia‐Yen Dai. Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein. The Kaohsiung Journal of Medical Sciences 2016; 32(10) doi: 10.1016/j.kjms.2016.08.002
|
| 649 |
Doaa I. Hashad, Perihan E. Salem, Dina M. Abdallah. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients. Scandinavian Journal of Clinical and Laboratory Investigation 2011; 71(8) doi: 10.3109/00365513.2011.624196
|
| 650 |
Mohammed Mostafa Al-Tawil, Ahmed Saeed Shoeeb, Amal Abbas, Ahmed El-Tawil, Manal Hamdy El-Sayed. Lipid Profile and Hepatic Steatosis in Hepatitis C Infected Egyptian Survivors of Childhood Cancer. Pediatric Hematology and Oncology 2015; 32(1) doi: 10.3109/08880018.2013.825355
|
| 651 |
Paul Y. Kwo. Regimens for Cirrhotic Patients. Clinics in Liver Disease 2015; 19(4) doi: 10.1016/j.cld.2015.06.006
|
| 652 |
M. RONDY, L. WIESSING, S. J. HUTCHINSON, C. MATHEÏ, F. MATHIS, V. MRAVCIK, L. NORDEN, M. ROSIŃSKA, O. SCUTELNICIUC, B. SULIGOI, F. VALLEJO, M. VAN VEEN, M. KRETZSCHMAR. Hepatitis C prevalence in injecting drug users in Europe, 1990–2007: impact of study recruitment setting. Epidemiology and Infection 2013; 141(3) doi: 10.1017/S0950268812000921
|
| 653 |
Jason T. Blackard, Ling Kong, Amanda K. Huber, Yaron Tomer. Hepatitis C Virus Infection of a Thyroid Cell Line: Implications for Pathogenesis of Hepatitis C Virus and Thyroiditis. Thyroid 2013; 23(7) doi: 10.1089/thy.2012.0507
|
| 654 |
Yu-Lung Chiu, Herng-Ching Lin, Nai-Wen Kuo, Senyong Kao, Hsin-Chien Lee. Increased risk of concurrent hepatitis C among Male patients with schizophrenia. Psychiatry Research 2017; 258 doi: 10.1016/j.psychres.2017.08.036
|
| 655 |
Miriam J. Alter. Tropical Infectious Diseases: Principles, Pathogens and Practice. 2011; doi: 10.1016/B978-0-7020-3935-5.00065-3
|
| 656 |
Umberto Vespasiani-Gentilucci, Giovanni Galati, Paolo Gallo, Antonio De Vincentis, Elisabetta Riva, Antonio Picardi. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens. World Journal of Gastroenterology 2015; 21(24): 7412-7426 doi: 10.3748/wjg.v21.i24.7412
|
| 657 |
Saira Sarfraz, Saeed Hamid, Syed Ali, Wasim Jafri, Anwar A Siddiqui. Modulations of cell cycle checkpoints during HCV associated disease. BMC Infectious Diseases 2009; 9(1) doi: 10.1186/1471-2334-9-125
|
| 658 |
Isei Tanida, Yoshitaka Shirasago, Ryosuke Suzuki, Ryo Abe, Takaji Wakita, Kentaro Hanada, Masayoshi Fukasawa. Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus. Japanese Journal of Infectious Diseases 2015; 68(4) doi: 10.7883/yoken.JJID.2014.309
|
| 659 |
Patricia Baré. Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré. World Journal of Hepatology 2009; 1(1): 67-71 doi: 10.4254/wjh.v1.i1.67
|
| 660 |
Wenkang Ma, Amr S Soliman, Wagida A Anwar, Ahmed Hablas, Tamer B El Din, Mohamed Ramadan, Ibrahim A Seifeldin, Mark L Wilson. Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives. BMJ Global Health 2018; 3(2) doi: 10.1136/bmjgh-2017-000572
|
| 661 |
Cíntia Bittar, Ana Carolina G Jardim, Lilian HT Yamasaki, Artur TL de Queiróz, Claudia MA Carareto, João Renato R Pinho, Isabel Maria VG de Carvalho-Mello, Paula Rahal. Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response. BMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-36
|
| 662 |
S. De Meyer, A. Ghys, G. R. Foster, M. Beumont, B. Van Baelen, T.‐I. Lin, I. Dierynck, H. Ceulemans, G. Picchio. Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes. Journal of Viral Hepatitis 2013; 20(6) doi: 10.1111/jvh.12046
|
| 663 |
Milagros Dávalos Moscol. Indications for treatment in chronic HCV infection. Annals of Hepatology 2010; 9 doi: 10.1016/S1665-2681(19)31724-7
|
| 664 |
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 2009; 51(4) doi: 10.1016/j.jhep.2009.05.008
|
| 665 |
Dilek BULUT, Merve Sefa SAYAR, Ali ACAR. The effect of direct-acting antivirals (DAA) on confirmed noninvasive fibrous parameters in chronic hepatitis C patients. Anatolian Current Medical Journal 2023; 5(4) doi: 10.38053/acmj.1343277
|
| 666 |
Gregory R Hart, Andrew L Ferguson. Empirical fitness models for hepatitis C virus immunogen design. Physical Biology 2015; 12(6) doi: 10.1088/1478-3975/12/6/066006
|
| 667 |
Sofia Lourenço, Fleur Costa, Béatrice Débarges, Thibault Andrieu, Annie Cahour. Hepatitis C virus internal ribosome entry site‐mediated translation is stimulated by cis‐acting RNA elements and trans‐acting viral factors. The FEBS Journal 2008; 275(16) doi: 10.1111/j.1742-4658.2008.06566.x
|
| 668 |
Chunhua Li, Manqiong Yuan, Ling Lu, Teng Lu, Wenjie Xia, Van H. Pham, An X.D. Vo, Mindie H. Nguyen, Kenji Abe. The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology 2014; doi: 10.1016/j.virol.2014.07.026
|
| 669 |
L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek, J.M. Pawlotsky, Y. Yazdanpanah. Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer. Clinical Microbiology and Infection 2011; 17(2) doi: 10.1111/j.1469-0691.2010.03245.x
|
| 670 |
Aqsa Ikram, Sadia Anjum, Muhammad Tahir. InSilico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2From Pakistan: A Step Towards Heterologous Vaccine Design. Hepatitis Monthly 2014; 14(4) doi: 10.5812/hepatmon.9832
|
| 671 |
Grégoire Vuagniaux, Arnaud Hamel, Rafael Crabbé, Hervé C. Porchet, Jean‐Maurice Dumont. Antiviral Drug Strategies. Methods and Principles in Medicinal Chemistry 2011; 50 doi: 10.1002/9783527635955.ch7
|
| 672 |
M. Michele Manos, Valentina A. Shvachko, Rosemary C. Murphy, Jean Marie Arduino, Norah J. Shire. Distribution of hepatitis C virus genotypes in a diverse US integrated health care population. Journal of Medical Virology 2012; 84(11) doi: 10.1002/jmv.23399
|
| 673 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_164-1
|
| 674 |
Yousryeia A. Ahmad, Ola Afifi, Safinaz Hussein, Rania Hafez, Eman Salaheldin. B-lymphocyte stimulator: can we consider it a marker for severity of hepatitis C virus-induced B-cell non-Hodgkin lymphoma?. The Egyptian Journal of Internal Medicine 2017; 29(3) doi: 10.4103/ejim.ejim_33_17
|
| 675 |
Chih-Ching Yeh, Meei-Maan Wu, Chia-Min Wu, Fung-Chang Sung, Chih-Hsin Muo, Arlene Te, Fu-Hsiung Su. Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan. Viruses 2021; 13(5) doi: 10.3390/v13050790
|
| 676 |
Faraz Salehi Moghadam, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Hanieh Mirtalebi, Sara Romani, Pedram Azimzadeh, Azar Sanati, Mohammad Reza Zali. Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report. Jundishapur Journal of Microbiology 2013; doi: 10.5812/jjm.6560
|
| 677 |
Chang Ho Lee, Young Ju Lee, Ji Hyun Kim, Jong Hoon Lim, Jung-Hye Kim, Wonkyo Han, Soo-Han Lee, Gyu-Jeong Noh, Seong-Wook Lee. Inhibition of Hepatitis C Virus (HCV) Replication by Specific RNA Aptamers against HCV NS5B RNA Replicase. Journal of Virology 2013; 87(12) doi: 10.1128/JVI.00405-13
|
| 678 |
Jeremiah Bowers, Emma Hughes, Nicholas Skill, Mary Maluccio, Daniel Raftery. Detection of hepatocellular carcinoma in hepatitis C patients: Biomarker discovery by LC–MS. Journal of Chromatography B 2014; 966 doi: 10.1016/j.jchromb.2014.02.043
|
| 679 |
Nicolas Brezillon, Dina Kremsdorf, Mary C. Weiss. Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens. Disease Models & Mechanisms 2008; 1(2-3) doi: 10.1242/dmm.000463
|
| 680 |
Mustafa Atas, Arzu Seyhan Karatepe Hashas, Süleyman Demircan, Fatma Mutlu Sarıguzel, Burhan Baskan, Isa Yuvacı, Emine Pangal, Ilhami Celik, Gokmen Zararsiz. The Investigation of HCV RNA in Tear Fluid and Aqueous Humor in Patients with Anti-HCV Antibody Positive Who Underwent Cataract Surgery. Ocular Immunology and Inflammation 2014; doi: 10.3109/09273948.2014.985386
|
| 681 |
John W. Ward, Deborah Holtzman. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00029-X
|
| 682 |
Kalisetty Chengaiahgari Maheswari, Ganganapalli Supraja, Kallimakula Venkata Reddy Saritha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00011-2
|
| 683 |
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
|
| 684 |
Sakshi Singh, Giovanni Colonna, Giovanni Di Bernardo, Francesca Bergantino, Marcella Cammarota, Giuseppe Castello, Susan Costantini. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes. Molecular BioSystems 2015; 11(11) doi: 10.1039/C5MB00434A
|
| 685 |
Kenrad E. Nelson, Hua Shan. Confirmatory testing of hepatitis C virus–positive enzyme immunoassay results in limited‐resource countries: should it be attempted?. Transfusion 2008; 48(6) doi: 10.1111/j.1537-2995.2008.01696.x
|
| 686 |
A. M. G. Brunasso, M. Puntoni, A. Gulia, C. Massone. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology 2011; 50(9) doi: 10.1093/rheumatology/ker190
|
| 687 |
Molly Jung, Mark H. Kuniholm, Gloria Y.F. Ho, Scott Cotler, Howard D. Strickler, Bharat Thyagarajan, Marston Youngblood, Robert C. Kaplan, Julia del Amo. The distribution of hepatitis B virus exposure and infection in a population‐based sample of U.S. Hispanic adults. Hepatology 2016; 63(2) doi: 10.1002/hep.28328
|
| 688 |
Nikhil Ashtekar, Garima Anand, Hirekodathakallu V. Thulasiram, Kunhiraman C. Rajeshkumar. New and Future Developments in Microbial Biotechnology and Bioengineering. 2021; doi: 10.1016/B978-0-12-821005-5.00014-4
|
| 689 |
Theresa Gather, Stephanie Walter, Daniel Todt, Stephanie Pfaender, Richard J. P. Brown, Alexander Postel, Paul Becher, Andreas Moritz, Florian Hansmann, Wolfgang Baumgaertner, Karsten Feige, Eike Steinmann, Jessika-M. V. Cavalleri. Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses. Journal of General Virology 2016; 97(10) doi: 10.1099/jgv.0.000561
|
| 690 |
Fabiola Atzeni, Ignazio Francesco Masala, Manuela di Franco, Piercarlo Sarzi-Puttini. Infections in rheumatoid arthritis. Current Opinion in Rheumatology 2017; 29(4) doi: 10.1097/BOR.0000000000000389
|
| 691 |
Z. M. Younossi, L. Zheng, M. Stepanova, C. Venkatesan, H. M. Mir. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2013; 37(7) doi: 10.1111/apt.12265
|
| 692 |
José Barreto Cruz Nogueira, Laís Cristina Santana Sena, Jullyana de Souza Siqueira Quintans, Jackson Roberto Guedes da Silva Almeida, Alex Vianey Callado França, Lucindo José Quintans Júnior. Side Effects of the Therapy With Peginterferon and Ribavirin in Chronic Hepatitis C. Journal of Pharmacy Practice 2012; 25(1) doi: 10.1177/0897190011415687
|
| 693 |
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension. International Journal of Molecular Sciences 2017; 18(8) doi: 10.3390/ijms18081626
|
| 694 |
Sumathi Ramachandran, David S. Campo, Zoya E. Dimitrova, Guo-liang Xia, Michael A. Purdy, Yury E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection. Journal of Virology 2011; 85(13) doi: 10.1128/JVI.02204-10
|
| 695 |
Fu-Hsiung Su, Chien-Sheng Wu, Fung-Chang Sung, Shih-Ni Chang, Chien-Tien Su, Ying-Hua Shieh, Chih-Ching Yeh, Yury E. Khudyakov. Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan. PLoS ONE 2014; 9(11) doi: 10.1371/journal.pone.0113579
|
| 696 |
Philippe A. Gallay. Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents. Immunologic Research 2012; 52(3) doi: 10.1007/s12026-011-8263-5
|
| 697 |
D. S. Campo, Z. Dimitrova, R. J. Mitchell, J. Lara, Y. Khudyakov. Coordinated evolution of the hepatitis C virus. Proceedings of the National Academy of Sciences 2008; 105(28) doi: 10.1073/pnas.0801774105
|
| 698 |
Edgar P. Simard, Ahmedin Jemal. The American Cancer Society's Principles of Oncology. 2018; doi: 10.1002/9781119468868.ch7
|
| 699 |
Suganya Selvarajah, Sheila Keating, John Heitman, Kai Lu, Graham Simmons, Philip J. Norris, Eva Operskalski, James W. Mosley, Michael P. Busch. Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.
Journal of General Virology
2012; 93(8) doi: 10.1099/vir.0.041277-0
|
| 700 |
Suganya Selvarajah, Leslie H Tobler, Graham Simmons, Michael P Busch. Host genetic basis for hepatitis C virus clearance: a role for blood collection centers. Current Opinion in Hematology 2010; 17(6) doi: 10.1097/MOH.0b013e32833e7544
|
| 701 |
Dawn N. Ward, Daniel C. Talley, Mrinalini Tavag, Samrawit Menji, Paul Schaughency, Andrea Baier, Paul J. Smith. UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication. Bioorganic & Medicinal Chemistry Letters 2014; 24(2) doi: 10.1016/j.bmcl.2013.12.012
|
| 702 |
Jin-Kyoung Oh, Elisabete Weiderpass. Infection and Cancer: Global Distribution and Burden of Diseases. Annals of Global Health 2014; 80(5) doi: 10.1016/j.aogh.2014.09.013
|
| 703 |
Alastair Heffernan, Graham S Cooke, Shevanthi Nayagam, Mark Thursz, Timothy B Hallett. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. The Lancet 2019; 393(10178) doi: 10.1016/S0140-6736(18)32277-3
|
| 704 |
J. I. O'Reilly, P. Ocama, C. K. Opio, A. Alfred, E. Paintsil, E. Seremba, A. N. Sofair. Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, Uganda. Journal of Tropical Medicine 2011; 2011 doi: 10.1155/2011/598341
|
| 705 |
Edoardo G. Giannini, Monica Basso, Vincenzo Savarino, Antonino Picciotto. Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and More. Digestive Diseases and Sciences 2010; 55(11) doi: 10.1007/s10620-010-1408-x
|
| 706 |
|
| 707 |
Matthew G.K. Benesch, Yi M. Ko, Todd P.W. McMullen, David N. Brindley. Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions. FEBS Letters 2014; 588(16) doi: 10.1016/j.febslet.2014.02.009
|
| 708 |
Suzanne Polis. Hepatitis C virus, pregnancy and postnatal care. Gastrointestinal Nursing 2015; 13(5) doi: 10.12968/gasn.2015.13.5.26
|
| 709 |
Moataz M. Sayed, Ahmed I. El-Shafie, Ahmed Fathy Hilal, Hoda A. Abdelsattar. Can hepatitis C virus core antigen be used as a reliable marker of viral load for hepatitis C virus infection in genotype 4?. Egyptian Liver Journal 2017; 7(1 and 2) doi: 10.1097/01.ELX.0000523559.96944.09
|
| 710 |
Shahroz Khan, Ijaz Ali, Malik Badshah, Mohammad Qaiser Khan, Zahida Haider, Sajid Ali, Imtiaz Ali Khan, Anwar Ullah. Molecular Epidemiology of Hepatitis C Virus Genotypes Among Chronically Infected Patients in Pakistan. Jundishapur Journal of Microbiology 2019; (In Press) doi: 10.5812/jjm.86428
|
| 711 |
Ghada H. Al-Ansary, Mohamed A.H. Ismail, Dalal A. Abou El Ella, Sameh Eid, Khaled A.M. Abouzid. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold. European Journal of Medicinal Chemistry 2013; 68 doi: 10.1016/j.ejmech.2013.07.006
|
| 712 |
Wei Leong Tan, Goh Yihui, Muhammad Radzi Abu Hassan. Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia. Epidemiology and Health 2015; 37 doi: 10.4178/epih/e2015032
|
| 713 |
Nalini K. Sharma, Averell H. Sherker. Chronic Viral Hepatitis. 2009; doi: 10.1007/978-1-59745-565-7_2
|
| 714 |
Dennis Hernandez, Paul Falk, Fei Yu, Guangzhi Zhai, Yong Quan, Teresa Faria, Kai Cao, Paul Scola, Fiona McPhee. Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity. Biochemical Pharmacology 2013; 85(1) doi: 10.1016/j.bcp.2012.10.002
|
| 715 |
Munazza Mansoor, William A. de Glanville, Ridwa Alam, Khawar Aslam, Mubashir Ahmed, Petros Isaakidis, Aneeta Pasha, Chrispin Chaguza. Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan. PLOS Global Public Health 2023; 3(9) doi: 10.1371/journal.pgph.0002076
|
| 716 |
Ashly E. Jordan, Don C. Des Jarlais, Kamyar Arasteh, Courtney McKnight, Denis Nash, David C. Perlman. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013. Drug and Alcohol Dependence 2015; 152 doi: 10.1016/j.drugalcdep.2015.03.039
|
| 717 |
Sreedhara H G, Rudramuneswara Swamy B P, Mahantesh S, Vijayakumara H G, Nagaraj E R. PREVALENCE OF HEPATITIS C VIRUS INFECTION IN NON INSULIN DEPENDENT DIABETIC PATIENTS (NIDDM). Journal of Evidence Based Medicine and Healthcare 2015; 2(34) doi: 10.18410/jebmh/2015/733
|
| 718 |
Ezichi F. Ofoezie, Chinwendu A. Ogbonna, Sandra C. Olisakwe, Chioma J. Anunobi, Ezinne T. George, Simeon Babarinde, Chidera G. Chukwuemeka, Uzochukwu E. Ogbonna, Chibuzo C. Amafili, Chibuzo V. Alisigwe, Onyinyechi J. Omaba, Henry N. Ogbonna. Role of infectious agents in cancer pathogenesis and therapy. The Microbe 2025; 6 doi: 10.1016/j.microb.2025.100284
|
| 719 |
Anna R. Hemnes, Ivan M. Robbins. Sildenafil Monotherapy in Portopulmonary Hypertension Can Facilitate Liver Transplantation. Liver Transplantation 2009; 15(1) doi: 10.1002/lt.21479
|
| 720 |
Qianqian Qin, M. Kumi Smith, Lu Wang, Yingying Su, Liyan Wang, Wei Guo, Lan Wang, Yan Cui, Ning Wang. Hepatitis C virus infection in China: an emerging public health issue. Journal of Viral Hepatitis 2015; 22(3) doi: 10.1111/jvh.12295
|
| 721 |
Abdelfattah M. Attallah, Mohamed M. Omran, Khaled Farid, Mahmoud El-Bendary, Tarek M. Emran, Mohamed S. Albannan, Ibrahim El-Dosoky. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clinica Chimica Acta 2012; 413(21-22) doi: 10.1016/j.cca.2012.06.031
|
| 722 |
Lilia M. Ganova-Raeva, Zoya E. Dimitrova, David S. Campo, Yulin Lin, Sumathi Ramachandran, Guo-liang Xia, Christiane Honisch, Charles R. Cantor, Yury E. Khudyakov. Detection of Hepatitis C Virus Transmission by Use of DNA Mass Spectrometry. The Journal of Infectious Diseases 2013; 207(6) doi: 10.1093/infdis/jis938
|
| 723 |
Kuan-Jen Chen, Chin-Kai Tseng, Fang-Rong Chang, Jin-Iong Yang, Chi-Chen Yeh, Wei-Chun Chen, Shou-Fang Wu, Hsueh-Wei Chang, Jin-Ching Lee, Erica Villa. Aqueous Extract of the Edible Gracilaria tenuistipitata Inhibits Hepatitis C Viral Replication via Cyclooxygenase-2 Suppression and Reduces Virus-Induced Inflammation. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0057704
|
| 724 |
Maya Guest, Ashley K. Kable, May M. Boggess, Mark Friedewald. Nurses’ sharps, including needlestick, injuries in public and private healthcare facilities in New South Wales, Australia. Healthcare infection 2014; 19(2) doi: 10.1071/HI13044
|
| 725 |
Cuiping Shao, Na Huo, Lanlan Zhao, Ying Gao, Xiaohong Fan, Yingying Zheng, Lifen Wang, Haiying Lu, Xiaoyuan Xu, Xiaohui Guo. The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients. European Journal of Endocrinology 2013; 168(5) doi: 10.1530/EJE-12-0775
|
| 726 |
Dursun Ekmekci, Shahnaz N. Shahbazova. Recent Developments and the New Directions of Research, Foundations, and Applications. Studies in Fuzziness and Soft Computing 2023; 423 doi: 10.1007/978-3-031-23476-7_15
|
| 727 |
F. Nazari, A.B. Gumel, E.H. Elbasha. Differential characteristics of primary infection and re-infection can cause backward bifurcation in HCV transmission dynamics. Mathematical Biosciences 2015; 263 doi: 10.1016/j.mbs.2015.02.002
|
| 728 |
Laura Esteban-Riesco, Frantz Depaulis, Alain Moreau, Yannick Bacq, Frédéric Dubois, Alain Goudeau, Catherine Gaudy-Graffin. Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection. Virology 2013; 444(1-2) doi: 10.1016/j.virol.2013.05.037
|
| 729 |
Ednelza da Silva Graça Amoras, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Bárbara Brasil Santana, Geraldo Ishak, Marialva Tereza Ferreira de Araújo, Sâmia Demachki, Simone Regina Souza da Silva Conde, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, Matias A Avila. NGF and P75NTR Gene Expression Is Associated with the Hepatic Fibrosis Stage Due to Viral and Non-Viral Causes. PLOS ONE 2015; 10(3) doi: 10.1371/journal.pone.0121754
|
| 730 |
Laetitia Zona, Rajiv Tawar, Mirjam Zeisel, Fei Xiao, Catherine Schuster, Joachim Lupberger, Thomas Baumert. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses 2014; 6(2) doi: 10.3390/v6020875
|
| 731 |
Richard T. Johnson, Christopher Power. Emerging Issues in Neurovirology: New Viruses, Diagnostic Tools, and Therapeutics. Neurologic Clinics 2008; 26(3) doi: 10.1016/j.ncl.2008.04.003
|
| 732 |
Jong Yeop Kim, Juhee Cho, Sung Ho Hwang, Ho Kil, Si Hyun Bae, Young Seok Kim, Han Chu Lee, Sook-Hyang Jeong. Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in Korea. Journal of Korean Medical Science 2012; 27(11) doi: 10.3346/jkms.2012.27.11.1371
|
| 733 |
Inmaculada Castillo, Javier Bartolomé, Juan Antonio Quiroga, Guillermina Barril, Vicente Carreño. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. Journal of Medical Virology 2009; 81(7) doi: 10.1002/jmv.21483
|
| 734 |
Leon D. Averbukh, George Y. Wu. Highlights for Dental Care as a Hepatitis C Risk Factor: A Review of Literature. Journal of Clinical and Translational Hepatology 2019; (X) doi: 10.14218/JCTH.2019.00023
|
| 735 |
G Lodi, R Pellicano, M Carrozzo. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Diseases 2010; 16(7) doi: 10.1111/j.1601-0825.2010.01670.x
|
| 736 |
John McLauchlan. Lipid droplets and hepatitis C virus infection. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009; 1791(6) doi: 10.1016/j.bbalip.2008.12.012
|
| 737 |
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation. Cancers 2022; 14(13) doi: 10.3390/cancers14133036
|
| 738 |
Mimi Ton, Michael J. Widener, Peter James, Trang VoPham. Food Environments and Hepatocellular Carcinoma Incidence. International Journal of Environmental Research and Public Health 2021; 18(11) doi: 10.3390/ijerph18115740
|
| 739 |
Zainab al-mussa, Hawazin Thamair. THE PREVALENCE RATE OF HEPATITIS C VIRUS IN BASRAH CITY AND THE COMMON CAUSATIVE RISK FACTORS. Iraqi National Journal of Medicine 2019; 1(2) doi: 10.37319/iqnjm.1.2.5
|
| 740 |
Katherine Bornschlegel, Magdalena Berger, Renu K. Garg, Amado Punsalang, Christy M. McKinney, R. Charon Gwynn, Lorna E. Thorpe. Prevalence of Hepatitis C Infection in New York City, 2004. Journal of Urban Health 2009; 86(6) doi: 10.1007/s11524-009-9396-x
|
| 741 |
Samia Afzal, Muhammad Idrees, Madiha Akram, Zunaira Awan, Bushra Khubaib, Mahwish Aftab, Zareen Fatima, Sadaf Badar, Abrar Hussain. Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-377
|
| 742 |
Victoria L. Demetriou, Leondios G. Kostrikis. Near‐full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4. Journal of Medical Virology 2011; 83(12) doi: 10.1002/jmv.22237
|
| 743 |
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Diseases 2008; 14(2) doi: 10.1111/j.1601-0825.2007.01436.x
|
| 744 |
Sam Hopkins, Michael Bobardt, Udayan Chatterji, Jose A. Garcia-Rivera, Precious Lim, Philippe A. Gallay. The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes. Antimicrobial Agents and Chemotherapy 2012; 56(7) doi: 10.1128/AAC.00693-12
|
| 745 |
. 2011; doi: 10.70675/a11e1df7zc699z4252z9596zcf8d38ca65f9
|
| 746 |
Ann D Kwong, Robert S Kauffman, Patricia Hurter, Peter Mueller. Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus. Nature Biotechnology 2011; 29(11) doi: 10.1038/nbt.2020
|
| 747 |
Hiromitsu Kumada, Joji Toyota, Takeshi Okanoue, Kazuaki Chayama, Hirohito Tsubouchi, Norio Hayashi. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan. Journal of Hepatology 2012; 56(1) doi: 10.1016/j.jhep.2011.07.016
|
| 748 |
Inna Rytsareva, David S. Campo, Yueli Zheng, Seth Sims, Cansu Tetik, Jain Chirag, Sriram P. Chockalingam, Sharma V. Thankachan, Amanda Sue, Srinivas Aluru, Yury Khudyakov. Efficient detection of viral transmission with threshold-based methods. 2015 IEEE 5th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS) 2015; doi: 10.1109/ICCABS.2015.7344723
|
| 749 |
Nuzhat Maqbool Peer, Vinod Joshi, Annette Angel, Bennet Angel, Vikram Singh Chauhan, Shareef Mohammed Buvvaji, Poorna Khaneja, Ambreen Shafaat Khan, Shilpa Barthwal, Neha Singh, Bhawna Sharma, Ramesh Joshi, Monika Dheer, Khushbu Kumari, Aarya Chitransh, Reshu Chauhan. Characterization of Circulating HCV Genotypes: A Cohort Study in Uttar Pradesh, India. Journal of Pure and Applied Microbiology 2024; 18(2) doi: 10.22207/JPAM.18.2.21
|
| 750 |
Banishree Saha, Manish C. Choudhary, Shiv K. Sarin. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection. AIDS 2013; 27(14) doi: 10.1097/QAD.0b013e32836285e4
|
| 751 |
Julie A. Lemm, John E. Leet, Donald R. O'Boyle, Jeffrey L. Romine, Xiaohua Stella Huang, Daniel R. Schroeder, Jeffrey Alberts, Joseph L. Cantone, Jin-Hua Sun, Peter T. Nower, Scott W. Martin, Michael H. Serrano-Wu, Nicholas A. Meanwell, Lawrence B. Snyder, Min Gao. Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures. Antimicrobial Agents and Chemotherapy 2011; 55(8) doi: 10.1128/AAC.00146-11
|
| 752 |
Giuseppe Indolfi, Alessandro Nesi, Massimo Resti. Intrafamilial transmission of hepatitis C virus. Journal of Medical Virology 2013; 85(4) doi: 10.1002/jmv.23522
|
| 753 |
Eiman Hussein, Jun Teruya. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Transfusion 2012; 52(11) doi: 10.1111/j.1537-2995.2012.03592.x
|
| 754 |
Chao Zhang, Adam Huys, Patricia A. Thibault, Joyce A. Wilson. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance. Virology 2012; 433(2) doi: 10.1016/j.virol.2012.08.039
|
| 755 |
NA Alaizari, SA Al‐Maweri, HM Al‐Shamiri, B Tarakji, B Shugaa‐Addin. Hepatitis C virus infections in oral lichen planus: a systematic review and meta‐analysis. Australian Dental Journal 2016; 61(3) doi: 10.1111/adj.12382
|
| 756 |
AT R-Viso, MIS Duarte, C Pagliari, ER Fernandes, RA Brasil, G Benard, CC Romano, S Ogusuku, NP Cavalheiro, CE Melo, AA Barone. Tissue and serum immune response in chronic hepatitis C with mild histological lesions. Memórias do Instituto Oswaldo Cruz 2010; 105(1) doi: 10.1590/S0074-02762010000100003
|
| 757 |
Jayant N. Acharya, Vitor H. Pacheco. Neurologic Complications of Hepatitis C. The Neurologist 2008; 14(3) doi: 10.1097/NRL.0b013e31815fa594
|
| 758 |
Yaroslava Karpova, David J. Orlicky, Edward E. Schmidt, Alexei V. Tulin. Disrupting Poly(ADP-ribosyl)ating Pathway Creates Premalignant Conditions in Mammalian Liver. International Journal of Molecular Sciences 2023; 24(24) doi: 10.3390/ijms242417205
|
| 759 |
Maria Betânia S Silva, Tarcísio M Andrade, Luciano K Silva, Itatiana F Rodart, Gisele B Lopes, Theomira MA Carmo, Maria Alice S Zarife, Inês Dourado, Mitermayer G Reis. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Memórias do Instituto Oswaldo Cruz 2010; 105(3) doi: 10.1590/S0074-02762010000300009
|
| 760 |
Atsuko Tsukimoto, Ryuichi Sugiyama, Makoto Abe, Hironori Nishitsuji, Yuko Shimizu, Kunitada Shimotohno, Gota Kawai, Hiroshi Takaku. A new role for PGA1 in inhibiting hepatitis C virus-IRES-mediated translation by targeting viral translation factors. Antiviral Research 2015; 117 doi: 10.1016/j.antiviral.2015.01.013
|
| 761 |
Pahari Chetia, Sonia Bhonchal Bhardwaj, Manoj Kumar. Assessment of knowledge, attitude and practices regarding hepatitis C virus disease among university students: a cross-sectional study. International Journal Of Community Medicine And Public Health 2025; doi: 10.18203/2394-6040.ijcmph20252922
|
| 762 |
Max Hopwood, Toby Lea, Peter Aggleton. Drug, sex and sociality: Factors associated with the recent sharing of injecting equipment among gay and bisexual men in Australia. International Journal of Drug Policy 2015; 26(2) doi: 10.1016/j.drugpo.2014.10.013
|
| 763 |
Stephanie Pfaender, Julia Heyden, Martina Friesland, Sandra Ciesek, Asim Ejaz, Joerg Steinmann, Jochen Steinmann, Angelika Malarski, Heribert Stoiber, Georgios Tsiavaliaris, Werner Bader, Gerhard Jahreis, Thomas Pietschmann, Eike Steinmann. Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk. The Journal of Infectious Diseases 2013; 208(12) doi: 10.1093/infdis/jit519
|
| 764 |
Nick Scott, Margaret Hellard, Emma Sue McBryde. Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges. Virulence 2016; 7(2) doi: 10.1080/21505594.2015.1085151
|
| 765 |
Eve-Isabelle Pécheur, Olivier Diaz, Jennifer Molle, Vinca Icard, Pierre Bonnafous, Olivier Lambert, Patrice André. Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins. Journal of Biological Chemistry 2010; 285(33) doi: 10.1074/jbc.M110.131664
|
| 766 |
Robert Hamatake, Andrew Maynard, Wieslaw M. Kazmierski. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry 2012; 47 doi: 10.1016/B978-0-12-396492-2.00022-9
|
| 767 |
Nabila El-Bassel, Louisa Gilbert, Assel Terlikbayeva, Chris Beyrer, Elwin Wu, Mingway Chang, Tim Hunt, Leyla Ismayilova, Stacey A. Shaw, Sholpan Primbetova, Yelena Rozental, Baurzhan Zhussupov, Marat Tukeyev. Effects of a Couple-Based Intervention to Reduce Risks for HIV, HCV, and STIs Among Drug-Involved Heterosexual Couples in Kazakhstan. JAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 67(2) doi: 10.1097/QAI.0000000000000277
|
| 768 |
. 2018; doi: 10.70675/88ae409az6769z4868z9051z5539dd2c5b98
|
| 769 |
Gabriel de Deus VIEIRA, Cledson Gonçalves VENTURA, Camila Maciel de SOUSA. OCCURRENCE AND SPATIAL DISTRIBUTION OF HEPATITIS C IN A WESTERN BRAZILIAN AMAZON STATE. Arquivos de Gastroenterologia 2014; 51(4) doi: 10.1590/S0004-28032014000400009
|
| 770 |
Donglan Lu, Xue Bai, Qiyuan Zou, Zuhuan Gan, Yufeng Lv. Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co‑expression network. Oncology Letters 2020; 20(3) doi: 10.3892/ol.2020.11844
|
| 771 |
Ahmad A. Hamed, Yasser W. Darwish, Manal Hamdy El-Sayed. ADAMTS13 Levels in Young Patients With β-Thalassemia Major. Clinical and Applied Thrombosis/Hemostasis 2015; 21(6) doi: 10.1177/1076029614558112
|
| 772 |
Rehab A. Mohamed, Hend M. Maghraby, Eman M. Abd El Salam, Hala M. Nageb, Eman E. Ahmad, Nagwa A. Mohamed. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2015; 27(1) doi: 10.4103/1110-7782.155832
|
| 773 |
Marta Cilla, Emmanuel A. Tsochatzis. Elastography of the Liver and Beyond. 2021; doi: 10.1007/978-3-030-74132-7_3
|
| 774 |
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of functionalized bisimidazoles bearing cyclic aliphatic-phenyl motifs as HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters 2014; 24(24) doi: 10.1016/j.bmcl.2014.10.057
|
| 775 |
Laurie S. Conklin, John D. Snyder. Principles and Practice of Pediatric Infectious Diseases. 2012; doi: 10.1016/B978-1-4377-2702-9.00062-3
|
| 776 |
Shira M. Goldenberg, Julio Montaner, Melissa Braschel, Eugenia Socias, Silvia Guillemi, Kate Shannon. Dual sexual and drug-related predictors of hepatitis C incidence among sex workers in a Canadian setting: gaps and opportunities for scale-up of hepatitis C virus prevention, treatment, and care. International Journal of Infectious Diseases 2017; 55 doi: 10.1016/j.ijid.2016.12.019
|
| 777 |
Michael W. Fried, Jama M. Darling, Stanley M. Lemon. Schiff's Diseases of the Liver. 2017; doi: 10.1002/9781119251316.ch25
|
| 778 |
Ying-Ting Lin, Yu-Hsuan Wu, Chin-Kai Tseng, Chun-Kuang Lin, Wei-Chun Chen, Yao-Chin Hsu, Jin-Ching Lee, Stephen J. Polyak. Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation. PLoS ONE 2013; 8(1) doi: 10.1371/journal.pone.0054466
|
| 779 |
F. Cao, M. J. Donlin, K. Turner, X. Cheng, J. E. Tavis. Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon α plus ribavirin therapy. Journal of Viral Hepatitis 2011; 18(5) doi: 10.1111/j.1365-2893.2010.01316.x
|
| 780 |
Yousra A. Mohamoud, Suzanne Riome, Laith J. Abu-Raddad. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. International Journal of Infectious Diseases 2016; 46 doi: 10.1016/j.ijid.2016.03.012
|
| 781 |
Margaret Robinson, Yang Tian, Nikos Pagratis, William E. Delaney. Current Protocols in Microbiology. 2011; doi: 10.1002/9780471729259.mc1707s12
|
| 782 |
Paola Pizzillo, Piero Luigi Almasio, Donatella Ferraro, Antonio Craxì, Rosa Di Stefano. HCV genotypes in Sicily: Is there any evidence of a shift?. Journal of Medical Virology 2009; 81(6) doi: 10.1002/jmv.21498
|
| 783 |
Melissa Palmer, Peter B. Bongiorno. Textbook of Natural Medicine. 2013; doi: 10.1016/B978-1-4377-2333-5.00171-1
|
| 784 |
V. M. Fleming, G. Harcourt, E. Barnes, P. Klenerman. Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection. Journal of General Virology 2010; 91(6) doi: 10.1099/vir.0.017699-0
|
| 785 |
|
| 786 |
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Eficacia de los antivirales de acción directa en la infección por el virus de la hepatitis C en pacientes en hemodiálisis. Nefrología 2017; 37(2) doi: 10.1016/j.nefro.2016.10.003
|
| 787 |
Koji Wada, Derek R. Smith, Tomohiro Ishimaru. Reluctance to care for patients with HIV or hepatitis B / C in Japan. BMC Pregnancy and Childbirth 2016; 16(1) doi: 10.1186/s12884-016-0822-2
|
| 788 |
Hiam Chemaitelly, Karima Chaabna, Laith J. Abu-Raddad, Massimo Ciccozzi. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(8) doi: 10.1371/journal.pone.0135281
|
| 789 |
Eric G Hilgenfeldt, Alex Schlachterman, Roberto J Firpi. Hepatitis C: Treatment of difficult to treat patients. World Journal of Hepatology 2015; 7(15): 1953-1963 doi: 10.4254/wjh.v7.i15.1953
|
| 790 |
Akosua Adom Agyeman, Richard Ofori-Asenso, Andy Mprah, George Ashiagbor. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1708-7
|
| 791 |
F N Germano, C A dos Santos, G Honscha, A Strasburg, B Gabbi, R A Mendoza-Sassi, E A Soares, H N Seuánez, M A Soares, A M B Martínez. Prevalence of hepatitis C virus among users attending a voluntary testing centre in Rio Grande, southern Brazil: predictive factors and hepatitis C virus genotypes. International Journal of STD & AIDS 2010; 21(7) doi: 10.1258/ijsa.2009.009089
|
| 792 |
Junko Matsuo, Masaaki Mizui, Hajime Okita, Keiko Katayama, Shiomi Aimitsu, Tatsuro Sakata, Makoto Obayashi, Toshio Nakanishi, Kazuaki Chayama, Yuzo Miyakawa, Hiroshi Yoshizawa, Junko Tanaka. Follow up of the 987 blood donors found with hepatitis C virus infection over 9–18 years. Hepatology Research 2012; 42(7) doi: 10.1111/j.1872-034X.2012.00966.x
|
| 793 |
Khushal J. Vekariya, Gautam P. Savaliya, Sabirkhan Pathan, Dipak B. Patil. Synthesis, antimicrobial evaluation, and computational investigation of novel thiazole-carbamate hybrids as dual antibacterial and antifungal agents. Main Group Chemistry 2026; doi: 10.1177/10241221261475805
|
| 794 |
Erica Southgate. Discourse, Power, and Resistance Down Under. Transgressions 2012; 88 doi: 10.1007/978-94-6209-037-8_11
|
| 795 |
Vineeth Kumar Reddy Bathina, Ravi Jayantilal Rathod, Laya Kairam, Manognya Gaddam. Mortality associated with chronic hepatitis C and liver cirrhosis: a retrospective study. International Journal of Research in Medical Sciences 2026; 14(3) doi: 10.18203/2320-6012.ijrms20260619
|
| 796 |
Yun-Ping Lim, Yu-An Hsu, Kun-Hsi Tsai, Fuu-Jen Tsai, Cheng-Yuan Peng, Wen-Ling Liao, Dong-Zong Hung, Ni Tien, Chien-Yih Lin, Lei Wan. The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese. BMC Immunology 2013; 14(1) doi: 10.1186/1471-2172-14-21
|
| 797 |
Pratima Dibba, Rosann Cholankeril, Andrew A. Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in Pregnancy. Diseases 2018; 6(2) doi: 10.3390/diseases6020031
|
| 798 |
. 2011; doi: 10.70675/8f9f5d3bz785dz404az8a14z18c6b1abe5f6
|
| 799 |
Sabrina de Brito Ramalho Luz Ferrão, José Fernando de Castro Figueiredo, Clara Fumiko Tachibana Yoshida, Afonso Dinis Costa Passos. Prevalência elevada de hepatite C no distrito de Botafogo, cidade de Bebedouro, interior do Estado de São Paulo, Brasil, 2007. Cadernos de Saúde Pública 2009; 25(2) doi: 10.1590/S0102-311X2009000200025
|
| 800 |
Qaisar Ali, Arshad Jamal, Muhammad Imran, Sajjad Ullah, Irfan Kalam, Shafi Ullah, Ahmed B Waqar.
Correlation of
IL28B
rs12979860 Genotype and Gender with Spontaneous Clearance of HCV Infection: A Pakistani Cross-Section Study
. Personalized Medicine 2018; 15(6) doi: 10.2217/pme-2018-0016
|
| 801 |
Takahiro Masaki, Satoko Matsunaga, Hirotaka Takahashi, Kenji Nakashima, Yayoi Kimura, Masahiko Ito, Mami Matsuda, Asako Murayama, Takanobu Kato, Hisashi Hirano, Yaeta Endo, Stanley M. Lemon, Takaji Wakita, Tatsuya Sawasaki, Tetsuro Suzuki, M. S. Diamond. Involvement of Hepatitis C Virus NS5A Hyperphosphorylation Mediated by Casein Kinase I-α in Infectious Virus Production. Journal of Virology 2014; 88(13) doi: 10.1128/JVI.03170-13
|
| 802 |
Aldemir B. Oliveira-Filho, Leila Sawada, Laine C. Pinto, Daiane Locks, Santana L. Bahia, I. Brasil-Costa, José Alexandre R. Lemos. HCV infection among cocaine users in the state of Pará, Brazilian Amazon. Archives of Virology 2013; 158(7) doi: 10.1007/s00705-013-1627-5
|
| 803 |
Mwumvaneza Mutagoma, Helene Balisanga, Dieudonné Sebuhoro, Aimable Mbituyumuremyi, Eric Remera, Samuel S. Malamba, David J. Riedel, Sabin Nsanzimana. Hepatitis C virus and HIV co-infection among pregnant women in Rwanda. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2269-0
|
| 804 |
Da-Jun Zhang, Wen-Fang Sun, Zhao-Jin Zhong, Rong-Mei Gao, Hong Yi, Yu-Huan Li, Zong-Gen Peng, Zhuo-Rong Li. Synthesis and Broad-Spectrum Antiviral Activity of Some Novel Benzo-Heterocyclic Amine Compounds. Molecules 2014; 19(1) doi: 10.3390/molecules19010925
|
| 805 |
Ricardo Recarey, Juan Cristina. Bayesian Coalescent Analysis of the Intra-Host Evolution of Hepatitis C Virus: Memory Genomes and Clinical Implications. Natural Science 2014; 6(09) doi: 10.4236/ns.2014.69061
|
| 806 |
Zaina Al Kanaani, Sarwat Mahmud, Silva P. Kouyoumjian, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. Royal Society Open Science 2018; 5(4) doi: 10.1098/rsos.180257
|
| 807 |
Donatien Serge Mbaga, Sebastien Kenmoe, Jacky Njiki Bikoï, Guy Roussel Takuissu, Marie Amougou-Atsama, Etienne Atenguena Okobalemba, Jean Thierry Ebogo-Belobo, Arnol Bowo-Ngandji, Martin Gael Oyono, Jeannette Nina Magoudjou-Pekam, Ginette Irma Kame-Ngasse, Alex Durand Nka, Alfloditte Flore Feudjio, Cromwel Zemnou-Tepap, Elie Adamou Velhima, Juliette Laure Ndzie Ondigui, Rachel Audrey Nayang-Mundo, Sabine Aimee Touangnou-Chamda, Yrene Kamtchueng Takeu, Jean Bosco Taya-Fokou, Chris Andre Mbongue Mikangue, Raoul Kenfack-Momo, Cyprien Kengne-Ndé, Carole Stephanie Sake, Seraphine Nkie Esemu, Richard Njouom, Lucy Ndip, Sara Honorine Riwom Essama. Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis. World Journal of Methodology 2022; 12(3): 179-190 doi: 10.5662/wjm.v12.i3.179
|
| 808 |
Nargiza Kurbanova, Rehan Qayyum. Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate. Clinical and Translational Science 2015; 8(5) doi: 10.1111/cts.12321
|
| 809 |
Sandro da Costa Ferreira, Marcos de Vasconcelos Carneiro, Fernanda Fernandes Souza, Andreza Corrêa Teixeira, Marcia Guimarães Villanova, José Fernando de Castro Figueiredo, Afonso Dinis Costa Passos, Leandra Naira Zambelli Ramalho, Sergio Zucoloto, Ana de Lourdes Candolo Martinelli. Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon. The Brazilian Journal of Infectious Diseases 2010; 14(4) doi: 10.1016/S1413-8670(10)70070-2
|
| 810 |
Hafiza
Rida Farooq Chudhary, Amjad Ali, Sadia Bibi, Muhammad Waqas, Shazia Rafique, Muhammad Idrees, Sobia Ahsan Halim, Magda H. Abdellattif, Ajmal Khan, Ahmed Al-Harrasi. Transcriptional
Analysis of TP53 Gene in Chronic Hepatitis
C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon,
and Ribavirin. ACS Omega 2023; 8(16) doi: 10.1021/acsomega.3c00903
|
| 811 |
Dahee Kim, Ja-Il Goo, Mi Il Kim, Sung-Jin Lee, Moonju Choi, Thoa Thi Than, Phuong Hong Nguyen, Marc P. Windisch, Kyeong Lee, Yongseok Choi, Choongho Lee. Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor. Molecules 2018; 23(8) doi: 10.3390/molecules23082083
|
| 812 |
Nana Wu, Qinjuan Ge, Qingchuan Feng, Jun Zhang, Xiaoxia Liu, Caihong Sun, Yongkang Xu, Guangli He, Chiyu Zhang. High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China. Indian Journal of Virology 2011; 22(2) doi: 10.1007/s13337-011-0041-4
|
| 813 |
Hosam Zaghloul, Mahmoud El-shahat. Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis. World Journal of Hepatology 2014; 6(12): 916-922 doi: 10.4254/wjh.v6.i12.916
|
| 814 |
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues. Expert Opinion on Drug Safety 2015; 14(9) doi: 10.1517/14740338.2015.1061992
|
| 815 |
Marc G. Ghany, Christopher M. Walker, Patrizia Farci. The Liver. 2020; doi: 10.1002/9781119436812.ch65
|
| 816 |
A. C. A. CULASSO, N. ALOISI, M. CANDELA, R. H. CAMPOS, P. BARÉ. Intrafamilial transmission of hepatitis C virus in patients with severe haemophilia A. Haemophilia 2012; 18(5) doi: 10.1111/j.1365-2516.2012.02792.x
|
| 817 |
Abdullah A. Mobarki, Maymoon M. Madkhali, Gasim Dobie, Muhammad Saboor, Aymen M. Madkhali, Basem Madkhli, Yahia Hummadi, Abdullah Meshi, Hesham M. Al-Mekhlafi, Mohammad S. Akhter, Hassan A. Hamali. Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region. Journal of Epidemiology and Global Health 2022; 12(3) doi: 10.1007/s44197-022-00051-7
|
| 818 |
Doa’a A. Saleh, Fatma M. Shebl, Samer S. El-Kamary, Laurence S. Magder, Alif Allam, Mohamed Abdel-Hamid, Nabiel Mikhail, Mohamed Hashem, Soraya Sharaf, Sonia K. Stoszek, G. Thomas Strickland. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010; 104(5) doi: 10.1016/j.trstmh.2010.01.009
|
| 819 |
Pierre Van Damme, Tinne Lernout, Koen Van Herck, Rui T. Marinho, Raymundo Paraná, Daniel Shouval. Oxford Textbook of Global Public Health. 2015; doi: 10.1093/med/9780199661756.003.0216
|
| 820 |
Yan Xu, Qi Zhang. Stem Cells and Cancer in Hepatology. 2018; doi: 10.1016/B978-0-12-812301-0.00015-3
|
| 821 |
Mlyashimbi Helikumi, Tinashe Victor Mupedza, Shingirai Tangakugara Murambiwa, Moster Zhangazha, Adquate Mhlanga. Modeling the Impact of Treatment Adherence on Hepatitis C Transmission Dynamics Among Intravenous Drug Users. Mathematical and Computational Applications 2026; 31(5) doi: 10.3390/mca31050176
|
| 822 |
Abdelfattah M. Attallah, Mohamed M. Omran, Wesam A. Nasif, Mohamed F. Ghaly, Abd El-Raheem R. El-Shanshoury, Mohga S. Abdalla, Hayat M. Sharada, Khaled Farid, Wageh El-Shony, El-Sayed M. Moussa, Ehab B. El-Domany, Eman Nour, Ibrahim Eldosoky. Diagnostic Performances of Hepatitis C Virus-NS4 Antigen in Patients with Different Liver Pathologies. Archives of Medical Research 2012; 43(7) doi: 10.1016/j.arcmed.2012.09.010
|
| 823 |
Ioannis Mylonas, Stefan Wirth. Infektionserkrankungen der Schwangeren und des Neugeborenen. 2013; doi: 10.1007/978-3-540-78325-1_12
|
| 824 |
Pornpun Vivithanaporn, Krista Nelles, Leah DeBlock, Stephen C. Newman, M. John Gill, Christopher Power. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. Journal of the Neurological Sciences 2012; 312(1-2) doi: 10.1016/j.jns.2011.08.025
|
| 825 |
|
| 826 |
F. Giudici, B. Bertisch, F. Negro, G. Stirnimann, B. Müllhaupt, D. Moradpour, A. Cerny, O. Keiser. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person‐centred approach. Journal of Viral Hepatitis 2016; 23(9) doi: 10.1111/jvh.12535
|
| 827 |
Hongbo Chen, Yinan Yao, Yifan Wang, Hua Zhou, Tianxiang Xu, Jing Liu, Guocheng Wang, Yongfeng Zhang, Xiang Chen, Qingwei Liu, Peng Huang, Rongbin Yu. Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection. International Journal of Environmental Research and Public Health 2016; 13(10) doi: 10.3390/ijerph13101030
|
| 828 |
Alexandre Martins Portelinha Filho, Charles Ulloffo do Nascimento, Talita Nicastro Tannouri, Charlene Troiani, Eloah Lopes Ascêncio, Renata Bonfim, Lourdes Aparecida Zampieri D'Andrea, Luiz Euribel Prestes-Carneiro. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil. Memórias do Instituto Oswaldo Cruz 2009; 104(7) doi: 10.1590/S0074-02762009000700003
|
| 829 |
F. Baghbani-arani, F. Roohvandv, M. R. Aghasadeghi, A. Eidi, S. Amini, F. Motevalli, S. M. Sadat, A. Memarnejadian, G. Khalili. Expression and characterization of Escherichia coli derived hepatitis C virus ARFP/F protein. Molecular Biology 2012; 46(2) doi: 10.1134/S0026893312020033
|
| 830 |
Marie-Claire Kleinegris, Ger H. Koek, Kelly Mast, Eveline H.C. Mestrom, Jef L.N. Wolfs, Edouard M. Bevers. Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity. European Journal of Pharmacology 2012; 693(1-3) doi: 10.1016/j.ejphar.2012.07.041
|
| 831 |
Mohammad Kargar, Ahzam Askari, Abbas Doosti, Sadegh Ghorbani-Dalini. Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis C virus. Indian Journal of Virology 2012; 23(1) doi: 10.1007/s13337-012-0067-2
|
| 832 |
Wanting Cheng, Ya Yang, Yibiao Zhou, Penglei Xiao, Yan Shi, Jianchuan Gao, Yue Chen, Song Liang, Wuli Yihuo, Xiuxia Song, Qingwu Jiang. Prevalence of hepatitis C virus infection and its correlates in a rural area of southwestern China: a community-based cross-sectional study. BMJ Open 2017; 7(8) doi: 10.1136/bmjopen-2016-015717
|
| 833 |
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients. Nefrología (English Edition) 2017; 37(2) doi: 10.1016/j.nefroe.2017.04.010
|
| 834 |
Victoria L Demetriou, Leondios G Kostrikis. Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Research Notes 2011; 4(1) doi: 10.1186/1756-0500-4-468
|
| 835 |
Freke Zuure, Susan Hahné, Thijs van de Laar, Maria Prins, Jim van Steenbergen. Modern Infectious Disease Epidemiology. Statistics for Biology and Health 2009; doi: 10.1007/978-0-387-93835-6_19
|
| 836 |
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapy. World Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
|
| 837 |
Kulanthaivel Langeswaran, Subbaraj Gowtham Kumar, Srinivasan Perumal, Rajendran Revathy, Maruthaiveeran Periyasamy Balasubramaniam. Limonin – A citrus limonoid, establish anticancer potential by stabilizing lipid peroxidation and antioxidant status against N-nitrosodiethylamine induced experimental hepatocellular carcinoma. Biomedicine & Preventive Nutrition 2013; 3(2) doi: 10.1016/j.bionut.2013.03.006
|
| 838 |
Xhevat Jakupi, Maja M. Lunar, Jana Mlakar, Ivana Matković, Norma P. Tavakoli, Beti Zafirova Ivanovska, Adriana Vince, Mario Poljak. HCV Infection among Injecting Drug Users in Prishtina, Kosovo. Hepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.80189
|
| 839 |
Francisco M. Averhoff, Nancy Glass, Deborah Holtzman. Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States. Clinical Infectious Diseases 2012; 55(suppl_1) doi: 10.1093/cid/cis361
|
| 840 |
Shakti Singh, Satish Vedi, Subodh Kumar Samrat, Wen Li, Rakesh Kumar, Babita Agrawal, Clive M. Gray. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines. PLOS ONE 2016; 11(1) doi: 10.1371/journal.pone.0146404
|
| 841 |
Paulina Mertowska, Konrad Smolak, Sebastian Mertowski, Ewelina Grywalska. Immunomodulatory Role of Interferons in Viral and Bacterial Infections. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210115
|
| 842 |
Birke Bartosch. Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolism. Journal of Hepatology 2009; 50(5) doi: 10.1016/j.jhep.2009.02.009
|
| 843 |
M. Estée Török. Manson's Tropical Infectious Diseases. 2014; doi: 10.1016/B978-0-7020-5101-2.00014-5
|
| 844 |
David Campo, Zoya Dimitrova, Yuri Khudyakov. Bioinformatics Research and Applications. Lecture Notes in Computer Science 2008; 4983 doi: 10.1007/978-3-540-79450-9_14
|
| 845 |
Hana Arshad, Subha Malik. Exploring Perception of Chronic Hepatitis C: An Idiographic Case Study. Pakistan Journal of Psychological Research 2020; 34(4) doi: 10.33824/PJPR.2019.34.4.40
|
| 846 |
Jade D Jamias, Dulcinea A Balce-Santos, Joseph C Bocobo, Madalinee Eternity D Labio, Ma. Antoinette DC Lontok, Therese C Macatula, Janus P Ong, Arlinkinging K Ong-Go, Stephen Wong, Ira I Yu, Diana A Payawal. The 2014 Hepatology Society of the Philippines Consensus Statements on the Diagnosis and Treatment of Hepatitis C. Philippine Journal of Internal Medicine 2015; 53(1) doi: 10.65564/pjim.199238be27
|
| 847 |
Philippe A. Gallay. Cyclophilin Inhibitors. Clinics in Liver Disease 2009; 13(3) doi: 10.1016/j.cld.2009.05.002
|
| 848 |
Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis, Stephen J. Polyak. Multiple Effects of Silymarin on the Hepatitis C Virus Lifecycle. Hepatology 2010; 51(6) doi: 10.1002/hep.23587
|
| 849 |
A. L. Baron, A. Schoeniger, P. Becher, C. Baechlein, J.-H. James Ou. Mutational Analysis of the Bovine Hepacivirus Internal Ribosome Entry Site. Journal of Virology 2018; 92(15) doi: 10.1128/JVI.01974-17
|
| 850 |
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Seyed Hossein Aalaei-Andabili, Ali Pouryasin, Nasser Ebrahimi Daryani, Mohsen Nassiri Toosi, Reza Malekzadeh, Mohammad Reza Zali, Mino Mohraz. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran. Hepatitis Monthly 2011; 11(9) doi: 10.5812/kowsar.1735143X.501
|
| 851 |
Samar K. Darweesh, Ayman Yosry, Mohammed Salah, Naglaa Zayed, Ahmad Khairy, Abubakr Awad, Mahasen Mabrouk, Ahmed Albuhairi. Acoustic radiation forced impulse-based splenic prediction model using data mining for the noninvasive prediction of esophageal varices in hepatitis C virus advanced fibrosis. European Journal of Gastroenterology & Hepatology 2019; 31(12) doi: 10.1097/MEG.0000000000001458
|
| 852 |
Javeria Rafique Rao, Shazia Rafique, Amjad Ali, Gouhar Rehman, Muhammad Ilyas, Muhammad Idrees. Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan. Archives of Virology 2021; 166(11) doi: 10.1007/s00705-021-05203-x
|
| 853 |
Hiam Chemaitelly, Sarwat Mahmud, Ghina R. Mumtaz, Lenka Benova, Houssein H. Ayoub, Silva P. Kouyoumjian, Zaina Al-Kanaani, Laith J. Abu-Raddad. Handbook of Healthcare in the Arab World. 2019; doi: 10.1007/978-3-319-74365-3_138-1
|
| 854 |
Alireza Akbarzadeh Baghban, Asma Pourhoseingholi, Farid Zayeri, Ali Akbar Jafari, Seyed Moayed Alavian. Application of Zero-Inflated Poisson Mixed Models in Prognostic Factors of Hepatitis C. BioMed Research International 2013; 2013 doi: 10.1155/2013/403151
|
| 855 |
Keith A. Berggren, Saori Suzuki, Alexander Ploss. Animal Models Used in Hepatitis C Virus Research. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21113869
|
| 856 |
Krisztina Hagymási, János Fehér. The effect of body weight reduction on the effectivity of combined peginterferon and ribavirin treatment in chronic HCV hepatitis. Orvosi Hetilap 2008; 149(46) doi: 10.1556/oh.2008.28493
|
| 857 |
Rubenilson Caldas Valois, Luciana Maria Cunha Maradei-Pereira, José Ângelo Barletta Crescente, Aldemir Branco de Oliveira-Filho, José Alexandre Rodrigues Lemos. HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZON. Revista do Instituto de Medicina Tropical de São Paulo 2014; 56(6) doi: 10.1590/S0036-46652014000600010
|
| 858 |
Hamza Irshad, Fatima Aziza, Anees Rahman. Prevalence of Hepatitis B and C Infection in Tehsil Fort Abbas, Pakistan. International Journal of Infection 2022; 9(2) doi: 10.5812/iji.103267
|
| 859 |
Louise Geddes, Jenny Iversen, Handan Wand, Aryan Esmaeili, Judith Tsui, Margaret Hellard, Gregory Dore, Jason Grebely, Paul Dietze, Julie Bruneau, Maria Prins, Megan D Morris, Naglaa H Shoukry, Andrew R Lloyd, Arthur Y Kim, Georg Lauer, Andrea L Cox, Kimberly Page, Lisa Maher. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clinical Infectious Diseases 2020; 70(1) doi: 10.1093/cid/ciz162
|
| 860 |
Mohamed El-Mesery, Mohammed El-Mowafy, Abdelaziz Elgaml, Laila F. Youssef, Sally Y. Abed. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients. Journal of Interferon & Cytokine Research 2017; 37(8) doi: 10.1089/jir.2016.0128
|
| 861 |
F DeWolfe Miller, Mahmoud S Elzalabany, Sara Hassani, Diego F Cuadros. Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation. World Journal of Hepatology 2015; 7(28): 2849-2858 doi: 10.4254/wjh.v7.i28.2849
|
| 862 |
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiology of hepatitis C virus infection. Revista da Associação Médica Brasileira (English Edition) 2011; 57(1) doi: 10.1016/S2255-4823(11)70024-8
|
| 863 |
Irshad ur Rehman, Gilberto Vaughan, Michael A. Purdy, Guo-liang Xia, Joseph C. Forbi, Livia Maria Gonçalves Rossi, Sadia Butt, Muhammad Idrees, Yury E. Khudyakov. Genetic history of hepatitis C virus in Pakistan. Infection, Genetics and Evolution 2014; 27 doi: 10.1016/j.meegid.2014.08.005
|
| 864 |
Leila MMB Pereira, Celina MT Martelli, Regina C Moreira, Edgar Merchan-Hamman, Airton T Stein, Regina Maria A Cardoso, Gerusa M Figueiredo, Ulisses R Montarroyos, Cynthia Braga, Marília D Turchi, Gabriela Coral, Deborah Crespo, Maria Luiza C Lima, Luis Claudio A Alencar, Marcelo Costa, Alex A dos Santos, Ricardo AA Ximenes. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-60
|
| 865 |
Marina Matas, Antònia Picornell, Carmen Cifuentes, Antoni Payeras, Antoni Bassa, Francesc Homar, F. Xavier López-Labrador, Andrés Moya, Maria M. Ramon, José A. Castro. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients. Infection, Genetics and Evolution 2010; 10(8) doi: 10.1016/j.meegid.2010.08.009
|
| 866 |
XIAO-RONG MAO, LI-TING ZHANG, HONG CHEN, PING XIAO, YOU-CHENG ZHANG. Correlation between the genetic variations in interleukin 28B and chronic hepatitis C virus genotypes in the Chinese population. Molecular Medicine Reports 2014; 10(2) doi: 10.3892/mmr.2014.2242
|
| 867 |
Gamal Badr, Nathalie Bédard, Mohamed S. Abdel-Hakeem, Lydie Trautmann, Bernard Willems, Jean-Pierre Villeneuve, Elias K. Haddad, Rafick P. Sékaly, Julie Bruneau, Naglaa H. Shoukry.
Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8
+
Memory T Cells
. Journal of Virology 2008; 82(20) doi: 10.1128/JVI.01083-08
|
| 868 |
|
| 869 |
Juliane Liese, Behnaz Ahangarian Abhari, Simone Fulda. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells. Cancer Letters 2015; 365(1) doi: 10.1016/j.canlet.2015.04.018
|
| 870 |
Rabiei Maryam, Mansour‐Ghanaei Fariborz, Massoudi R. Hosein, Golshekan Hadi. Oral conditions in hepatitis C virus‐infected Iranian patients: a case‐control study. Journal of Investigative and Clinical Dentistry 2012; 3(3) doi: 10.1111/j.2041-1626.2012.00121.x
|
| 871 |
Sara Ashtari, Mohsen Vahedi, Mohammad Amin Pourhoseingholi, Maryam Karkhane, Zahra Kimiia, Asma Pourhoseingholi, Azadeh Safaee, Bijan Moghimi-Dehkordi, Mohammad Reza Zali, Seyed Moayed Alavian. Direct Medical Care Costs Associated With Patients Diagnosed With Chronic HCV. Hepatitis Monthly 2013; 13(4) doi: 10.5812/hepatmon.8415
|
| 872 |
Daniel Fuster, David Nunes, Debbie M. Cheng, Richard Saitz, Jeffrey H. Samet. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses 2021; 13(5) doi: 10.3390/v13050716
|
| 873 |
Vadim Brjalin, Riina Salupere, Tatjana Tallo, Tatiana Kuznetsova, Ljudmilla Priimägi, Valentina Tefanova. Efficacy of Peginterferon alfa-2a and Ribavirin Combination Therapy in Treatment-naive Estonian Patients with Chronic Hepatitis C. Central European Journal of Public Health 2012; 20(2) doi: 10.21101/cejph.a3706
|
| 874 |
Malik Muhammad Sohail. Belief in God’s Help During Hepatitis C: A Qualitative Study on Muslim Patients in Pakistan. Journal of Religion and Health 2020; 59(2) doi: 10.1007/s10943-018-0700-5
|
| 875 |
Fei Zhao, Jin Zhao, Lei Song, Ya-Qing Zhang, Zhong Guo, Ke-Hu Yang. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa
. Apoptosis 2017; 22(11) doi: 10.1007/s10495-017-1421-z
|
| 876 |
Marco Pompei, Maria Emilia Di Francesco, Silvia Pesci, Uwe Koch, Sue Ellen Vignetti, Maria Veneziano, Paola Pace, Vincenzo Summa. Novel P2–P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy. Bioorganic & Medicinal Chemistry Letters 2010; 20(1) doi: 10.1016/j.bmcl.2009.11.005
|
| 877 |
Sibasish Manna, Koushik Das, Sougata Santra, Emily V. Nosova, Grigory V. Zyryanov, Sandipan Halder. Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities. Viruses 2023; 15(9) doi: 10.3390/v15091826
|
| 878 |
Fu-Hsiung Su, Chyi-Huey Bai, Thi Nga Le, Chih-Hsin Muo, Shih-Ni Chang, Arlene Te, Fung-Chang Sung, Chih-Ching Yeh. Patients With Chronic Hepatitis C Virus Infection Are at an Increased Risk of Colorectal Cancer: A Nationwide Population-Based Case-Control Study in Taiwan. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.561420
|
| 879 |
Jorge T. Insua. Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: Yes. Current Hepatitis Reports 2013; 12(4) doi: 10.1007/s11901-013-0188-0
|
| 880 |
Takeshi SAITO, Michael Gale Jr.. RIG-I mediated hepatic innate immune signaling that controls HCV infection.. Uirusu 2008; 58(2) doi: 10.2222/jsv.58.105
|
| 881 |
Rajesh Shah. Hepatitis C Nosode: The preparation and homeopathic pathogenetic trial. Homeopathy 2013; 102(3) doi: 10.1016/j.homp.2013.02.002
|
| 882 |
Jean-François Gélinas, Thomas Fabre, Philippe Willems, Reynold C. Leung, Jacob George, Bernard Willems, Julie Bruneau, Naglaa H. Shoukry. IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test. Immunogenetics 2013; 65(6) doi: 10.1007/s00251-013-0688-7
|
| 883 |
Silvia Martina Ferrari, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga. Environmental Issues in Thyroid Diseases. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00050
|
| 884 |
Jyoti Barokar, Allen McCutchan, Reena Deutsch, Bin Tang, Mariana Cherner, Ajay R. Bharti. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction. Journal of NeuroVirology 2019; 25(6) doi: 10.1007/s13365-019-00767-6
|
| 885 |
Paul Y. Kwo, Maaz B. Badshah. New hepatitis C virus therapies. Current Opinion in Organ Transplantation 2015; 20(3) doi: 10.1097/MOT.0000000000000198
|
| 886 |
Tim J Benstead, Colin H Chalk, Natalie E Parks. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection. Cochrane Database of Systematic Reviews 2014; 2014(12) doi: 10.1002/14651858.CD010404.pub2
|
| 887 |
Ndiémé Ndongo-Thiam, Pascale Berthillon, Elisabeth Errazuriz, Isabelle Bordes, Sylvie De Sequeira, Christian Trépo, Marie-Anne Petit. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology 2011; 54(2) doi: 10.1002/hep.24386
|
| 888 |
Katherine J. Hahn, Anita Kohli, Zayani Sims, Shyamasundaran Kottilil. Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment. Open Forum Infectious Diseases 2015; 2(3) doi: 10.1093/ofid/ofv091
|
| 889 |
. 2018; doi: 10.70675/f7adebd1z4d68z4e22zbba9z0a29d133bf75
|
| 890 |
Ozlen Atug, Hakan Akin, Yesim Ozen Alahdab, Berrin Ceyhan, Nurdan Tozun, Osman Ozdogan. Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report. Cases Journal 2009; 2(1) doi: 10.1186/1757-1626-2-6464
|
| 891 |
G. Mousseau, S. Kota, V. Takahashi, D. N. Frick, A. D. Strosberg. Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. Journal of General Virology 2011; 92(1) doi: 10.1099/vir.0.023325-0
|
| 892 |
Limin Chen, Shilin Li, Yujia Li, Xiaoqiong Duan, Bing Liu, Ian McGilvray. Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy. Expert Review of Proteomics 2013; 10(3) doi: 10.1586/epr.13.15
|
| 893 |
Emilie Crouchet, Mathieu Lefèvre, Eloi R Verrier, Marine A Oudot, Thomas F Baumert, Catherine Schuster. Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux. Gut 2017; 66(5) doi: 10.1136/gutjnl-2015-311289
|
| 894 |
Yasunori Yamaguchi, Akihiro Tamori, Yasuhito Tanaka, Shuji Iwai, Sawako Kobayashi, Hideki Fujii, Hiroyasu Morikawa, Atsushi Hagihara, Masaru Enomoto, Norifumi Kawada. Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2. Hepatology Research 2012; 42(6) doi: 10.1111/j.1872-034X.2011.00956.x
|
| 895 |
Habeeb Salameh, Maen Masadeh, Muhannad Al Hanayneh, Vincent Petros, Matthew Maslonka, Arjun Nanda, Ashwani K Singal. <i>PNPLA3</i> polymorphism increases risk for and severity of chronic hepatitis C liver disease. World Journal of Hepatology 2016; 8(35): 1584-1592 doi: 10.4254/wjh.v8.i35.1584
|
| 896 |
Joachim Lupberger, Nicolaas Van Renne, Thomas F. Baumert. Signaling Pathways in Liver Diseases. 2015; doi: 10.1002/9781118663387.ch34
|
| 897 |
Annunziata Faustini, Paola Colais, Emanuele Fabrizi, Anna Maria Bargagli, Marina Davoli, Domenico Di Lallo, Anteo Di Napoli, Patrizio Pezzotti, Chiara Sorge, Rita Grillo, Carla Maresca, Olga Recchia, Carlo A Perucci. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-97
|
| 898 |
Satarupa Sengupta, Eleanor Powell, Ling Kong, Jason T. Blackard, Gulam Waris. Effects of HCV on Basal and Tat-Induced HIV LTR Activation. PLoS ONE 2013; 8(6) doi: 10.1371/journal.pone.0064956
|
| 899 |
Tatiana Martins, Danubia Felippe Grassi de Paula Machado, Fabiana Schuelter-Trevisol, Daisson Jose Trevisol, Roger Augusto Vieira e Silva, Janaina Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Prevalence and factors associated with HCV infection among elderly individuals in a southern Brazilian city. Revista da Sociedade Brasileira de Medicina Tropical 2013; 46(3) doi: 10.1590/0037-8682-0026-2013
|
| 900 |
Ivo Ditah, Fausta Ditah, Pardha Devaki, Oforbuike Ewelukwa, Chobufo Ditah, Basile Njei, Henry N. Luma, Michael Charlton. The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010. Journal of Hepatology 2014; 60(4) doi: 10.1016/j.jhep.2013.11.014
|
| 901 |
Samia Afzal, Muhammad Idrees, Mazhar Hussain.
De Novo modeling of Envelope 2 protein of HCV isolated from Pakistani patient and epitopes prediction for vaccine development. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-115
|
| 902 |
Giuseppe Indolfi, Elisa Bartolini, Chiara Azzari, Laura Becciolini, Maria Moriondo, Maurizio de Martino, Massimo Resti. Intrafamilial transmission of hepatitis C virus: Infection of the father predicts the risk of perinatal transmission. Journal of Medical Virology 2008; 80(11) doi: 10.1002/jmv.21316
|
| 903 |
Leila Sawada, Andréia Cristina Costa Pinheiro, Daiane Locks, Adriana do Socorro Coelho Pimenta, Priscila Rocha Rezende, Deborah Maia Crespo, José Ângelo Barletta Crescente, José Alexandre Rodrigues de Lemos, Aldemir Branco de Oliveira Filho. Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Revista da Sociedade Brasileira de Medicina Tropical 2011; 44(1) doi: 10.1590/S0037-86822011000100003
|
| 904 |
Fangfang Chen, Dingyong Sun, Yuming Guo, Wei Guo, Zhengwei Ding, Peilong Li, Jie Li, Lin Ge, Ning Li, Dongmin Li, Zhe Wang, Lu Wang, Ravi Jhaveri. Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005–2012. PLOS ONE 2015; 10(6) doi: 10.1371/journal.pone.0129746
|
| 905 |
Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3148-z
|
| 906 |
Sedigheh Amini Kafi‐abad, Houri Rezvan, Hassan Abolghasemi, Ali Talebian. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49(10) doi: 10.1111/j.1537-2995.2009.02245.x
|
| 907 |
Norio Akuta, Joji Toyota, Yoshiyasu Karino, Fusao Ikeda, Akio Ido, Katsuaki Tanaka, Koichi Takaguchi, Atsushi Naganuma, Eiichi Tomita, Kazuaki Chayama, Shigetoshi Fujiyama, Yukiko Inada, Hitoshi Yoshiji, Hideaki Watanabe, Hiroki Ishikawa, Fiona McPhee, Stephanie Noviello, Hiromitsu Kumada. Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection. Journal of Gastroenterology 2018; 53(9) doi: 10.1007/s00535-018-1445-3
|
| 908 |
L. C. Mendes, P. A. Ferreira, N. Miotto, L. Zanaga, E. S. L. Gonçales, M. N. Pedro, M. S. Lazarini, F. L. G. Júnior, R. S. B. Stucchi, A. G. Vigani. Elastogram quality assessment score in vibration‐controlled transient elastography: Diagnostic performance compared to digital morphometric analysis of liver biopsy in chronic hepatitis C. Journal of Viral Hepatitis 2018; 25(4) doi: 10.1111/jvh.12822
|
| 909 |
Udayan Chatterji, Jose A. Garcia-Rivera, James Baugh, Katarzyna Gawlik, Kelly A. Wong, Weidong Zhong, Clifford A. Brass, Nikolai V. Naoumov, Philippe A. Gallay. The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-Resistance. Antimicrobial Agents and Chemotherapy 2014; 58(6) doi: 10.1128/AAC.00016-14
|
| 910 |
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in Egypt. Diagnostic Microbiology and Infectious Disease 2018; 92(2) doi: 10.1016/j.diagmicrobio.2018.05.013
|
| 911 |
George Boon-Bee Goh, Wan-Cheng Chow, Renwei Wang, Jian-Min Yuan, Woon-Puay Koh. Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study. Hepatology 2014; 60(2) doi: 10.1002/hep.27054
|
| 912 |
Yasmine S El Abd, Ashraf A Tabll, Noha G Bader El Din, Alaa El-Dien S Hosny, Rehab I Moustafa, Reem El-Shenawy, Khaled Atef, Mostafa K El-Awady. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-391
|
| 913 |
Francisca Monsalve-Castillo, Liliana Gómez-Gamboa, Leonor Chacín-Bonilla, Leticia Porto-Espinoza, Luciana Costa-León. Hepatitis C virus infection in hemodialysis patients in Maracaibo, Venezuela. Revista do Instituto de Medicina Tropical de São Paulo 2012; 54(1) doi: 10.1590/S0036-46652012000100010
|
| 914 |
Myron John Tong, Patrick Weijen Chang, Thatcher Thi Huynh, Alexander Anthony Rosinski, Lori Terese Tong. Adverse events associated with ribavirin in sofosbuvir‐based therapies for patients with chronic hepatitis C: A community practice experience. Journal of Digestive Diseases 2016; 17(2) doi: 10.1111/1751-2980.12313
|
| 915 |
Liesl M. Hagan, Raymond F. Schinazi. Best strategies for globalHCVeradication. Liver International 2013; 33(s1) doi: 10.1111/liv.12063
|
| 916 |
Lorenza Di Marco, Simona Cannova, Emanuele Ferrigno, Giuseppe Landro, Rosario Nonni, Claudia La Mantia, Fabio Cartabellotta, Vincenza Calvaruso, Vito Di Marco. A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). Viruses 2025; 17(2) doi: 10.3390/v17020163
|
| 917 |
Tanaji T. Talele, Payal Arora, Shridhar S. Kulkarni, Maulik R. Patel, Satyakam Singh, Maksim Chudayeu, Neerja Kaushik-Basu. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry 2010; 18(13) doi: 10.1016/j.bmc.2010.05.030
|
| 918 |
Stephanie Jiménez Irausquin, Austin L. Hughes. Distinctive pattern of sequence polymorphism in the NS3 protein of hepatitis C virus type 1b reflects conflicting evolutionary pressures. Journal of General Virology 2008; 89(8) doi: 10.1099/vir.0.2008/000992-0
|
| 919 |
Ali Hamza, Iftikhar Ahmad, Muhammad Uneeb. Fuzzy logic and Lyapunov‐based non‐linear controllers for HCV infection. IET Systems Biology 2021; 15(2) doi: 10.1049/syb2.12014
|
| 920 |
Tarique Sarwar, Ahmad Almatroudi, Saleh A. Almatroodi, Hajed Obaid A. Alharbi, Arshad Husain Rahmani.
In silico
analysis of bioactive compounds of Nigella sativa as potential inhibitors of NS5B RdRp protein involved in the pathogenesis of hepatitis C virus
. Journal of Biomolecular Structure and Dynamics 2026; 44(1) doi: 10.1080/07391102.2025.2515254
|
| 921 |
E. G. GIANNINI, M. BASSO, V. SAVARINO, A. PICCIOTTO. Sustained virological response to pegylated interferon and ribavirin is maintained during long‐term follow‐up of chronic hepatitis C patients. Alimentary Pharmacology & Therapeutics 2010; 31(4) doi: 10.1111/j.1365-2036.2009.04201.x
|
| 922 |
Jesmin Mondal, Jayeeta Das, Rajesh Shah, Anisur Rahman Khuda-Bukhsh. A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway. Journal of Integrative Medicine 2016; 14(3) doi: 10.1016/S2095-4964(16)60251-0
|